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ABSTRACT
The low efficiency of the nuclear transfer (NT) procedure requires large number of
oocytes to produce embryos and live offspring. A series of experiments were conducted to
evaluate the ability of the bovine cytoplast to reprogram nuclei from horses and llamas. In a
preliminary study, equine oocytes from small (<20mm diameter) follicles were either
pretreated with roscovitine or placed in maturation (IVM only) prior to NT. Roscovitine
pretreatment did not improve nuclear maturation rates (roscovitine pretreatment 57% vs. IVM
only 66%) and no fusion was obtained from roscovitine-pretreated oocytes after NT. Another
preliminary study was conducted with the objective to produce llama NT embryos and to
compare their development in two in vitro culture conditions (G1.2® vs. CR1aa). No
difference was found in the number of embryos cleaved after 2 d of culture. This resulted in
the first scientific report of somatic cell NT, in vitro culture and transfer of NT embryos in the
llama. In the next experiment, adult horse and llama fibroblasts were injected into enucleated
cow oocytes. The results showed the cow cytoplasm is capable of partially reprogramming
nuclei from other species and support a few mitotic divisions. However, this study also
showed a consistent embryonic developmental arrest at the 8- to 16- cell stage when horse or
llama donor cells were used as donor nuclei. When a more closely related species of donor
cell (banteng) and recipient oocyte (domestic cattle) were used for NT, no embryonic
developmental arrest was found. Embryos progressed to achieve high blastocyst rates
(banteng male cell line 28% vs. banteng female cell line 15%). Two banteng interspecies NT
pregnancies were established and subsequently lost from the banteng male cell line. In the
final study, the effect of a mixed mitochondrial population (heteroplasmy) on early embryonic

x

development was investigated. Ooplasmic transfer performed in combination with NT
procedure indicated presence of foreign mitochondria clustered in a small portion of the
cytoplasm in early stages of embryo development. When goat ooplasm was transferred into
interspecies (cow oocyte-goat donor cell) NT embryos, fusion and cleave rates were reduced
suggesting an increased level of heteroplasmy or nuclear-ooplasmic incompatibilities.

xi

CHAPTER I
INTRODUCTION
In 1914, Hans Spemann demonstrated that salamanders had pluripotent nuclei up to the
16-cell stage (Spemann, 1938). In this classic study, the author utilized a hair from his son to
constrict a newly fertilized salamander zygote, isolating the nucleus on one side. It was observed
that the nucleated side cleaved and developed to the 16-cell stage, at which time the hair was
loosened to allow one of the nuclei to pass through the constriction and into the nonnucleated
portion. The ligature was then completely tightened, cutting the embryo in half. Cell division
occurred in the newly nucleated portion of the cytoplasm, eventually resulting in twin larvae
(Spemann, 1938). Research by other groups demonstrated that nuclei from early amphibian
embryos transferred to appropriate cytoplasm were totipotent (Briggs and King, 1952; Gurdon,
1961, 1962; McKinnell, 1962). However, as researchers transferred nuclei from individuals more
advanced developmentally, the success rates decreased. Nuclei from differentiated cells of adult
frogs only supported development to tadpoles. During this time, classic research demonstrated
that sexual reproduction could be completely replaced by defining necessary conditions for
culturing somatic carrot cells (Steward et al., 1958, 1970).
These impressive results were followed by a report of a successful nuclear transfer of
embryonic nuclei in mice (Illmensee and Hoppe, 1981) by directly injecting inner cell mass
(ICM) cell nuclei into enucleated zygotes. However, these results were followed by the reports
that full development in mice was not possible after nuclear transfer (McGrath and Solter, 1983a,
1983b). Their report in 1983 described the use of the cytoskeletal inhibitor cytochalasin B (CB)
and a virus-mediated cell fusion technique that allowed efficient pronuclear transplantation and
full-term development in the mouse (McGrath and Solter, 1983a). Although pronuclear transfer
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in the mouse resulted in viable offspring the transfer of nuclei from 2-cell blastomeres into
enucleated zygotes produced very few blastocysts (13%) and no development to term (McGrath
and Solter, 1983a, 1983b). It was then concluded that the nuclei of advanced differentiated cells
were irreversibly programmed and, in a memorable line, the authors stated: “…the cloning of
mammals by nuclear transfer is biologically impossible…” Even with these discouraging results,
other groups still considered this an unanswered point. It had previously been stated that failure
to demonstrate totipotency in transplanted nuclei could be due to inadequate knowledge of the
control of gene expression and not to a permanently altered DNA structure (McKinnell, 1962).
The body of research in domestic animals has been driven by the economic value of farm
animals. The first report of mammalian embryonic nuclear transfer occurred using enucleated,
metaphase-II sheep oocytes fused with 8- or 16-cell embryonic blastomeres (Willadsen, 1981,
1986). This landmark achievement was followed by multiple efforts to clone cattle and other
species. Numerous examples of successful nuclear transfer using embryonic donor cells have
been reported for sheep (Willadsen, 1986), cows (Prather et al., 1987; Bondioli et al., 1990),
rabbits (Stice and Robl, 1988; Collas et al., 1992a), pigs (Prather et al., 1989) mice (Kono and
Tsunoda, 1989), goats (Yong and Yuqiang, 1998) and monkeys (Meng et al., 1997). Morula and
blastocyst stage donor cells were also shown to be totipotent and capable of being reprogrammed
by the cytoplasmic factors in cows (Willadsen et al., 1991) and rabbits (Yang and Anderson,
1992).
The first offspring produced by the transfer of a cultured cell line was reported in 1996
(Campbell et al., 1996b). In this study, cells were derived from the embryonic disk of an in vivo
produced day-9 sheep embryo. The cells, which remained in culture in vitro for a prolonged
period of time (6 to 13 subpassages) adopted an epithelial morphology prior to being used as
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donors for the nuclear transfer procedure. The significance of this study was threefold: (1) it
demonstrated that differentiated cells, cultured for prolonged periods of time had the ability to be
reprogrammed and originate a new individual, (2) it proved cultured cells could be induced to
enter and temporarily arrested at a so-called G0 or quiescent state and (3) it led the way for the
production of Dolly, the first mammal cloned from an adult, differentiated somatic cell.
In 1997, the world was fascinated by the birth of Dolly, a sheep created not from the
fertilization of an oocyte and a sperm, but by the transfer of a nucleus from a fully differentiated
somatic cell into a mature oocyte devoid of its own nuclear DNA by the process of NT (Wilmut
et al., 1997). In their pathway to produce Dolly, Dr. Wilmut and colleagues learned to appreciate
the cleverness of DNA being able to remodel and reprogram itself, given the appropriate
conditions and timing. The announcement of the birth of a healthy animal cloned from a
differentiated adult somatic cell ignited a firestorm of public and scientific interest in the field.
This remarkable achievement led to an explosion of studies dealing with cell-cycle regulation,
sources of and techniques of establishing stem cell lines and on early embryo development.
Since Dolly, eleven other mammalian species have been cloned from differentiated somatic cells, including the cow (Cibelli et al., 1998; Kato et al., 1998), mouse (Wakayama et al.,
1998), goat (Baguisi et al., 1999), pig (Betthauser et al., 2000; Polejaeva, 2001), gaur (Lanza et
al., 2000), mouflon (Loi et al., 2001), rabbit (Chesné et al., 2002), domestic cat (Shin et al.,
2002), mule (Woods et al., 2003), horse (Galli et al., 2003) and rat (Zhou et al., 2003). The
development of this technology will have a significant impact in livestock breeding practices
(Wilmut et al., 2000), the biotechnology and pharmaceutical industry (Ziomek, 1998; Baguisi et
al., 1999), human medicine (Lanza et al., 1999a; Cibelli et al., 2001), the companion animal
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market (Westhusin et al., 2001; Shin et al., 2002) and the preservation of endangered species
(Lanza et al., 2000; Loi et al., 2001).
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CHAPTER II
LITERATURE REVIEW
The birth of cloned animals from adult somatic cells provided the evidence that
mammalian development has a far greater developmental plasticity than had been imagined years
ago (Wilmut et al., 1997). Somatic cell nuclear transfer (NT) cloning involves removing nuclear
DNA from a mature oocyte (enucleation) and inserting a donor cell nucleus (reconstruction)
derived from a somatic cell. The donor nucleus is then subjected to a complete “reprogramming”
by undetermined factors located inside the ooplasm, which enable the complete set of
instructions that were once turned off in the differentiated donor nucleus to become active and
commence development, not as another somatic cell, but as a 1-cell embryo (Campbell, 1999).
Nuclear transfer is a complex procedure, and each step affects the overall efficiency. The
unpredictability of the technology due to biological variation of the recipient oocytes and the
donor cells is difficult to control. Therefore, standardization of the steps is important to obtain
consistent results.

Factors Affecting Nuclear Transfer Efficiency
Enucleation and Reconstruction
The enucleation step is critical in NT. Because the chromosomes of mammalian oocytes
are indiscernible with most light microscopy techniques, the position of the chromosomes is indirectly determined by the location of the first polar body or directly observed under ultraviolet
light after staining oocytes with a DNA-specific dye (e.g., Hoechst-33342). The enucleation step
is usually accomplished by using a sharp borosilicate pipette that has been beveled and spiked to
aid in the penetration of the zona pellucida (Nour and Takahashi, 1999). An alternative method,
which was first developed in mice oocytes, is to make a cut in the zona pellucida directly above
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the first polar body and then compress the oocyte by applying pressure with a glass-cutting
needle to expel the a small portion of the ooplasm (Tsunoda et al., 1986). The expelled ooplast
remains intact, and is therefore suitable for DNA staining to confirm the removal of metaphase
spindle without subjecting the oocyte to the harmful effects of ultraviolet light. The detrimental
effects of DNA dyes and ultraviolet light exposure on oocytes and their developmental potential
have been documented in the past (Smith et al., 1993a, 1993b; Dominko et al., 2000). Although
this technique eliminates the use of ultraviolet light, it has been documented that first polar
bodies of a metaphase-II oocyte often migrate and do not always remain in proximity to the
chromosomes in the metaphase-II spindle (Bordignon and Smith, 1998; Dominko et al., 2000;
Liu et al., 2000).
These obstacles have determined the advent of alternative approaches to the enucleation
of oocytes. Pretreatment of mouse oocytes with 3% sucrose was effective in aiding the
visualization of the metaphase spindle and chromosomes with standard light microscopy (Wang
et al., 2001) and a 0.3 M sucrose treatment was found to be effective in facilitating the
localization of the bovine chromosomes (Liu et al., 2002). Because the enucleation step requires
a high degree of visual and manual control, other methods of enucleation have also been
explored. Cloned piglets were born after chemically assisted enucleation of the oocytes (Yin et
al., 2002). In this study, a brief treatment of the metaphase-II porcine oocytes in demecolcine and
sucrose resulted in a membrane protrusion that contained the condensed chromosomes, which
were easily visualized and aspirated into a pipette without the need of staining. Although the
mechanisms of action of demecolcine are not clear, the appearance of the protrusion might be
related to the condensation of maternal chromosomes (Yin et al., 2002). Recently, a handmade
somatic cell cloning was reported for cattle (Oback et al., 2003; Vajta et al., 2003). Mature,
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metaphase-II oocytes were stripped of their zonae pellucidae using 1.5 mg/ml of pronase and
manually bisected using an Ultra Sharp splitting blade (AB Technologies, Pullman, WA). The
demi-oocyes were then stained for nuclear DNA and only those without a metaphase spindle
were selected for fusion with donor somatic cells. An individual donor cell was attached to an
ooplast using phytohemagglutinin and ooplast-somatic cell pairs were fused using standard
electrofusion protocols (Vajta et al., 2003). More recently, this handmade technique (with
variations) was used by a group in Italy to produce the world’s first horse cloned by somatic cell
NT (Galli et al., 2003).
In the mouse, cow and horse, improved results have been achieved with Piezo-driven
enucleation and reconstruction (Choi et al., 2002a, 2002b; Galli et al., 2002). Because the Piezo
drill generates mechanical pulses that travel longitudinally along the microinjection pipette and
vibrate the pipette tip, drilling through the zona pellucida and the oolema are facilitated without
producing any net forward movement of the pipette. This is especially useful in species with
fragile oocytes or hard zonae pellucidae, such as the mouse and the horse (Choi et al., 2002a).
Because the pipette used for Piezo-driven injection (7 to 10 µm) is smaller than those used in
traditional NT (20 to 25 µm), it also allows for the direct injection of donor cells or nuclei into
the cytoplasm without the need for electrofusion (Wakayama et al., 1998; Lee et al., 2003).
Activation
During fertilization, the sperm entry triggers a series of intracellular short-lived calcium
oscillations critical to oocyte activation. Calcium is released in a pulsatile manner from internal
stores, including the endoplasmic reticulum and mitochondria (Yanagimachi, 1994) and this
elevation in intracellular Ca2+ can persist for several hours (Carroll and Swann, 1992; Kline and
Kline, 1992; Miyazaki et al., 1993). These calcium oscillations are responsible for the cascade of
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events that follow, including the cortical granule reaction (Miyazaki et al., 1990), zona pellucida
reaction (Yanagimachi, 1994) and the escape from the metaphase-II arrest (Whitaker and Irvine,
1984). However, this is not the case after NT, where the lack of sperm-induced fertilization steps
requires the use of artificial activation in order to trigger nuclear reprogramming and further
embryonic development (Wells et al., 1999). Different artificial protocols have been developed
to activate mammalian oocytes by simulating the biochemical and physiological events that
normally occur during sperm-oocyte interaction. Maturation promoting factor (MPF) and
mitogen-activated protein (MAP) kinase are the most likely targets of calcium-stimulated events,
because inactivation of these kinases is a prerequisite to the resumption and completion of
meiosis, subsequent pronuclear formation and DNA synthesis (Collas et al., 1993; Verlhac et al.,
1994; Moos et al., 1996).
Maturation promoting factor was first described as a complex of two subunits: a catalytic
subunit, p34cdc2 and a regulatory subunit, cyclin B. p34cdc2 is a protein kinase regulated by
changes in its phosphorylation state and by its association with cyclin. Throughout the cell cycle,
the level of p34cdc2 remains constant but the level of cyclin varies. Maturation promoting factor
peaks at metaphase in association with nuclear envelope breakdown, chromatin condensation,
reorganization of the cytoskeleton and the formation of the mitotic spindle (Doree and Galas,
1994; Moos et al., 1996). Maturation promoting factor inactivation, which is necessary for the
cell to exit the metaphase-II arrest, involves cyclin proteolysis by the proteosome system
(Glotzer et al., 1991).
In vertebrates, mature oocytes are arrested at metaphase-II of the meiotic division, with
elevated MPF activity maintained by a cytostatic factor (CSF), which prevents the ubiquitindependent degradation of cyclin B and thus, inactivation of MPF. Intracellular Ca2+ oscillations
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triggered by sperm down-regulate CSF activity and allow for the degradation of cyclin.
Proteolytic degradation of cyclin B and subsequent MPF inactivation releases oocytes from
metaphase arrest and allows the beginning or resumption of mitotic cycles (Lorca et al., 1993).
In NT procedures, enucleated oocytes fused with a diploid donor cell must be artificially
activated to continue development, since somatic cell nuclei cannot initiate activation (Campbell,
1999). Different artificial activation treatments attempt to mimic sperm-triggered events and
induce parthenogenic development in metaphase-II oocytes. Some of these treatments, such as
ethanol, electrophoration, calcium ionophore, ionomycin or inositol 1,4,5 triphosphate induce
calcium oscillations and release mitotic arrest (Presicce and Yang, 1994; Soloy et al., 1997; Liu
et al., 1998; Mitalipov et al., 1999;). However, the activity of MPF is quickly restored with
recondensation of chromosomes and re-entry of activated oocytes into a new M-phase arrest,
also known as metaphase-III.
To prevent this premature restoration of MPF activity, additional treatments that non-specifically inhibit protein synthesis such as (cycloheximide, CHX) or that inhibit protein
phosphorylation (6-dimethylaminopurine, DMAP) (Soloy et al., 1997; Liu et al., 1998) must be
used in the activation protocol. Therefore, sequential activation approaches with ionomycin/DMAP, calcium ionophore/CHX, or inositol 1,4,5-triphosphate/DMAP that result in high
activation and parthenogenic rates (Barcroft et al., 1998; Mitalipov et al., 1999) have been
reported. DMAP acts by blocking the second reduction division preventing karyokinesis of the
newly transferred diploid nucleus, thus allowing diploid development to proceed (Susko-Parrish
et al., 1994). CHX does not interfere with the spindle apparatus and results in haploid
development if cytochalasin is not added to depolymerize the actin microfilaments (Booth et al.,
2001).
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In addition, detrimental effects of these non-specific, broad spectrum protein synthesis
and/or kinase inhibitors are suspected during later embryonic development. In the cow,
developmental competence of oocytes was compromised after blocking maturation at the
germinal vesicle stage for 24 hour with CHX or DMAP (Lonergan et al., 1997). In contrast,
purine derivatives such as roscovitine, butyrolactone-I or olomoucine, which specifically inhibit
MPF and MAP kinase, have been used to delay meiotic progression of bovine oocytes without
affecting their subsequent developmental potential to the blastocyst stage (Mermillod et al.,
2000). This also suggests that these components might have a potential application not only in
oocyte maturation (nuclear and cytoplasmic) but to promote parthenogenic activation as well.
Selection of Donor Cells
Various cell types, such as embryonic cells (Campbell et al., 1993), fibroblasts (Kato et
al., 1998), mammary gland cells (Wilmut et al., 1997), cumulus granulosa cells (Wakayama et
al., 1998), oviduct cells (Kato et al., 2000), leukocytes (Galli et al., 1999), mural granulosa cells
(Wells et al., 1999), germ cells (Bordignon et al., 2003), embryonic stem cells (Eggan et al.,
2001) and liver cells (Brem and Kuhholzer, 2002a) have been used as donor cells for production
of cloned animals. However, it is still unclear which type is the most efficient for nuclear transfer
into oocytes (Kato et al., 2000). When the efficiency of various cell types from adult, newborn
and fetal male and female donor cells was compared, the percentage of blastocysts produced
from each cell type was found not to be significantly different (Kato et al., 2000). Similar results
were obtained using various cell types derived from mice of different strains, sexes and ages
(Wakayama and Yanagimachi, 2001).
Initially, all cloned animals derived from adult somatic cells were produced using cells
from the female reproductive system, such as mammary gland (Wilmut et al., 1997), oviduct
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(Kato et al., 1998), cumulus and mural granulosa cells (Wakayama et al., 1998; Wells et al.,
1999; Kato et al., 2000) raising the question of whether male individuals could be cloned.
However, male mice were cloned from tail skin cells (Wakayama and Yanagimachi, 1999) and
no significant differences were found in the developmental rates of embryos reconstituted with
male or female nuclei in cattle (Kato et al., 2000) and mice (Wakayama and Yanagimachi,
2001).
Because fetal cells are believed to have less genetic damage and more proliferative ability
(as measured by cell doublings) than adult somatic cells, they have been the cell type of choice
as nuclear donors (Hill et al., 2000a). However, this presents a limitation in that the individual
the donor cells are derived from (a fetus) has not had the chance to demonstrate its genetic merit
(an adult) prior to somatic cell nuclear transfer. No significant differences were found in bovine
embryo developmental rates to the blastocyst stage with adult, newborn, or fetal cell nuclei;
however, abortion in later stages of pregnancy were higher for cloned fetuses derived from adult
cells (Kato et al., 2000). Similarly, no differences among embryos derived from fetal and adult
bovine fibroblasts with regard to fusion, cleavage and blastocyst formation were detected
(Niemann et al., 2002). However, more fetal losses after transfer into recipients were noted with
embryos reconstructed with adult bovine donor cells (Hill et al., 2000c; Niemann et al., 2002).
Genetic damage may occur during the in vitro culture of donor cells prior to NT. Cells
cultured for prolonged periods of time are known to increase in their levels of aneuploidy over
time (Freshney, 2000). Therefore, fresh or short-term cultured (<10 subpassages) donor cells
have been the cell type of choice for the production of cloned embryos. In contrast, one study reported higher developmental rates to the blastocyst stage for embryos reconstituted with adult
somatic cells that had been subpassaged 10 to 15 times compared with that of embryos recon-
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stituted from cells with a lower number of subpassages (Kubota et al., 2000). In addition, cloned
calves were obtained from embryos reconstituted with high-subpassaged cells, with all cloned
fetuses derived from low-subpassaged donor cells aborting during pregnancy (Kubota et al.,
2000). Similar results were obtained using enhanced green fluorescent protein gene transfected
and nontransfected bovine granulosa cell donor cells where in vitro developmental rates of
cloned embryos derived from cells at passage 15 were higher that those for embryos derived
from cells at lower subpassages (Arat et al., 2001). Results within and among various research
laboratories are often conflicting due to procedural effect, oocyte variability, inherent differences
among donor cell lines, age of donor animals or to effects of in vitro culture conditions..
Stages of Donor Cell Cycle
Understanding the cell cycle synchrony requirements in an NT scenario was a major
contributing factor to the success of the first somatic cell NT (Campbell et al., 1996b). Studies
aimed at understanding the regulation of the cell cycle indicated that the use of G0 cells could be
beneficial for the success of NT procedures (Wilmut et al., 1997). In the scientific literature, G0
and G1 cells are often grouped together as G0/G1, although these phases are quite distinct. G0
cells exit the normal cell division cycle and enter a quiescent state, whereas, G1 is a transient
stage between M-phase and S-phase in proliferating cells. Currently, there is no clear molecular
correlation between cell quiescence and defined differences in chromatin structure. In addition,
using the terms ‘serum-starved’ and ‘quiescent’ interchangeably should be avoided when
referring to in vitro cell cultures for nuclear transfer, as quiescence is a state that cells can enter
spontaneously while serum-starvation can cause a state of stress with potentially more profound
implications within the cells (Wells et al., 2003).
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Quiescent cells presumably arrested in G0 phase of the cell cycle have commonly been
used to produce cloned animals (Campbell et al., 1996b; Wilmut et al., 1997; Baguisi et al.,
1999; Kues et al., 2000; Reggio et al., 2001; Gibbons et al., 2002; Wells et al., 2003; Yu et al.,
2003) and the specific method used to arrest donor cells can markedly affect fetal survival to
term and neonatal survival (Gibbons et al., 2002). However, proliferating cells have also been
successfully used for NT (Cibelli et al., 1998), although the exact stage of the donor cell cycle
was never verified. Thus far, only statistical probabilities on cell stage percentages in G0/G1, G2,
M and S-phases have been provided as evidence of the cell cycle stage (Boquest et al., 1999).
Most oocytes from amphibians and mammals become developmentally arrested at the
germinal vesicle stage in prophase of the first meiotic division. After an appropriate stimulation,
meiosis resumes, the germinal vesicle breaks down, the first meiotic division is completed and
the oocyte becomes arrested at metaphase of the second meiotic division. During the fertilization
process, the second meiotic division is completed and the second polar body is extruded. This is
followed by male and female chromatin decondensation and pronuclei formation. After DNA
replication, equal segregation of the genetic material occurs by mitosis and the zygote cleaves to
form two daughter blastomeres (Campbell et al., 1996a).
Maturation/meiosis/mitosis-promoting factor (MPF) is of critical importance during
activation (Masui and Markert, 1971). MPF has been identified as a complex of two proteins,
cyclin and p34cdc2, a protein kinase regulated by changes in its phosphorylation state and by its
association with cyclins (Nurse, 1990). Throughout the cell division cycle, the concentration of
p34cdc2 remains constant, whereas, the concentration of cyclin varies (Masui, 1992). The
activation of p34cdc2 kinase triggers entry of the cell into mitosis or meiosis and results in
breakdown of the nuclear envelope, chromosome condensation, reorganization of the cy-
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toskeleton and changes in cell morphology (Nurse, 1990). MPF activity during oocyte
maturation is maximal in metaphase of both first and second meiotic divisions. When the oocyte
becomes arrested at metaphase-II, MPF activity remains high, then following fertilization or
chemical activation, MPF activity rapidly declines.
During the cell cycle, chromosomal DNA is replicated only once. The mechanisms by
which a cell coordinates this event and prevents re-replication still remain unclear, although
maintenance of an intact nuclear envelope appears to be of utmost importance (Blow and
Laskey, 1988). The development of reconstructed embryos following nuclear transfer appears to
be dependent upon a variety of factors and cell cycle synchrony appears to be a critical aspect.
The donor nucleus must be in G1 or G0 when transferred to fresh oocytes with high levels of
MPF to condense normally and maintain correct ploidy of subsequent embryos at the end of the
first cell cycle (Campbell et al., 1996a). The high levels of MPF in the mature, metaphase-II
oocyte cause nuclear envelope breakdown (NEBD) and chromosome condensation of the
transferred nucleus, irrespective of the cell cycle stage of the donor cell. Subsequently, the
exposure of the chromosomes to the licensing factors in the oocyte cytoplasm leads to the
replication of DNA following the decay of MPF activity and the reformation of the nuclear
membrane (Campbell et al., 1996a, 1993; Dinnyés et al., 2002).
Primarily, two types of cytoplasts have been used as hosts for NT: (1) the enucleated and
activated metaphase-II cytoplast (low MPF) and (2) the enucleated but not activated cytoplast
(high MPF) (Campbell et al., 1996a; Dinnyés et al., 2002). When nuclei are transplanted to
metaphase-II arrested cytoplasts, high levels of MPF lead to premature chromatin condensation
(PCC) and NEBD. In contrast, when nuclei are transferred to previously activated cytoplasts,
NEBD and PCC do not occur because the MPF activity has already declined.
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The response of the introduced donor nuclei is quite different for these two scenarios (Dinnyés
et al., 2002). In the metaphase-II cytoplast, donor chromatin immediately condenses, in
conjunction with the breakdown of the nuclear envelope (Collas and Robl, 1991). Spindle
microtubules then form in association with condensed chromatin (Pinto-Correia et al., 1993).
When the embryo karyoplast is activated, causing a decrease in MPF, a nucleus forms and
acquires the morphology of a large pronucleus (Collas and Robl, 1991). If DNA synthesis has
commenced prior to NEBD, then DNA replication will take place, resulting in abnormal ploidy
and a defective embryo. Furthermore, the progression of DNA synthesis in the donor nucleus is
not compatible with normal chromatin condensation, which also results in a defective embryo.
Consequently, only nuclei that have not entered the S-phase (G1 or alternatively G0 nuclei)
produce normal embryos when transplanted to a non-activated cytoplast (Collas et al., 1992b).
Early studies in bovine NT embryos reconstructed by transfer into metaphase-II cytoplasts showed that all nuclei underwent NEBD and DNA synthesis after reformation of the nuclear envelope, regardless of their cell cycle stage (Campbell et al., 1993). Thus, it was
hypothesized that only G1 nuclei should be used when transferring to metaphase-II cytoplasts.
During NT procedures, all nuclei transferred into a cytoplasm with high MPF activity undergo
NEBD and chromatin condensation. As chromosome condensation is induced prematurely in the
donor nucleus, this event has been referred to as PCC. The degree of PCC appears to vary with
the MPF activity and the duration of exposure and, in addition, the cell cycle of the transferred
nucleus has profound implications on the outcome (Campbell et al., 1996a). Observations in both
somatic cell hybrids (Johnson and Rao, 1970) and NT embryos (Collas and Robl, 1991) showed
that the chromatin of S-phase nuclei induced to undergo PCC by exposure to MPF has a typical
pulverized appearance and chromosome analysis showed a high incidence of abnormalities in
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such nuclei (Collas et al., 1992a). In contrast, when G1 or G2 phases undergo PCC, the chromatin condensed to form elongated chromosomes with single-chromatids and double-stranded
chromatids, respectively (Collas et al., 1992a). In contrast, when the activated cytoplast is used,
little change is noted in the transplanted nucleus. DNA synthesis, if initiated, is completed or, if
not initiated, progresses normally. This type of recipient cytoplast is compatible with both G1 and
S-phase stages of the donor cycle (Collas et al., 1992a). Morphologically, little change is
observed in the nucleus following the transfer to activated cytoplasts. This type of cytoplast has
also been termed a ‘Universal Recipient’ (Campbell et al., 1993) and although blastocysts have
been produced, no pregnancy has developed to term suggesting incomplete or inappropriate
nuclear reprogramming (Dinnyés et al., 2002).
Cell Line Cloning Efficiency
The developmental capacity of bovine cloned embryos differs among donor cell lines,
even if they are derived from the same tissue or organ (Kato et al., 2000). Results obtained from
NT using four primary cell lines of adult bovine somatic cells indicated that the primary donor
cell culture has a significant impact on in vitro development, initial pregnancy rates and
percentage of live births (Dinnyés et al., 2002; Miyoshi et al., 2003). In addition, similar results
were obtained from pig cloning studies, in which nine different somatic cell cultures used in NT
procedures resulted in 10 initial pregnancies from four of the cell lines. However, development
past 90 days of gestation was achieved with only one cell line (Kuhholzer et al., 2001). It has
been hypothesized that the differences among cell lines for both cattle and pigs may be due to
epigenetic effects, because even within a primary cell culture, the generation of cell lines shows
that some lines are more suitable than others as nuclear donors for NT (Kuhholzer et al., 2001;
Miyoshi et al., 2003).
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Nuclear Reprogramming and Genomic Activation
Reports of successful generation of cloned animals by NT of somatic cells indicated that
somatic nuclei could reverse their developmental block to recover totipotency when introduced
into appropriate cytoplasmic environments (Kim et al., 2002). The early stages of normal
embryogenesis are regulated by maternally inherited gene products stored in the oocyte
cytoplasm. As development proceeds and maternally inherited informational molecules decay,
the process of early embryogenesis then becomes dependent on the expression of genetic
information derived from the embryonic genome. There are species-specific differences in the
developmental period at which the transition from control by maternally inherited molecules to
that of embryonic genome-derived transcription products occurs (Table 2.1). The major features
that characterize the timing of the switch from maternal to embryonic genome control include:
(1) loss or decay of mRNA molecules of maternal origin, (2) activation of transcription of the
embryonic genome, (3) developmental arrest in the presence of transcriptional inhibitors and 4)
marked qualitative changes in protein synthetic patterns. The switch is also often associated with
a so-called critical or developmental block stage during in vitro culture of preimplantation
embryos (Telford et al., 1990).
The most detailed information on embryonic genome activation has been obtained from
the mouse embryos. It the murine species, the transition period between development dependent
on maternally derived gene transcripts and the initiation of transcriptional activity by the embryonic genome occurs around the 2-cell stage (Schultz, 1986; Telford et al., 1990). It was
shown that mouse embryos cultured from the 1-cell stage in presence of transcriptional inhibitors
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Table 2.1. Summary of stage of transition from maternal to embryonic control in embryos from several mammalian species
(Telford et al., 1990)
Cell stage when characteristic feature is observed

Feature

Mouse

Rabbit

Pig

Sheep

Cow

Human

2

8-16

NRa

8-16

NR

4-8

RNA synthesis from embryonic genome is initiated

1-2

1-2

4

NR

8

4

Change in qualitative pattern of protein synthesis

1-2

2-16

NR

8-16

8-16

4-8

2

NR

4-8

8-16

8-16

4-8

Developmental arrest in α-amanitin culture

In vitro developmental culture block
a

NR: not reported
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do not develop beyond the 2-cell stage and it was shown that there is a major turnover in mRNA
during the 1-cell to 2-cell stage that involves both the degradation of preexisting maternal mRNA
and the beginning of synthesis of new mRNA from the embryonic genome (Golbus et al., 1973).
Additionally, another component that is likely associated with the maternal-embryonic
genome switch in the mouse embryo is the 2-cell in vitro block. Most random-bred strains
produce embryos that, when removed at the 1-cell stage and cultured under conventional
conditions, arrest at the G2 phase of the second cell cycle (Muggleton-Harris et al., 1982;
Goddard and Pratt, 1983; Pratt and Muggleton-Harris, 1988). The reasons for this in vitro
phenomenon are not clear. The effects of the 2-cell block have been shown to be reversible by
transfer of cytoplasm from the oocytes of nonblocking mouse strains (Muggleton-Harris et al.,
1982) and can be circumvented by improved in vitro culture conditions (Chatot et al., 1989).
Nonetheless, the in vitro block has been shown to coincide with the time of transition from
maternal to embryo genomic control. Embryos appear to be particularly sensitive to culture
conditions during this critical phase of their development (Chatot et al., 1989; Telford et al.,
1990).
In the cow and the sheep, the timing of the switch from maternal to embryo genomic
control has been reported to occur at the 8- to 16-cell stage (Camous et al., 1984), though others
have reported it to occur as early as the 8-cell stage (Kopency et al. 1989a, 1989b). When the
qualitative patterns of protein synthesis were examined at different stages of development,
marked changes were detected in 8- to 16-cell stage embryos (Frei et al., 1989). The quantitative
and qualitative changes in protein synthesis and the late onset of new RNA synthesis in bovine
embryos is consistent with the hypothesis that maternal messages are gradually degraded from
fertilization through the 8-cell stage, at which time control of transcription shifts from the
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maternal to the embryonic genome. As in mouse embryos, the shift from maternal to embryonic
control of transcription in the cow is temporally associated with the developmental block found
in cultured embryos.
Recent studies using long term exposure of 2-cell to 4-cell stage embryos to [3H] uridine
followed by autoradiography have revealed that transcriptional activity can be detected early in
the development of bovine embryos and treatment with the transcriptional inhibitor α-amanitin
blocked incorporation (Plante et al., 1994; Viuff et al., 1996; Liu and Foote, 1997; Memili et al.,
1998). In addition, bovine embryos labeled at the 2-cell stage with
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S methionine revealed

transcriptional and translational activity (Memili et al., 1998). Together, these findings suggest
that there may be a low level of transcriptional activity between the 2- and the 4-cell stage
bovine embryos.
A critical period in the culture of pig embryos, analogous to the 2-cell block in mice and
the 8- to 16-cell block in sheep and cows, has been reported to occur at the 4-cell stage (Davis,
1985), as determined by [3H] uridine incorporation and autoradiography (Kopecny et al., 1989a).
Interestingly, NT experiments have also suggested the time of in vitro arrest as a possible
indicator for the timing of maternal-embryonic transition in pig embryos (Prather et al., 1989).
The period of maternal-embryonic transition in rabbit embryos appears to be somewhat different
from other species (Telford et al., 1990). There is no measurable loss of mRNA during early
cleavage as occurs in the mouse and the developmental arrest after in vitro culture in α-aminitin
was observed at the 8- to 16-cell stage (Manes, 1973).
In the human, the difficulty of obtaining human preimplantation embryos precludes
extensive studies of the biochemical changes that occur during early development. However, one
study showed that qualitative changes in protein synthesis were detected at the 4-cell stage
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(Braude et al., 1979b) and these changes coincided with the 4-cell block observed in the presence
of α-aminitin (Braude et al., 1979a). Together, these observations suggested that the maternal
genome controls development up to the 4-cell stage, at which time expression of the embryonic
genome is necessary for further development.
For this embryonic takeover to occur in the NT scenario, the transferred nucleus must
change its gene expression pattern to that of an early embryonic nucleus. This process is
generally termed nuclear reprogramming, and is generally preceded by the altering of chromatic
configuration or chromatin remodeling. Early studies demonstrated that the metaphase-II
arrested, non-activated oocytes were more effective in supporting development of embryos
reconstructed with differentiated nuclei than activated oocytes (Kim et al., 2002). This
demonstrated that the success in chromatin remodeling, from differentiated nuclei to totipotent
ones, was dependent of the cell cycle stage of the recipient ooplasm (Campbell et al., 1993,
1996a).
With the objective of describing the molecular/biochemical nature of chromatin
remodeling, NT embryos were produced by injection of cumulus cells into either nonactivated or
activated enucleated oocytes. More than half (56.1%) of the embryos transferred to the
nonactivated cytoplasts developed to the morula or blastocyst stage, whereas, very few (1%) of
the embryos reconstructed with preactivated cytoplasts developed to advanced stages (Kim et al.,
2002). Results from this experiment indicated that the successful remodeling of somatic nuclei is
brought about by a process similar to that of normally fertilized embryos and failure of preactivated cytoplasts to remodel somatic nuclei was attributed to the inability of the ooplasmic
environment to trigger obligatory events in chromatin remodeling, such as silencing of
transcription and loosening of the chromatin structure (Kim et al., 2002).
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Epigenetic Effects
It has been estimated that 0.1 to 1% of all mammalian genes are repressed on a single
chromosome (Surani, 2001). This phenomenon, termed ‘genomic imprinting’, causes some genes
to be expressed according to their parental origin and results in a developmental asymmetry in
the function of parental genomes (Ferguson-Smith and Surani, 2001). This explains why, in
mammals, parthenogenic development to live offspring is not possible (Reik et al. 2001a,
2001b). Imprinted genes are generally implicated in the regulation of fetal growth, development
and function of the placenta, as well as, postnatal behavior (Reik and Walter, 2001). The two
parental genomes are formatted during gametogenesis to respond to the oocyte environment and
proceed during development.
The zygote biochemically remodels the paternal genome shortly after fertilization and
before embryo genomic activation through epigenetic modifications (Rideout et al., 2001). These
epigenetic modifications include DNA methylation, assembly of histones into nucleosomes and
the remodeling of chromatin-associated proteins and X-chromosome inactivation (Rideout et al.,
2001). Epigenetic changes affect the local structure, composition and remodeling of chromatin,
which in turn defines and maintains the accessibility and transcriptional competence of the
nucleosomal DNA template (Wolffe and Matzke, 1999).
DNA Methylation
DNA methylation takes place mainly on the 5’–cytosine residues at CpG dinucleotides.
Of the normal 30,000-40,000 genes in the human genome, approximately 29,000 are linked to
CpG islands (Bestor, 2000). These CpG islands are normally found unmethylated in at least four
cases: imprinted genes, X-linked genes in females, germline-specific and tissue-specific genes.
Therefore, DNA methylation plays a critical role in the determination of cell fate and cell type-
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specific gene expression (Shi et al., 2003). DNA methylation is catalyzed by enzymes of the
cytosine methyltransferases group (Dnmts). Targeted Dnmt 1 disruption in mice was shown to be
lethal in mid gestation (Li et al., 1992). Dnmt 3a and Dnmt 3b have been proposed as de novo
methyltransferases potentially involved in the set up of the initial patterns of methylation during
embryogenesis (Okano et al., 1999).
Most of the imprinted genes have differentially methylated regions. After fertilization,
differential methylation of imprinted genes needs to be maintained. However, it has been shown
that during preimplantation development there is genome-wide demethylation. The biological
reason and mechanisms for this genome-wide demethylation is still unknown, although it has
been proposed that it might prime the genome for widespread transcriptional activation (Walsh
and Bestor, 1999).
DNA methylation has been extensively described in the mouse. Two major waves of
demethylation and remethylation have been described, the first occurring in the fetus during
germ cell development and the second after fertilization during early embryonic development
(Shi et al., 2003). The paternal genome undergoes major transformations within the cytoplasm of
the oocyte during fertilization, including remodeling of sperm chromatin by replacement of
protamines with histones followed by genome-wide demethylation (Perreault, 1992). The active
demethylation of the paternal genome was shown to occur a few hours after fertilization and
before the first cell division in mice (Mayer et al., 2000; Santos et al., 2002), whereas, the
genome-wide demethylation of maternal genome occurs gradually (Rougier et al., 1998; Santos
et al., 2002). Genome-wide de novo methylation occurs at the blastocyst stage in mice,
preferentially in the inner cell mass (Dean et al., 2001). The basic events of DNA demethylation
are conserved to some extent in the rat, pig and cow (Shi et al., 2003). In the bovine
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preimplantation embryo, considerable de novo methylation has been detected from the 8- to 16cell stage (Dean et al., 2001). The process of DNA methylation has been proposed to have an
important role in imprinting, both in silencing genes like H19 (Reik and Walter, 2001b) and
activating others, such as IGF2 and IGF2r (Sleutels and Barlow, 2002). However, the role of
methylation in genomic stability is still a matter of debate. The mechanisms by which deficient
methylation leads to aberrant regulation of a substantial proportion of endogenous genes are still
unclear (Okano et al., 1999).
The successful cloning of mammals by the transfer of embryonic or somatic cell nuclei
into an enucleated oocyte demonstrated that the genetic and epigenetic programs can be reversed
and that nuclear totipotency can be restored (Gurdon and Colman, 1999; Shi et al., 2003).
However, the nucleus of the cell transferred to an enucleated oocyte must be quickly
reprogrammed to express the genes needed for normal early embryonic development.
Experimental evidence indicates that the abnormalities observed in cloned animals are due, at
least in part, to the faulty or incomplete establishment, maintenance and resetting of epigenetic
states during and after nuclear transfer (Dean et al., 2001; Young et al., 2001). Several studies
have reported anomalies in the methylation patterns of early preimplantation cloned embryos.
Dean et al. (2001) reported that the initial demethylation appeared to be conserved in 1cell cloned bovine embryos. However, it was found that the further passive demethylation
appeared to be absent in those embryos, and a precocious de novo methylation was described at
the 4- to 8-cell stage. In contrast, other studies failed to find any demethylation in cloned bovine
embryos (Bourc'his et al., 2001).
The demethylation/remethylation waves generally appear to coincide with the activation
and transcription of the embryonic genome. In mammals, it is well known that the onset of ge-
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nomic activation differs between species, occurring at the 2-cell stage in mice, 4-cell stage in
pigs, and the 8- to 16-cell stage in cows (Campbell, 1999). It has been proposed that the delayed
or aberrant demethylation/remethylation wave observed in preimplantation cloned embryos may
impair the normal progression towards the activation of the genome (Shi et al., 2003). Overall,
these studies demonstrated that incomplete or aberrant methylation patterns occur during
reprogramming of the donor genome in cloned embryos.
Genomic Imprinting
Among the abnormalities observed in cloned animals are placental abnormalities (Hill et
al., 2001a), fetal overgrowth and perinatal death (Hill et al., 2000c). Increased fetal and placental
weights were reported in cloned mice produced from ES cells. These abnormalities were not
reported in pups derived from tetraploid aggregation, suggesting abnormalities resulted from the
nuclear transfer procedure (Eggan et al., 2001). In contrast, no abnormalities have been reported
in placentae of cloned goats and pigs (Keefer et al., 2001; Polejaeva, 2001).
In mammals, both maternal and paternal genomes are needed for normal development.
By the mechanisms of genomic imprinting, specific genes are allowed to express dependent on
their parental origin (Surani et al., 1984). Therefore, functional differences between maternal and
paternal genome are present during early embryo development. The paternal genome exerts its
effects in the extraembryonic tissues, whereas the maternal genome will have influence in the
development of the embryo (McGrath and Solter, 1984; Surani et al., 1984). Imprinted genes
have been proposed to have a key role in processes; such as placentation, homeostasis, lactation
(Lefebre et al., 1998) and many of these processes have been reported to be deficient in cloned
animals. Both DNA methylation and chromatin packaging have been implicated as imprinting
marks. However, little is known how they are established and maintained (Shi et al., 2003). It has

25

been proposed that when a somatic nucleus is introduced into an enucleated oocyte, the
methylation of imprinted genes needs to be protected from genome-wide demethylation so that
imprints are maintained intact in the cloned organism. In this case, reprogramming could
interfere with proper maintenance of imprints and this could explain, at least in part, the low
efficiency of animal cloning (Shi et al., 2003).
Various cell types have been used as nuclear donors. Nuclear reprogramming involves
structural and functional modifications associated with the acquisition of pluripotency or
totipotency of embryonic and somatic nuclei transplanted to enucleated oocytes (Gurdon et al.,
1975). Two approaches have been used to induce the reprogramming of the donor nucleus. The
first focuses on exposing the transplanted nucleus for prolonged periods of time to the oocyte
ooplasmic environment during the M phase with the corresponding high levels of MPF
(DiBernardino et al., 1984; Wakayama et al., 1998). The second approach involves inducing
nuclear quiescence in cultured cells before they are used as nuclear donors (Wilmut et al., 1997).
Both approaches attempt to modify the structure and function of donor chromatin to render it
more accessible to the reprogramming factors present in the ooplasm.
The efficiency of reprogramming by the cytoplast varies considerably among different
types of cells or even different lines of the same type of cells. It has been proposed that
epigenetic differences could be a major reason for this underlying variability (Shi et al., 2003).
However, cell viability does not seem to be a prerequisite for effective nuclear reprogramming.
In a recent study, Loi et al. (2002) produced live cloned lambs from the injection of
nonviable, heat-treated granulosa cells into enucleated sheep oocytes demonstrating that
denatured somatic cells can be reactivated after nuclear transfer and develop to blastocysts in
vitro and subsequently to viable offspring. In this study, cells were denatured by incubation at 55
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or 75°C. No live offspring were produced from the 75°C treatment group, and 4 cloned lambs
were born from the 55°C treatment group. Of these four, only one was surviving at the time the
study was published.
X-chromosome Inactivation
During early development of eutherian mammals, one of the chromosomes is inactivated
to ensure compensation for X-linked products. The inactivated X chromosome (Xi) is
characterized by late DNA replication and epigenetic chromatin modifications. CpG islands of
many X-linked genes are methylated on Xi but not on the active chromosome (Xa) (Shi et al.,
2003). Dosage compensation for X-linked genes between males and females is achieved by
transcriptional inactivation of one of the two X chromosomes (Lyon, 1961). An untranslated
RNA, encoded by the Xist (X-inactive specific transcript) gene that is expressed only from Xi, is
necessary for the initiation of inactivation (Li et al., 1992; Penny et al., 1996). Continuous
presence of Xist RNA acts together with DNA methylation and histone hypoacetylation to
accomplish high fidelity inheritance of the inactive form (Park and Kuroda, 2001). In the female
nucleus, one X chromosome is inactivated because it expresses the Xist RNA. The other X
chromosome escapes silencing and remains active.
On the other hand, in somatic cell nuclear transfer the recipient oocyte receives one Xi
and one Xa from the donor cell. In bovine cloned embryos, aberrant patterns of X-chromosome
inactivation have been noted (Xue et al., 2002). The abundance of Xist transcripts was
significantly higher in bovine cloned embryos produced from adult somatic cells than in those
produced from fetal cells (Wrenzycki et al., 2002). Another study showed aberrant patterns of Xlinked genes, as well as, hypomethylation of Xist in the organs of deceased cloned calves (Xue et
al., 2002).
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Long-lasting Effects of Epigenetic Alterations
Many cloned offspring exhibit abnormal phenotypes and some of these carry subtle
epigenetic changes. Although some groups have claimed that no obvious abnormalities were
found in mature cloned animals from somatic cells (Lanza et al., 2001; Heyman et al., 2002), a
multitude of researchers have observed various long-term abnormalities in cloned animals, which
varied with type of donor cell and species used for NT (Hill et al., 2000a, 2002; Eggan et al.,
2001; Brem and Kuhholzer, 2002b; Ogonuki et al., 2002; Miyoshi et al., 2003; Wells et al.,
2003). The majority of cloned mice in one study were found to suffer from pneumonia, hepatic
failure, obesity and impaired immune functions (Ogonuki et al., 2002). Some cloned calves and
goats have also shown malfunction of the immune system (Renard et al., 1999; Bourc'his et al.,
2001). The long-lasting effect of somatic cell cloning is currently an active area of research and
the effects of abnormal epigenetic reprogramming on preimplantation development are currently
under investigation.

Mitochondria
Mitochondria are complex, semi-autonomous organelles found in the cytoplasm of all
aerobic eukaryotic cells, except mature red blood cells and some protozoans. The double
membranes of mitochondria regulate transport of molecules and these organelles are the site of
most of the metabolic reactions that produce adenosine triphosphate (ATP). Large molecules
transit the outer membrane through nonspecific porin channels; the inner membrane, heavily
invaginated and forming cristae, is where the enzymes of the electron transfer chain are located.
It is also within this inner membrane that the Krebs cycle and β-oxidation take place (Hutchinson
et al., 1974). The metabolic requirement of a cell for oxygen reflects its metabolic activity and
the levels of ATP produced in the mitochondria are often reflective of cell function (Moyes et al.,
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1998). Cells with a larger oxidative capacity, such as those found in the liver, heart, muscle and
neural tissue, generally have large numbers of mitochondria per cell (Brown and Wallace, 1994).
The number of mitochondria present in gametes is a matter of controversy, mainly due to
the methods used for counting and reporting these organelles. Confusion over the number of
mitochondria and mitochondrial DNA (mtDNA) copy number are spread throughout the
scientific literature. In humans, the mtDNA is a closed circular molecule of 16,500 nucleotides
located within the inner mitochondrial membrane (Shoffner and Wallace, 1990). Mammalian
mtDNA codes for 13 enzymes used in the mitochondrial energy-generating pathway, 22 tRNAs
and 2 rRNAs (Smith and Alcivar, 1993b).
It has been reported that the typical mammalian sperm midpiece contains a range of 50 to
75 mitochondria (Bahr and Engler, 1970; DeMartino et al., 1979; Hecht et al., 1984). However,
Pikó and Matsumoto (1976) have reported in the mouse a mtDNA copy number of 1,000 to
10,000 for most of the body cells and an even higher (100,000) mtDNA copy number in mature
oocytes (Pikó and Matsumoto, 1976; Michaels et al., 1982; Gyllensten et al., 1985; Gyllensten et
al., 1991). It was proposed that the higher copy number present in mature oocytes is due to the
fact that no mtDNA replication is observed during early embryogenesis, and therefore a larger
number of copies might be needed to support the energy demands of the cells during this period
(Pikó and Matsumoto, 1976).
Mitochondrial Inheritance
Mitochondrial inheritance is also still a subject of much debate. For many years it was
assumed that mitochondrial genes, in contrast to nuclear genes, have an exclusively maternal
mode of inheritance in mammals (Hutchinson et al., 1974; Giles et al., 1980; Hayashi et al.,
1983). Mitochondria from the sperm tail have been shown to be carried into the oocyte at
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fertilization in numerous studies (Szöllösi, 1965; Hiraoka and Hirao, 1988). The absence of
paternal mitochondria was in part explained by the 1:1000 ratio between paternal and maternal
mtDNA molecules (Pikó and Matsumoto, 1976; Michaels et al., 1982; Gyllensten et al., 1985;
Gyllensten et al., 1991). However, in a classical study conducted by Gyllensten et al. (1991)
using polymerase chain reaction (PCR), paternally inherited mtDNA molecules were detected at
a frequency of 10-4 relative to maternal contributions in inbred mice backcrossed for 26
generations.
Although most of the evidence indicating leakage of paternal transmission of mtDNA
derives from interspecific crosses, some researchers suggested paternal mitochondria might be an
artifact. A nested PCR assay was used to detect sperm mtDNA in individual mouse embryos
(Kaneda et al., 1995). In embryos produced by IVF of Mus musculus oocytes with the same
strain spermatozoa, paternal mtDNA could only be detected in zygotes at the pronuclear stage
and its disappearance coincided with the loss of membrane potential in sperm-derived
mitochondria, as measured by Rhodamine-123 fluorescence. In contrast, when Mus spretus
spermatozoa were used to fertilize Mus musculus oocytes, paternal mtDNA was detected at the
pronuclear stage, 2-cell stage and in the resulting neonates. Kaneda et al. (1995) proposed that an
underlying mechanism in the cytoplasm of the zygote may allow for the recognition and
elimination of sperm mitochondria on the basis of nuclear encoded proteins, and that this
mechanism might be species-specific.
The results of the work conducted by Gyllensten et al. (1991) has been questioned by
other researchers, who have suggested that the congenic strains of mice used in detecting
paternal leakage may have retained a stable level of heteroplasmy and this heteroplasmy could
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have arisen from mitochondrial fusion as was previously proposed to have occurred in a least
one strain of mice produced by ooplasmic transfer (Meirelles and Smith, 1998).
Nuclear-mitochondrial Interactions
Little is known about the coordination of expression between nuclear and mitochondrial
genomes. Any alterations that arise in the components of the mtDNA or RNA that recognize and
bind to nuclear-encoded regulatory elements must be balanced by compensatory mutations in the
nuclear genes, as the mitochondrial genome mutates much more rapidly than the nuclear genome
(Cummins, 1998). This interdependence is believed to drive the species-specificity previously
observed in nuclear-mitochondrial interaction (Kenyon and Moraes, 1997).
In 1998, a study reported decreased physical and growth performance of congenic mice
with mismatch between the nuclear and mitochondrial genomes (Nagao et al., 1998a). The type
of mtDNA was also shown to affect the developmental ability of preimplantation congenic
mouse embryos (Nagao et al., 1998b). In this study, the mtDNA-congenic strain was established
from backcrossing Mus musculus female mice to B6 male mice for 20 generations and it was
shown that the percentage of embryos reaching the blastocyst stage was reduced from 94 to 35%
depending on their mtDNA composition. It was concluded that since in early embryonic
development mitochondria contribute to the energy production in preimplantation embryos, their
developmental ability may be influenced by the type of maternally derived mtDNA and possible
incompatibilities among nuclear and mitochondrial genomes could impair early embryonic
development.
In addition, the ubiquitin system has been implicated in the early degradation of
paternally inherited mitochondria and ubiquitin-dependent proteolysis has been proposed to have
a role in the recognition and selective elimination of paternal mitochondria and mtDNA after
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fertilization in mammals (Smith and Alcivar, 1993b; Hiendleder et al., 2003; Nagao et al.,
1998b).
Heteroplasmy
Most organisms seem intolerant of heteroplasmy for mtDNA, even though stable
heteroplasmic lineages can be created artificially (Jenuth et al., 1996; Jenuth et al., 1997). When
it occurs, it generally arises from de novo mutation during oogenesis and in humans is frequently
associated with progressive mitochondrial bioenergetic diseases in the offspring (Cummins,
1998). It is suspected that many homoplastic mutations are probably lethal in early
embryogenesis, due to oxidative phosphorylation insufficiency (Shoffner and Wallace, 1990).
Ooplasm transfer (OT) is a technique that involves the transfer of a small amount
(generally 5 to 15%) of foreign ooplasm into a recipient oocyte (Barritt et al., 2001a). The
transfer of small amounts of donor ooplasm likely includes mRNAs, various proteins, mitochondria, as well as, other factors and organelles (Barritt et al., 2001a) and it opens the possibility for
the mixing of two different maternal mtDNA sources (heteroplasmy). Early studies in the animal
field lead to the ultimate implementation of the ooplasmic transfer technique in humans. In 1996,
work conducted by Levron et al. provided the basis for the first attempts of OT in humans, by
obtaining mouse zygotes after fusion with synchronous and asynchronous cytoplasts.
Heteroplasmic mice were produced after transfer of cytoplasts followed by electrofusion and
demonstrated that mitochondrial genotypes in cytoplast- and karyotyped-reconstructed embryos
were segregated during the preimplantation period (Meirelles and Smith, 1998).
Since the birth of a child was announced after OT (Cohen et al., 1997), the technique has
become the subject of debate in the human field. Its application to overcome fertilization failures
in older women has become a matter of concern due to the possibility of heteroplasmy of
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mitochondrial DNA and related mitochondrial diseases, such as mitochondrial cytopathy,
Kearns-Sayre Syndrome, Barth Syndrome, Alpers disease and mitochondrial encephalopathy.
Subsequently, researchers attempted to determine if active mitochondria were transferred
from human donor oocytes to recipient oocytes, and if these mitochondria could persist in
preimplantation embryos. Observations after 48 hours of transfer showed segregation of labeled
mitochondria to some, but not to all, blastomeres and demonstrated the recipient oocyte
contained a heteroplasmic population of mitochondria after ooplasmic transfer (Barritt et al.,
2001b). In addition, heteroplasmy was identified in 2 of 15 ooplasm transfer children using direct
PCR (Brenner et al., 2000).
Although the underlying mechanisms of OT in the human are not known, it has been
proposed that the injection of healthy donor mitochondria may give an additional ‘boost’ to
compromised oocytes from infertile patients (Van Blerkom et al., 1995) and also may inhibit
apoptotic mechanisms (Van Berklom et al., 1998). However, children born by this approach are
potentially recipients of two nuclear DNA genomes, one from each parent; and two mitochondrial genomes, one from the mother and one from the ooplasm donor. The implications of
the levels of heteroplasmy seen in these children are still under investigation.

Interspecies Nuclear Transfer
There are basically two approaches to the success of the application of NT technology in
any given species: (1) to adjust the multiple parameters that affect the overall efficiency of the
NT procedure and (2) to explore the use of a more readily available, universal recipient ooplasm
for NT in species were the availability of oocytes is restricted.
The bovine ooplasm has been shown to be able to reprogram somatic cell nuclei from
other species. After transfer into enucleated, metaphase-II bovine oocytes, nuclei from sheep,
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pig, monkey and rat skin cells underwent nuclear swelling. It was reported that cell division and
formation of an embryonic blastocele cavity occurred at the time characteristic of embryos from
the species of the donor nuclei (Dominko et al., 1999a). It must be noted, however, that no
parthenogenically activated control was run in this study, as well as no pregnancies were
reported.
Successful interspecies NT, either giving birth to live offspring or producing nearly
termed fetuses, has been achieved by several groups concerned with the preservation of
endangered species. When dermal fibroblasts of an endangered bovid, the gaur (Bos gaurus)
(Lanza et al., 2000), granulosa cells from an endangered sheep, the mouflon (Ovis orientalis
musimon) (Loi et al., 2001) and fetal fibroblasts from water buffalo (Bublaus bubalis)
(Kitiyanant et al., 2001) were introduced into enucleated oocytes of cow, sheep and cow, 12%,
30% and 33% of the reconstructed embryos developed to the blastocyst stage, respectively.
The first interspecies NT offspring was reported for the gaur by Lanza et al., (2000) but
unfortunately died within the first 48 hours. Using domestic sheep (Ovis aries) as recipient
cytoplasts two pregnancies were established after interspecies NT using an exotic argali (Ovis
ammon) for donor karyoplasts, however both of these pregnancies were reported to have been
lost by 59 days of gestation (White et al., 1999). More recently, domestic sheep (Ovis aries)
enucleated oocytes used as cytoplasts for adult mouflon cells (Ovis orientalis musimon) resulted
in one live offspring (Loi et al., 2001).
Other interspecies NT studies using the bovine cytoplast as a universal recipient included
the injection of somatic cells from pigs (Yoon et al., 2001), saolas (Bui et al., 2002), elands
(Damiani et al., 2003), horses (Li et al., 2002a; Sansinena et al., 2002), bears (Ty et al., 2003)
and humans (Cibelli et al., 2001), however no confirmed pregnancies have been reported. In
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addition, equine enucleated oocytes have been used as recipients for somatic cells from a mule
fetus producing pregnancies (Woods et al., 2002) and three live offspring have been born
(Woods et al., 2003) at the time of writing this literature review.
The use of alternative NT techniques, such as interspecies NT, is an exciting possibility
for species with limited availability of oocytes and recipients as well as for endangered or exotic
species. Although some studies have shown promising results initially, the mechanisms of
nuclear reprogramming by the oocyte are still unknown and the extent of the ‘universality’ of the
bovine cytoplast remains under investigation.
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CHAPTER III
EFFECT OF DIFFERENT PRETREATMENTS ON IN VITRO
MATURATION OF EQUINE OOCYTES AND SUBSEQUENT
SOMATIC CELL NUCLEAR TRANSFER EFFICIENCY
Introduction
Somatic cell nuclear transfer (NT) has been accomplished in several species, including
the sheep (Campbell et al., 1996b; Wilmut et al., 1997), cow (Cibelli et al., 1998; Kato et al.,
1998), mouse (Wakayama et a., 1998), goat (Baguisi et al., 1999), pig (Betthauser et al., 2000;
Onishi et al., 2000; Polejaeva et al., 2000), gaur (Lanza et al., 2000), mouflon (Loi et al., 2001),
rabbit (Renard et al., 2002), mule (Woods et al., 2003b), horse (Galli et al., 2003) and domestic
cat (Shin et al., 2002). To date, NT in the horse has only been met with limited success. Because
cloning is still an unpredictable and inefficient procedure, particularly if the end point is live
offspring, the effect of the numerous variables on the overall outcome is difficult to separate. Of
these variables, oocyte maturation, the source of nuclei used for NT, the fusion and the activation
methods are among the most important aspects to be considered when comparing results among
different laboratories (Galli et al., 2002).
Several cell types have been used successfully in bovine NT experiments, such as mural
granulosa (Kato et al., 1998; Wells et al., 1999), leukocytes (Galli et al., 1999), cumulus
granulosa (Alberio et al., 2001) and fetal and adult fibroblasts (Cibelli et al., 1998; Hill et al.,
2000c; Zakhartchenko et al., 2001; Galli et al., 2002). In the horse, sources of nuclei previously
used for NT include cumulus (Hinrichs et al., 2000b), fetal and adult fibroblasts (Reggio et al.,
2000; Li et al., 2002b; Choi et al., 2003).
High fusion rates of equine adult somatic cells with equine oocytes have been previously
reported form several laboratories. One of the early attempts of NT in the horse reported fusion
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rates of 81% for quiescent and 52% for proliferating adult equine fibroblasts (Reggio et al.,
2000). The same year, a fusion efficiency of 48% was reported for equine oocytes with equine
somatic cells (Hinrichs et al., 2000b). More recently, greater fusion rates were reported when
combining electrofusion with Sendai virus (82%) compared with the electrofusion technique
alone (57%) (Li et al., 2002b). Although the fusion efficiencies reported by different laboratories
for the horse are comparable to those previously reported for the cow (Cibelli et al., 1998;
Campbell, 1999; Colman, 2000), this step is still a source of variability in the outcome of the NT
procedure. To by-pass the necessity for fusion, Piezo-driven injection of equine somatic cells in
combination with activation using equine sperm cytosolic factor were used for NT, reporting a
cleavage rate as high as 51% (Choi et al., 2002a). Although an acceptable cleavage was obtained,
only 11% of these embryos revealed the presence of normal nuclei after Hoechst-33342 staining.
Activation is another important component in the NT procedure. During the process of
fertilization, sperm entry triggers a series of intracellular calcium oscillations critical to oocyte
activation. Maturation promoting factor (MPF) and mitogen-activated protein (MAP) kinase are
the most likely targets of calcium-stimulated events because inactivation of these kinases is a
prerequisite to the resumption and completion of meiosis, subsequent pronuclear formation and
the synthesis of DNA (Collas et al., 1993; Verlhac et al., 1994; Moos et al., 1996). Maturation
promoting factor is a complex of two subunits: a catalytic subunit, p34cdc2 and a regulatory
subunit, cyclin B (Doree and Galas, 1994). Association of these subunits and the subsequent
activation of MPF occur in a specific order by dephosphorylation of the p34cdc2 subunit at
threonine-14 and tyrosine-15, and by phosphorylation at threonine-161 (Schultz and Kopf,
1995). Maturation promoting factor peaks at metaphase of the mitotic cycles in association with
nuclear envelope breakdown, chromatin condensation, and the formation of the mitotic spindle
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(Doree and Galas, 1994; Moos et al., 1996). Maturation promoting factor inactivation, which is
necessary for the cell to exit mitosis, involves cyclin proteolysis by the proteosome system
(Glotzer et al., 1991).
In vertebrates, mature oocytes are arrested at metaphase-II of the meiotic division, with
elevated MPF activity maintained by a cytostatic factor (CSF), which prevents ubiquitindependent degradation of cyclin B and thus, inactivation of MPF (Yanagimachi, 1994).
Intracellular Ca2+ oscillations triggered by sperm down-regulate CSF activity and allow
degradation of cyclin. Proteolytic degradation of cyclin B and subsequent MPF inactivation
releases oocytes from metaphase arrest and allows the beginning or resumption of mitotic cycles
(Lorca et al., 1993).
Different artificial activation treatments attempt to mimic sperm-triggered events and
induce parthenogenic development in metaphase-II oocytes. Some of these treatments, such as
ethanol, electroporation, calcium ionophore, ionomycin or inositol 1,4,5 triphosphate induce
calcium oscillations and release the mitotic arrest (Presicce and Yang, 1994; Soloy et al., 1997;
Liu et al., 1998; Mitalipov et al., 1999). However, the MPF activity is quickly restored with
recondensation of chromosomes and the re-entry of activated oocytes into a new M-phase arrest,
also known as metaphase-III. To prevent this, additional treatments that inhibit protein synthesis
(cycloheximide, CHX) or protein phosphorylation (6-dimethylaminopurine, DMAP) must be
used (Soloy et al., 1997; Liu et al., 1998). This has led to the use of sequential approaches with
ionomycin/DMAP, calcium ionophore/CHX or inositol 1,4,5-triphosphate/DMAP that result in
high activation and parthenogenic rates (Barcroft et al., 1998; Mitalipov et al., 1999). However,
detrimental effects of the use of these non-specific, broad spectrum protein synthesis and/or
kinase inhibitors are suspected.
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In the cow, the developmental competence of oocytes was compromised after blocking
maturation at the germinal vesicle stage for 24 h with CHX or DMAP (Lonergan et al., 1997). In
contrast, purine derivative compounds such as roscovitine, butyrolactone I or olomoucine, which
specifically inhibit MPF and MAP kinase, have been used to delay meiotic progression of bovine
oocytes without affecting their subsequent potential for development to the blastocyst stage in
cattle (Mermillod et al., 2000; Lonergan et al., 2000). This also suggests that these components
might have a potential application not only in the process of oocyte maturation (nuclear and
ooplasmic) but also in promoting parthenogenic activation.
A small number of reports of oocyte activation have been published for the horse, either
parthenogenically (Choi et al., 2001b; Hinrichs et al., 2002), after the use of cytoplasmic sperm
injection (Grøndahl et al., 1997; Kato et al., 1997; Galli et al., 2000; Li et al., 2000; Hinrichs et
al., 2002; Dell'Aquila et al., 2003) or somatic cell NT (Hinrichs et al., 2000; Reggio et al., 2000;
Choi et al., 2002a; Li et al., 2002b; Li and Allen, 2002a; Choi et al., 2003; Lagutina et al., 2003;
Li et al., 2003). Recently, sperm cytosolic extract has gained attention as an alternative for the
artificial activation of oocytes. A maximum of 49% cleavage rate was reported after
parthenogenic activation of horse oocytes injected with various concentrations of stallion
cytosolic sperm extract (Choi et al. 2002a, 2002b).
Even with numerous efforts, cleavage and blastocyst production after NT in the horse are
still poor. Cleavage rates of 22% were reported after NT with a combination of Piezo-driven cell
injection and activation using stallion cytosolic sperm extract (Choi et al. 2002a, 2002b),
however, none of the embryos developed past the 10-cell stage in vitro. Recently, a novel
approach to the NT procedure was described, in which horse oocytes were stripped of their zona
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pellucidae prior to enucleation (Lagutina et al., 2003). Using this procedure, this group achieved
an impressive 85% cleavage rate.
Only a few groups have produced in vitro cultured blastocysts after somatic cell NT in
the horse (Li et al., 2002b; Lagutina et al., 2003). In an experiment comparing the development
of horse oocytes reconstructed with nuclei of either fetal (FFC) or adult (SFC) equine fibroblasts,
cleavage rates were 53% for FFC and 35% for SFC and blastocyst rates were 4% for FFC and
7% for SFC (Li et al., 2002b). Using the zona-free technique, a 4% blastocyst rate was obtained
after 8 d of in vitro culture with SOFaa medium (Lagutina et al., 2003).
Although a few groups have produced cloned embryos in vitro, only one reported the
establishment of an equid pregnancy in the scientific literature. Recently, several pregnancies
were reported from mule fetal fibroblasts electrofused with in vivo matured equine oocytes and
transferred immediately to the oviduct of synchronized recipient mares (Woods et al., 2002).
Seven of the 195 (3.6%) transferred cloned mule embryos resulted in embryonic vesicles.
Although only one vesicle developed into an embryo proper detectable by ultrasonography, all
seven pregnancies were spontaneously resorbed between d 27 and 61 of gestation. It was this
group that reported the live birth of two cloned, healthy mules at the time of writing this
literature review (Woods et al., 2003). Following the announcement of the first two cloned
equids, the live birth of a cloned horse was announced (Galli et al., 2003). Prometea, a healthy
filly, was carried to term by the same mare that originated the donor cell line, making the first
cloned horse born from its twin dam.
The low efficiency of the somatic cell NT procedure requires that large numbers of
meiotically competent equine oocytes be available for maturation. In vitro maturation rates of
equine oocytes have been reported by several laboratories, and are generally lower and more
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variable than those of other domestic species (Hinrichs et al., 1993; Del Campo et al., 1995;
Squires, 1996; Alm and Hinrichs, 1996; Choi et al., 1993; Hinrichs and Schmidt, 2000a; Franz et
al., 2001; Hinrichs et al., 2002; Dell'Aquila et al., 2003; Marchal et al., 2003;). Although the
source of this variability is still unknown, it has been attributed in part to the selection of oocytes
for in vitro culture. A recent study evaluated oocyte meiotic competence as related to granulosa
cell apoptosis reported that, although follicle size was not significantly correlated to apoptosis,
the proportion of oocytes maturing in vitro was significantly greater in oocytes issuing from
apoptotic follicles than in those issuing from healthy ones (Dell'Aquila et al., 2003). In addition,
it was found that significantly more oocytes with expanded cumulus (Exp) than compact
cumulus (Cp) originated from apoptotic follicles. This supports previous studies that reported the
Cp oocytes having a lower meiotic competence (Alm and Hinrichs, 1996; Hinrichs and
Williams, 1997) and slower maturation rate (Hinrichs et al., 1993; Zhang et al., 1989; Alm and
Hinrichs, 1996) than Exp oocytes.
The method of oocyte collection has also been proposed to have a significant impact on
the outcome of in vitro oocyte maturation. Using abattoir-derived ovaries, aspiration of follicles
resulted in a lower oocyte recovery rate and higher prevalence of oocytes with partial cumulus
when compared to follicle scraping (Dell'Aquila et al., 2001). Although these results may
indicate differences in collection techniques, the fact that transvaginal ultrasound-guided aspiration (TUGA) allows repeated collection of equine oocytes without the need of a surgical
procedure often makes it the only alternative to obtain equine oocytes for research or clinical
procedures. Previous observations at this laboratory suggested that the oocyte recovery rate from
small follicles (<20 mm) was higher than from larger follicles, and a larger pool of small follicles
was available for TUGA at any given time (Hylan, personal communication). Although other
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laboratories (Hinrichs et al., 1990) have reported lower meiotic competence of the oocytes from
small (<20 mm) follicles, an effort was made to study the proportion of those maturing in vitro
and determine if oocytes from small follicles would be suitable for NT procedures.
Oocyte maturation, both nuclear and ooplasmic, is an important aspect in the
development of somatic cell NT procedures for the horse. Ooplasmic oocyte maturation involves
the synthesis of proteins from nuclear and mitochondrial transcripts used during early embryonic
development. Recently, purine derivatives directed toward the inhibition of MPF have gained
attention as a way to maintain oocytes at the GV stage, while allowing ooplasmic maturation to
take place in vitro. With the overall objective of increasing the number of mature, metaphase-II
oocytes available for NT, a first experiment was conducted to evaluate the nuclear status of
equine oocytes matured in vitro using a sequential maturation medium. A second study was
conducted to evaluate the effect of roscovitine prematuration in oocytes from small equine
ovarian follicles and to use these in vitro matured oocytes for equine NT procedures.

Materials and Methods
Experiment 3.1
Oocyte Collection
Twenty-nine normally cycling, mixed-breed mares of good body condition scores (body
condition scores ranged from 6 to 8 on a scale of 1 to 9) were selected for a single aspiration
after ≥28 d of no stimulation during the 2002 breeding season. Oocytes were aspirated using the
ultrasound-guided follicular aspiration technique previously reported by this laboratory (Cochran
et al., 1998, 2000). All follicles >5 mm of diameter were aspirated. Briefly, a 12-gauge doublelumen stainless steel needle (Cook® Veterinary Products, Inc., Bloomington, IN) was inserted
through the vaginal wall via a transvaginal ultrasonic transducer attached to a needle guide.
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Negative pressure (~90 mm Hg) was constantly applied using a vacuum pump while oocyte
collection medium (phosphate-buffered solution, 2% calf serum (HyClone, Logan, UT), 2 USP
units of heparin and 100 units of penicillin-G/mL) was flushed into the follicle cavity at least 8
times, while the follicle was massaged rectally. Sufficient pressure was applied by the incoming
oocyte collection medium to expand the follicle wall and to allow detachment of the cumulusoocyte complex (COC). The aspirate was collected in autoclaved glass 500 mL bottles. No
attempt was made to separate aspirates by follicular size and contents were searched for COC
under a dissecting microscope.
Oocyte Maturation
Cumulus-oocyte complexes were randomly allocated to one of five treatments (Table
3.1). Oocytes were exposed to pre-maturation medium consisting of 100% preovulatory
follicular fluid supplemented with 75 µM of roscovitine. Pre-maturation was allowed for 0 to
24 h, followed by a 24- to 36-h exposure to the maturation medium. The maturation medium was
the same for all the treatment groups, and consisted of TCM-199, 10% FBS, 5 µg/mL of FSH,
10 µg/mL of LH, 1 µg/mL of E2, 100 ng/mL of EGF and 100 ng/mL of IGF-1. At the end of
maturation, oocytes were denuded of cumulus by vigorous pipetting for 2 to 3 min in TL-HEPES
containing 100 units/mL of hyaluronidase (Sigma, St. Louis, MO). Oocytes were labeled with
2 µg/mL of Hoechst-33342 for 3 min and then observed with epifluorescent illumination to
visualize the metaphase plate and assess nuclear status.

Experiment 3.2
Oocyte Collection and Maturation
Twenty-nine mixed-breed, cycling mares of good body condition score (body condition
scores ranged from 6 to 8 on a scale of 1 to 9) were aspirated for 6 consecutive times during the
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Table 3.1. Sequential prematuration and maturation of equine in vivo-harvested oocytes
Treatment

No. oocytes

Time in pre-maturation
medium (h)

Time in maturation
medium (h)

Total time in vitro (h)

A

7

12-13

24

36-37

B

16

14-17

24

38-41

C

27

18-20

25

43-45

D

21

22-24

26

48-50

E

36

0

36

36
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2002 breeding season. The mares were treated daily with 0.444 mg of altrenogest (Regumate®,
Hoechst Roussel Vet., Warren, NJ) per kg of body weight for a total period of 91 d (d 1 = first
day of treatment) for the duration of the experiment.
During periods of progesterone dominance such as pregnancy, both cattle (Ginther et al.,
1989) and mares continue to show follicular wave emergence and growth (Ginther and Bergfelt,
1992). Oral altrenogest, a synthetic progestin, has been shown to reduce the occurrence of
follicular dominance in mares (Lofstedt et al., 1989). Since previous studies have shown that
oocytes collected from pregnant donor mares are viable and capable of producing live foals
(Cochran et al., 1998; Meintjes et al., 1995), the altrenogest treatment used in our study aimed at
inducing a pseudopregnant state in the mares in which follicular dominance would be minimized
and large numbers of follicles could be aspirated.
Seven days after the initiation of altrenogest treatment, all mares were subjected to a
follicle ablation procedure, during which all ovarian follicles >5 mm in diameter were punctured
and follicular fluid was collected via TUGA. The objectives of performing follicular ablation
were (1) to remove all atretic follicles present and (2) to induce a new wave of follicular growth
for subsequent oocyte collection procedures.
After the follicle ablation procedure, all mares were aspirated for oocyte collection at
14-d intervals. Ultrasound-guided oocyte collection was performed as described in Experiment
3.1. At the time of aspirations, follicles were classified as pre-ovulatory (>35 mm diameter, not
used in this experiment), subordinate (20-35 mm diameter) or small (<20 mm diameter). The
oocytes recovered from subordinate follicles were subjected to in vitro maturation (IVM) in
TCM-199, 15% estrous mare serum, 5 µg/mL of FSH, 10 µg/mL of LH and 1 µg/mL of E2 for
36 h. Oocytes aspirated from small follicles were randomly allocated to IVM only or pre-treated
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for 48 h prior to IVM in roscovitine (50 µM) prepared in TCM-199. At the end of treatment,
oocytes were stripped of cumulus by pipetting in TL-HEPES containing 100 units/mL of
hyaluronidase. Nuclear maturation was assessed by visualization of first polar body using a
dissecting scope and NT procedure was performed on metaphase-II oocytes.
Nuclear Transfer
Only mature, metaphase-II oocytes with intact membrane and good ooplasmic morphology were used for NT. Oocytes were labeled with 3 µg/mL of Hoechst-33342 for 3 min to
allow observation of nuclear DNA under UV illumination. The oocytes were then washed in
modified TL-HEPES (mTLH; TL-HEPES supplemented with 10% FBS and 0.1% gentamicin)
and placed in an elongated 150-µL micromanipulation droplet containing 0.2 µg/mL of
cytochalasin D (Sigma). The micromanipulation droplet was overlaid with mineral oil (Sigma,
embryo tested). All micromanipulations of equine oocytes were conducted on the stage of an
inverted microscope (Nikon Diaphot) equipped with Hoffman Modulation Contrast objectives,
Narishige micromanipulators, Uniblitz VMM-D1 shutter system (Vincent Associates, Rochester,
NY) and epifluorescent illumination. A 120-µm diameter (o.d.) pipette was used to hold the
oocytes by negative pressure.
After a brief exposure (<5 s) to ultraviolet light to visualize nuclear DNA, the metaphase
spindle with a small amount of surrounding ooplasm was removed by negative pressure applied
to a 15-µm enucleation pipette. Because of the inherent fragility of equine oocytes, no attempt
was made to remove the first polar body. Once enucleated, the cytoplasts were held in modified
TCM (mTCM; TCM-199 supplemented with 10% FBS and 0.1% gentamicin) at 38.5ºC and
5% CO2 in humidified air.
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Female adult equine fibroblasts used as nuclear donors were at passage three of culture.
Donor cells were serum starved (0.5% FBS) for 3 to 5 d to induce presumptive quiescence prior
to NT procedures. Reconstruction was performed in a 200-µL elongated droplet of mTLH
containing 0.2 µg/mL of cytochalasin D overlaid with mineral oil (Sigma, embryo tested). A single adult fibroblast was inserted into the perivitelline space of an enucleated oocyte. Fusion of
karyoplast-cytoplast couplets was performed in a microslide fusion chamber with stainless steel
electrodes separated by a 1-mm gap. The chamber was filled with fusion buffer (0.3 M mannitol,
0.1 mM MgSO4⋅7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4 mg/mL of BSA (Fraction V,
Sigma). The couplets were then fused by two consecutive DC pulses (3.0 kV/cm for 30 µs)
delivered by a BTX Electrocell Manipulator 200 (Genetronics, San Diego, CA). Couplets were
evaluated for fusion by microscopic examination within a 1-h period. Chemical activation was
performed with a 5-min exposure to 5 µM of ionomycin (Sigma) and 6 min in TL-HEPES with
30 mg/mL of BSA (Fraction V, Sigma) followed by a 3-h incubation period in 10 µg/mL of
cycloheximide (Sigma) with 6 µg/mL of cytochalasin D prepared in CR1aa medium (Rosenkrans
et al., 1993).
After micromanipulation, embryos were cultured for 48 h in 35-µl droplets of CR1aa
medium in a modular incubator chamber (Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5%
O2, 5%CO2 and 90% N2.

Results
Experiment 3.1
A total of 192 follicles were punctured in 29 cycling mares in a single aspiration and a
total of 115 oocytes were recovered (60% recovery), yielding a mean of 3.96 oocytes/mare. A
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total of 107 of these oocytes were classified as non-degenerate and randomly allocated to five
treatments.
Nuclear status results are summarized in Table 3.2. Of the 7 oocytes allocated to
Treatment A (12 to 13 h of prematuration + 24 h of maturation), 1 (14%) was found to be in the
germinal vesicle (GV) stage, 1 (14%) was in the germinal vesicle breakdown (GVBD) stage,
1 (14%) was in metaphase-I (M I) stage, 1 (14%) was in metaphase-II (M II) stage and 3 (43%)
were degenerate. Of the 16 oocytes allocated to Treatment B (14 to 17 h of prematuration + 24 h
of maturation), 3 (19%) were found to be in GV stage, 2 (12%) were in GVBD stage, 7 (44%)
were in M I stage, none (0%) were in M II stage and 4 (25%) were degenerate. Of the 27 oocytes
allocated to Treatment C (18 to 20 h prematuration + 25 h maturation), 3 (11%) were found to be
in GV stage, 2 (7%) were in GVBD stage, 13 (48%) were in M I stage, 1 (4%) was in M II stage
and 8 (30%) were found to be degenerate. Of the 21 oocytes allocated to Treatment D (22 to 24 h
prematuration + 26 h maturation), 3 (11%) were found to be in the GV stage, none (0%) were in
the GVBD stage, 11 (52%) were in the M I stage, 4 (19%) were in M II stage and 3 (14%) were
found to be degenerate. Of the 36 oocytes allocated to Treatment E (0 h prematuration + 26 h
maturation), 2 (5%) were found to be in the GV stage, none (0%) were in GVBD stage, 6 (17%)
were in M I stage, 22 (61%) were in M II stage (Figure 3.1) and 6 (17%) were degenerate.
Experiment 3.2
Of a total of 346 ovarian follicles collected in 6 aspirations, 71 (20%) were classified as
subordinate (20-35 mm) and 275 (80%) follicles were classified as small (<20 mm) at the time of
TUGA. A total of 217 oocytes were recovered from 346 follicles for an overall recovery rate of
63%. When classified according to follicular size, 71 subordinate follicles yielded 24 oocytes
(34% recovery), whereas, 275 small follicles wielded 193 oocytes (70% recovery rate).
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Table 3.2. Nuclear status of in vitro matured equine oocytes after sequential prematuration and
maturation treatments
No. oocytes

GV (%)a

GVBD (%)b

MI (%)c

MII (%)d

Degenerate (%)

A

7

1 (14)

1 (14)

1 (14)

1 (14)

3 (43)

B

16

3 (19)

2 (12)

7 (44)

0 (0)

4 (25)

C

27

3 (11)

2 (7)

13 (48)

1 (4)

8 (30)

D

21

3 (11)

0 (0)

11 (52)

4 (19)

3 (14)

E

36

2 (5)

0 (0)

6 (17)

22 (61)

6 (17)

Treatment

a

Germinal vesicle.
Germinal vesicle breakdown.
c
Metaphase I.
d
Metphase II.
b
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a

b

c

40 µm

Figure 3.1. Equine oocytes allocated to Treatment E (Experiment 3.1). (a) Prior to IVM, 20 X objective. (b) After 26 h of IVM,
10 X objective. (c) Metaphase-II oocyte, 40 X objective.
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Results of this experiment are summarized in Table 3.3. Of a total of 24 oocytes
recovered from subordinate follicles, 12 (50%) reached metaphase-II stage after 36 h of in vitro
maturation. Of these mature oocytes, 9 (75%) were successfully enucleated, as evidenced by
intact oolema after removal of first polar body, 7 (78%) survived reconstruction without lysing
and 5 (71%) were fused.
A total of 193 oocytes were recovered from small follicles, and these were randomly
allocated to IVM (n = 100) or roscovitine pre-maturation followed by IVM (n = 93). Of the 100
oocytes allocated to IVM, 66 (66%) reached the metaphase-II, 30 (45%) were successfully
enucleated, 22 (73%) were reconstructed and 12 (55%) fused. Of the 93 oocytes allocated to
roscovitine pre-maturation followed by IVM, 53 (57%) reached the metaphase-II, 30 (57%) were
successfully enucleated, 20 (67%) were reconstructed and none (0%) fused. However, significantly more (P<0.05) couplets fused with ova from subordinate and small (IVM) treatments
compared with the small (roscovitine + IVM) treatment (71%, 55% and 0%, respectively).

Discussion
One of the largest obstacles in establishing a repeatable protocol for NT for the horse is
the inability to collect and mature large numbers of good quality oocytes from donor mares. The
low follicle number per ovary (Hinrichs, 1991; Hinrichs et al., 1993; Del Campo et al., 1995), the
difficulty recovering oocytes from follicles (Hawley et al., 1995) and the scarce information
regarding the process of selection of oocytes for optimal meiotic and developmental competence
(Dell'Aquila et al., 2001) are key factors contributing to the overall inefficiencies.
Although transvaginal aspiration of follicles has been reported to yield lower recovery
rates than follicle scraping (Dell'Aquila et al., 2003), the lack of abattoir-derived ovaries has
made TUGA the only alternative for oocyte collection in this laboratory. In the past, oocyte
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Table 3.3. Effect of oocyte source (by follicle size) and roscovitine pretreatment on in vitro
maturation and nuclear transfer efficiency
No.
oocytes

No. (%)
Mature

No. (%)
enucleated

No. (%)
reconstructed

No. (%)
fused

Subordinate (IVM only)

24

12 (50)

9 (75)

7 (78)

5 (71)a

Small (IVM only)

100

66 (66)

30 (45)

22 (73)

12 (55)a

Small (Roscovitine + IVM)

93

53 (57)

30 (57)

20 (67)

0 (0)b

Total

217

131 (60)

69 (53)

49 (71)

17 (35)

Treatment

ab

Values in columns with different superscripts are different (Chi square, P<0.05).
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recovery rates for small, unstimulated follicles have been reported to be lower than those from
larger, preovulatory follicles (Hinrichs et al., 1990) and recovery rates were reported to increase
with follicular size, which also reflected increased oocyte maturity and tendency toward
expanded cumuli. However, results from this laboratory (Hylan, personal communication)
revealed there is a larger number of small (<20 mm) than large (>20 mm) follicles present in the
ovary at any given time, regardless of the stimulation protocol.
In this study, treatment with oral altrenogest in combination with follicle reduction after
7 d of initiation of treatment resulted in a larger (80%) population of small ovarian follicles at the
time of TUGA. Interestingly, the oocyte recovery rate according to follicular size was also higher
for small follicles than for follicles larger than >20 mm (70 vs. 34% recovery). This observation
is consistent with previous results for this laboratory, but is not in agreement with results
previously reported by other groups. Previously, oocyte recovery from small, immature follicles
has been reported to be as low as 1 to 16% (Vogelsang et al., 1983; Palmer et al., 1987). It was
proposed that the close attachment of the immature COC to the follicular wall might make the
oocytes from small oocytes less likely to be aspirated. It must be noted, however, that this
recovery rate was obtained using the technique of puncturing the follicle with a needle through
the flank while the ovary was manipulated per rectum and not using TUGA. In our study, every
follicle is flushed, the follicular wall is stretched and massaged numerous times, which may have
made the COC more likely to detach after repeated flushes and aspirations.
Oocyte maturation and differentiation is a complex process starting during fetal life and
culminating in a preovulatory follicle as the oocyte reaches its full competence to resume meiosis
and successfully accomplish both nuclear and ooplasmic aspects of maturation (Mermillod et al.,
2000). Nuclear maturation is characterized by chromatin condensation, disappearance of the
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nucleolus and disassembly of the nuclear membrane, leading to GVBD (Krischek and Meinecke,
2001). The GV stage is an important stage for the transcription and translation, not only for
stage-specific molecules needed for GVBD, but also for synthesis and storage of transcripts and
proteins that play an important role in further embryo development (Khatir et al., 1998).
The importance of terminal oocyte differentiation during late folliculogenesis was
demonstrated by comparing maturation and developmental potential of oocytes harvested from
follicles of different sizes in various species (Mermillod et al., 2000). When a meiotically
competent oocyte is removed from its follicular environment, it spontaneously resumes meiosis.
This meiotic resumption involves condensation of chromosomes, which results in the block of
the transcription process (Lonergan et al., 1994; Wu et al., 1996). Therefore, an oocyte that is removed from the follicular environment in the early stages, such as oocytes from smaller size
follicles, is deprived of important steps in its differentiation.
Early attempts to maintain oocytes at the GV stage to allow further ooplasmic maturation
included prematuration in follicular fluid (Tsafriri and Channing, 1975; Aguilar et al., 2001), coculture with mural granulosa (Van Tol et al., 1996) or theca cells (Richard and Sirard, 1996)
cells, although these treatment showed only a temporary arrest of the oocyte in GV stage.
Because resumption of meiosis is highly dependent on the MPF activation, chemical approaches
such as the inhibition of protein synthesis with cycloheximide (Lonergan et al., 1997; Saeki et
al., 1997) or the inhibition of phosphorylation with 6-DMAP (Saeki et al., 1997) have previously
been attempted. However, the nonspecific nature of these compounds resulted in the loss of
developmental potential at the end of the prematuration treatments. Recently, the use of more
specific inhibitors to maintain oocytes at the GV stage has gained considerable attention.
Specific cdc-kinase inhibitors; such as butyrolactone I (Lonergan et al., 2000), roscovitine
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(Mermillod et al., 2000; Krischek and Meinecke, 2001; Marchal et al., 2001; Franz et al., 2002;
Lagutina et al., 2002) or their mixture (Ponderato et al., 2001) have been used to prevent meiotic
resumption without compromising further developmental potential.
In our study (Experiment 3.1), the prematuration of oocytes pooled from all follicle sizes
in roscovitine with follicular fluid did not improve nuclear maturation rates obtained after permissive maturation. In fact, the highest maturation rate was obtained when oocyte maturation
was conducted in maturation medium alone (Treatment 5), indicating the incubation in follicular
fluid with roscovitine for a prolonged period of time may have negatively affected not only
ooplasmic maturation, but also the ability of the chromosomes to condense and resume the
normal steps of nuclear maturation.
Studies conducted previously with the bovine model reported that follicular fluid from
both small and medium follicles had the greatest ability to keep oocytes in GV stage, however,
follicular fluid from large follicles at estrus had less ability to inhibit GVBD (Ayoub and Hunter,
1993). It is possible that the preovulatory equine follicular fluid used in this study was ineffective
in arresting equine oocytes at the GV stage, although assessment of the nuclear status of the
oocytes at the end of the in vitro prematuration and prior to maturation should have been
conducted to support this statement.
In our study (Experiment 3.2), the pretreatment of oocytes from small follicles in
roscovitine did not have a significant effect on the proportion of oocytes reaching the metaphaseII stage after maturation. This is in agreement with previous studies that have shown that,
although roscovitine was effective in maintaining the oocytes in meiotic arrest, the nuclear
maturation rates were not significantly affected by the preincubation treatment (Khatir et al.,
1998; Mermillod et al., 2000; Ponderato et al., 2001; Franz et al., 2002). Although roscovitine,
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butyrolactone and other purine derivatives have been shown to be effective in maintaining
meiotic arrest for prolonged periods of time, the beneficial effects of the permissive ooplasmic
maturation on oocyte maturation and embryo development still remain to be demonstrated.
Numerous studies in different species, such as the cow (Lonergan et al., 1997; Mermillod et al.,
2000; Ponderato et al., 2001), pig (Krischek and Meinecke, 2001; Marchal et al., 2001) and horse
(Franz et al., 2002; Franz et al., 2003) have achieved effective arrest in a dose-dependent manner
and have shown the arresting effect to be fully reversible. However, roscovitine was recently
shown to increase developmental potential of Cp equine oocytes but not of Ex oocytes after ICSI
(Franz et al., 2003).
Interestingly, our study (Experiment 3.2) showed that none of the roscovitine-treated
oocytes from small follicles fused after NT. A previous study in the cow had also reported a
significantly lower cleavage rate after NT with oocytes pretreated with roscovitine for 24 h
(Lagutina et al., 2002). Because in our study the roscovitine-treated oocytes remained in culture
for approximately 84h (48 h roscovitine + 36 h IVM), it is possible that membrane stability
might have been compromised. This would explain the lack of fusion in that treatment, and more
research is needed to clarify this point.
In conclusion, our study showed that it is possible to obtain acceptable maturation rates in
oocytes from small follicles and use these oocytes in NT procedures. Although at this point the
value of the roscovitine treatment remains questionable, compounds that inhibit the meiotic
resumption of oocytes could potentially be used to pool equine oocytes in larger groups before
entering in vitro maturation, thus facilitating the subsequent procedure of NT.
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CHAPTER IV
PRODUCTION OF NUCLEAR TRANSFER LLAMA (Lama glama)
EMBRYOS FROM IN VITRO MATURED LLAMA OOCYTES
Introduction
The Camelidae family consists of two genera: Camelus and Lama. The genus Lama is
comprised of four species: the llama (Lama glama), the alpaca (Lama pacos), the guanaco (Lama
guanicoe) and the vicuña (Lama vicugna). These four species are collectively known as the
South American or New World camelids (Bravo et al., 2000). During the last two decades the
worldwide demand for domestic South American camelids has increased mainly due to their
value as exotic pets. However, the application of assisted reproductive technologies has proven
difficult in these species due to inherent characteristics of their reproductive physiology.
Llamas are induced ovulators; therefore, they do not exhibit a typical estrus but rather
prolonged periods of receptivity followed by brief episodes of anestrous behavior (San-Martin et
al., 1968; England et al., 1969). Ovarian follicles develop in waves with an interval of 15 to 20 d
(Adams et al., 1990) and in the absence of pregnancy the corpus luteum declines approximately
10 d after infertile copulation (Sumar, 1983; Aba et al., 1995). Consequently, these animals have
a shorter luteal phase than spontaneously ovulating ruminants. The absence of a spontaneously
occurring luteal phase during which traditional superovulatory agents are normally administered,
in addition to the presence of a dominant follicle that prevails for an extended period of time in
pregnant females, makes the synchronous stimulation of small follicles difficult to achieve.
Several approaches have been attempted, including the administration of 1,000 IU of equine
chorionic gonadotropin (eCG) given to females during an induced luteal phase (Bourke et al.,
1992, 1995), treatment with 500 IU of eCG, 220 mg of FSH in descending doses over 4 d or a
combination of both during estrus (Correa et al., 1997). More recently, a 52% oocyte recovery
57

was achieved by transvaginal ultrasound guided follicular aspiration (TUGA) in females that
were superstimulated with a combination of 100 IU of eCG and 400 mg of FSH (Follitropin®)
over a 6-d period (Brogliatti et al., 2000).
In vitro maturation (IVM) and in vitro fertilization (IVF) have also been attempted in
South American camelids (Del Campo et al., 1992, 1994). Abattoir-derived oocytes matured in
TCM-199 plus gonadotropins and fetal calf serum at 38°C and 5% CO2 under humidified
atmosphere achieved a 62% nuclear maturation rate (metaphase-II stage). In another study,
nuclear maturation of 30% was reported after 30 h of in vitro maturation (Del Campo et al.,
1994). This was also the first report of IVF-derived embryos produced in the llama, produced
with epididymal spermatozoa and co-cultured in medium with llama oviduct epithelial cells
(LOEC) for 9 d.
Since Wilmut et al., (1997) announced the birth of the first mammal cloned by the
procedure of somatic cell nuclear transfer (NT) other species have been produced by the transfer
of a differentiated somatic cell into an enucleated oocyte, namely the cow (Cibelli et al., 1998;
Kato et al., 1998), mouse (Wakayama et a., 1998), goat (Baguisi et al., 1999), pig (Betthauser et
al., 2000; Onishi et al., 2000; Polejaeva et al., 2000), gaur (Lanza et al., 2000), mouflon (Loi et
al., 2001), rabbit (Renard et al., 2002), domestic cat (Shin et al., 2002), mule (Woods et al.,
2003) and horse (Galli et al., 2003). This technology has potential applications in livestock
breeding (Wilmut et al., 2000), biotechnology and the pharmaceutical industry (Ziomek, 1998),
human medicine (Lanza et al., 1999a, 1999b), companion animals (Westhusin et al., 2001) and
endangered species (Lanza et al., 2000).
To date, there have been no reports of somatic cell NT in llamas. The application of this
technique to the llama industry could be helpful in the propagation of genetically valuable
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animals. Also, future experiments in interspecies NT using llama oocytes as hosts and vicuña
donor cells could potentially aid in the conservation and propagation of endangered species.
Such applications of the NT technology will be feasible once the basic procedure has been
established for the llama. Therefore, the main objective of this study was to perform somatic cell
NT in the llama. In addition, two different NT embryo culture protocols for this species were
compared.

Materials and Methods
Preparation of Adult Llama Fibroblast Donor Cells
All skin biopsies (Figure 4.1) were obtained from a llama herd located in Bozeman,
Montana (Genesearch, Inc., Bozeman, MT). To obtain primary cultures, the skin biopsy was
placed in a 35 x 10-mm Falcon™ petri dish (Becton and Dickinson, Lincoln Park, NJ). Using
sterile curved scissors, dermal tissue was finely minced to a smooth consistency. Culture
medium consisting of TCM-199 (Gibco, Grand Island, NY), 15% fetal bovine serum (FBS,
HyClone, Logan, UT) and gentamicin (Gibco) was added. Tissue suspension was transferred to a
15-mL centrifuge tube using a sterile transfer pipette, and washed by swirling the tube and
allowing the tissue to settle in the bottom. Supernatant was discarded and 3 mL of new culture
medium was added. This process was repeated three times, after which tissue was transferred to
a 35-mm petri dish. Excess medium was aspirated leaving 500 to 700 µl to ensure good oxygen
tension over the tissue. All cultures were conducted at 38.5ºC and 5% CO2 in humidified
atmosphere. Once a fibroblast cell layer was established, the cells were grown in 25-cm2 tissue
culture flasks (Costar™, Cambridge, MA) until they reached 95% confluency. Cells were then
trypsinized (Sigma, St. Louis, MO) counted in a hemacytometer, and re-seeded at a density of
100,000 cells in 25-cm2 tissue culture flasks. After two subpassages, the cultured cells were
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a

b

Figure 4.1. Donor llama used for nuclear transfer. (a) Pure Argentine female llama used
as karyoplast donor (picture courtesy of Paul and Sally Taylor, Bozeman, MT). (b) Adult
female llama fibroblasts (Rebaño Escondido Querencia) after three subpassages prior to
nuclear transfer procedure, 40 X objective.
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exposed to a cryoprotectant solution consisting of TCM-199, 20% calf serum, 5% dimethylsulfoxide (DMSO) and frozen in aliquots of 500,000 cells per vial. To prepare adult fibroblasts
as donors for NT, cells were thawed and cultured in TCM-199 containing 15% FBS and
gentamicin in 25-cm2 tissue culture flasks.
Superstimulation, Oocyte Recovery and Maturation
Llama superstimulation was conducted in Bozeman, MT during the month of September.
Fourteen adult female llamas (ages 2 to 16 years) with good body condition (scores 6 to 8 on a 1
to 9 scale) were available for superstimulation. The superstimulation protocol (Figure 4.2)
consisted of an initial dominant follicle removal (DFR) on the morning of d 0. Dominant follicle
removal and manual rupture of the follicle was performed by rectal manipulation, followed by
confirmation with ultrasonography. A second DFR was performed 12 d later, after which
gonadotropin stimulation was immediately initiated. Gonadotropin stimulation consisted of a
total dose of 200 mg of FSH (Follitropin-V, Vetrepharm, Ontario, CA) in twice daily (i.m.) doses
(50, 30, 20 mg) over a 3-d interval.
Llamas were ultrasounded for ovarian structures on d 15 after initiation of stimulatory
treatment and classified as good (>15 ovarian follicles), medium (10 to 15 ovarian follicles) or
poor (<10 ovarian follicles) responders. Only those llamas classified as good and medium responders were selected for ovary recovery. Ovariectomies were performed by flank laparotomy
on d 16 after initiation of the superstimulation protocol. Excised ovaries were rinsed with
phosphate-buffered solution (PBS) and oocytes were aspirated using a 20-g needle attached to a
10-ml syringe. Once aspirated, the follicles were sliced and walls were scraped with a scalpel
blade into a search dish. Recovered cumulus-oocyte complexes (COC) were evaluated as
follows: grade 1 (denuded), grade 2 (corona radiata only), grade 3 (multiple layers of compact

61

OVARIECTOMY

50 mg pFSH
(a.m., p.m.)
30 mg pFSH
(a.m., p.m.)
20 mg pFSH
(a.m., p.m.)
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13
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Time (days)
Figure 4.2. Llama superstimulation protocol using porcine follicle stimulating hormone (pFSH).
Dominant follicle reduction (DFR) was performed on d 0 (a.m.) and d 12 (a.m.) of treatment.
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cumulus), grade 4 (expanded cumulus layer) and degenerate. All COC (except degenerate
oocytes) were included in the study. Groups of 100 COC were rinsed and placed in maturation
medium in sterile 5-ml culture test tubes (Fisherbrand, Pittsburgh, PA). The maturation medium
consisted of TCM-199, 5 µg/mL of FSH (F-2293 Sigma), 10 µg/mL of LH (L-9773 Sigma),
1 µg/mL of estradiol 17β (E-2758 Sigma) and 10% FBS. Tubes were placed in a portable
incubator at 39ºC and transported to the LSU Embryo Biotechnology Laboratory at Louisiana
State University, Baton Rouge, Louisiana for nuclear transfer procedures. After 30 h of
maturation, oocytes were stripped of their cumulus investments by pipetting repeatedly in
TL-HEPES (BioWittaker, Walkersville, MD) supplemented with 210 units/mL of hyaluronidase
(Sigma). The oocytes were washed in modified TL-HEPES (mTLH; TL-HEPES supplemented
with 10% FBS and gentamicin) and nuclear maturation was established by visualization of the
first polar body under a dissecting microscope.
Nuclear Transfer
Groups of 25 metaphase-II llama oocytes were labeled with 2 µg/mL of Hoechst-33342
for 3 min to allow visualization of the metaphase plate. Micromanipulation was performed in a
180-µL elongated droplet of mTLH containing 6 µg/mL of cytochalasin D (Sigma) overlaid with
mineral oil (Sigma). All micromanipulations were conducted on an inverted microscope (Nikon
Diaphot) equipped with Hoffman Modulation Contrast objectives, a pair of Narishige
micromanipulators and epifluorescent illumination. Oocytes were held by negative pressure
applied to a holding pipette (120 µm outside diameter). After brief (<20 s) exposure to ultraviolet
light to visualize nuclear DNA, the metaphase plate and polar body with a small amount of
surrounding ooplasm were removed by negative pressure applied to an enucleation pipette
(20 µm outside diameter, 35º bevel, spiked). Once enucleated, the cytoplasts were held in
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modified TCM (mTCM; TCM-199 supplemented with 10% FBS and gentamicin) at 38.5ºC and
5% CO2.
Donor cells prepared for use as nuclear donors for NT were at passage three of culture.
Prior to NT procedures the donor cells were serum starved (0.5% FBS) for 3 to 5 d to induce
quiescence. A single cell suspension was prepared by trypsinization and cells were immediately
used for transfer into cytoplasts. Reconstruction was performed in groups of 30 cytoplasts.
Micromanipulation was performed in a 180-µL elongated droplet of mTLH containing 6 µg/mL
of cytochalasin D (Sigma) overlaid with mineral oil. A single adult llama fibroblast (15 to 20 µm
diameter) was inserted into the perivitelline space of an enucleated oocyte and close contact
between the donor cell membrane and oolema was visually confirmed.
Fusion of karyoplast-cytoplast couplets was performed in a microslide fusion chamber
with stainless steel electrodes separated by a 1-mm gap. The chamber was filled with fusion
buffer (0.3 M mannitol, 0.1 mM MgSO4.7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4 mg/mL
of BSA) and couplets were manually aligned and fused by two consecutive DC pulses (1.4
kV/cm for 25 µs) delivered by a BTX Electrocell Manipulator 200 (Gentronics, San Diego, CA).
Couplets were evaluated for fusion by microscopic examination within a 1-h period and
activation was immediately performed on the fused couplets. Chemical activation was performed
by a 5-m exposure to 5 µM ionomycin (Sigma) followed by a 3-h incubation in 10 µg/mL of
cycloheximide (Sigma) prepared in either in CR1aa medium (Rosenkrans et al., 1993) or G1.2™
(Vitrolife, Vero Beach, FL) medium.
Embryos were cultured in 35-µL droplets of CR1aa medium (Treatment A) or G1.2™
medium (Treatment B) at 38.5ºC and 5% O2, 5%CO2 and 90% N2 humidified atmosphere and
cleavage was assessed on d 2 of culture.
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Transfer of NT Llama Embryos
All the embryo transfers to recipient llamas (surgical and nonsurgical) were performed 4
to 5 d after gonadotropin releasing hormone (GnRH) analog administration. Recipients were
administered 40 µg of gonadorelin diacetate tetrahydrate (Cystorelin®, Merial, Duluth, GA) i.m.
when a follicle of 9 to 13 mm was present in the ovary. Transfers to recipient llamas coincided
with 4 d of embryo in vitro culture.
For the surgical transfers, llamas were placed in dorsal recumbency position and a
standard mid-ventral laparotomy procedure was performed. The uterus and uterine tubes were
exteriorized and embryos were transferred to the left oviduct, irrespective of the side of ovulation. A small plastic Embryon catheter (Rolon Medical, UK) was inserted through the ostium
advancing the catheter as far as possible into the infundibulum of the oviduct and embryos
(2 per female) were transferred (range = 8- to 32-cell stage). One embryo (morula stage) was
transferred nonsurgically. Using a Cassou artificial insemination (AI) apparatus and a 0.25-mL
plastic semen straw the embryo was transferred into the left uterine horn of a synchronized
recipient.
Pregnancy status was verified on d 14 and 21 post-transfer by ultrasonography. Although
one female that received embryos from Treatment A exhibited a small amount of uterine fluid,
no pregnancies were confirmed.
Statistical Analysis
Mean cleavage rate of NT llama embryos and embryo development rate were compared
by Chi-square analysis. The differences between groups were considered to be statistically
significant when P<0.05.
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Results
Superstimulation, Oocyte Aspiration and Maturation
Of a total of 14 superstimulated females, 7 (50%) were classified as good responders as
determined by presence of ovarian follicles, 2 (14%) were classified as medium responders and
5 (36%) were classified as poor responders (Figure 4.3).
A total of 307 follicles were aspirated from both good and medium responders, and a
total of 298 (97%) oocytes were recovered. There was a significant difference in the number of
oocytes recovered from good (261/264) compared with the medium (37/43) responders (P<0.05).
The mean (± SEM) number of ovarian follicles per aspirated female was 37.7 ± 3 and 21.5 ± 2.5
for good and medium responders, respectively. The mean number of oocytes recovered was
37.3 ± 5.6 and 18.5 ± 3.5 for good and medium responders, respectively (Table 4.1).
In vitro maturation results are presented in Table 4.2. Of a total of 298 oocytes aspirated,
69 were damaged during transport or subsequent stripping; therefore they were not included in
the group evaluated for nuclear maturation. Of the 229 remaining oocytes, 52% reached nuclear
maturation (metaphase-II stage) and 48% were classified as immature oocytes. Of these
immature oocytes, 16% were at the germinal vesicle (GV) stage, 8% had germinal vesicle
breakdown (GVBD) and 23% were in metaphase-I (M I) stage.
Nuclear Transfer
Of a total of 120 metaphase-II oocytes (Figure 4.4), 84 (70%) were successfully
enucleated, 80 (95%) were reconstructed with female adult llama fibroblasts and 50 (62.5%)
fused. The fused couplets were randomly allocated (25 per treatment) to culture in CR1aa
medium (Treatment A) or G1.2 medium (Treatment B).
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a

b

Figure 4.3. Ovarian response to stimulation protocol. (a) Ultrasound image of
ovary from female classified as good responder. (b) Excised ovaries from FSHstimulated female llama.
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Table 4.1. Number of follicles aspirated and oocytes recovered from superstimulated female llamas
Ovarian
response

No. of
llamas

No. follicles
aspirated

No. (%) oocytes
recovered

Good

7

264

261 (99)a

Medium

2

43

37 (86)b

Total

9

307

298 (97)

a,b

Values with different superscripts within a column are significantly different (Chi square analysis, P<0.05).

68

Table 4.2. Nuclear status of llama oocytes after 30 h of in vitro maturation
Immature

Mature

No. oocytes
aspirated

No. oocytes
strippeda

GVb

GVBDc

M Id

M IIe

298

229

37 (16%)

19 (8%)

53 (23%)

120 (52%)

a

Total oocytes not damaged during transport.
Germinal vesicle.
c
Germinal vesicle breakdown.
d
Metaphase-I.
e
Metaphase-II.
b
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a

b

40 µm

40 µm

Figure 4.4. Metaphase-II llama oocytes prior to enucleation. (a) At metaphase-II selection, 40 X objective. (b) Prior to enucleation,
40 X objective.
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Cleavage and transfer results are shown in Table 4.3. There was no effect of culture
treatments on the number of couplets cleaved (d 2) or transferred (d 4). Cleavage rate was 32 %
for Treatment A and 40 % for Treatment B (Fig. 4.5). There were no significant difference in
cleavage rate between treatments (P<0.05).
Four 8- to 16-cell stage embryos from Treatment A and six 8- to 16-cell stage embryos
from Treatment B were surgically transferred to the left oviduct of five synchronized recipients
(2 embryos per female). One morula-stage embryo from Treatment A was nonsurgically
transferred to the uterus of one synchronized recipient. Labeling of the remaining nontransferred
embryos with Hoechst-33342 revealed presence of nuclei in the blastomeres (Figure 4.6).
Ultrasonography at 14 d post-transfer verified that no pregnancies were established.

Discussion
In previous studies, superstimulation was used mainly for embryo production and embryo
transfer (Taylor et al., 2001). The ovarian response in past studies was variable and in most cases
it was measured in terms of number of ovulations and embryo recovery rates (Correa et al., 1997;
Ratto et al., 1997, 2002), not in terms of oocyte production. Only one study (Brogliatti et al.,
2000) reported the use of superstimulation followed by TUGA in llamas with the objective of
oocyte collection, producing a 52% oocyte recovery rate. Our present study resulted in a 64%
ovarian response, yielding a 97% oocyte recovery rate and a mean of 33 recovered oocytes per
animal. These results are comparable with those obtained by Del Campo et al. (1994), who used
nonstimulated, abattoir ovaries, reporting a mean oocyte recovery of 27 oocytes per llama. Their
study also reported 26 degenerate oocytes unsuitable for IVM, which indicates some oocytes
likely came from regressing or atretic follicles. Interestingly, oocytes examined in our study did
not reveal signs of degeneration. A possible explanation is that two DFR procedures prior to the
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Table 4.3. Cleavage and embryo transfer results from two in vitro culture treatmentsa
Treatment
group

No. fused
couplets

No. (%)
cleaved

No. (%)
transferredd

No.
pregnant

A (CR1aa) mediumb

25

8 (32)

5 (62.5)

0

B (G1.2) mediumc

25

10 (40)

6 (60)

0

a

No significant differences between treatment groups.
Rosenkrans et al. (1993).
c
Vitrolife, Vero Beach, FL.
d
Ten 8- to 16-cell stage embryos were surgically transferred to 5 recipients, 1 morula-stage embryo was nonsurgically
transferred to one synchronized recipient.
b
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a

b

c

40 µm

40 µm

40 µm

Figure 4.5. Llama embryos (d 2) produced by somatic cell nuclear transfer (40X objective). (a) A 2-cell NT llama embryo (Treatment
A). (b) A 3-cell NT llama embryo (Treatment A). (c) An 8-cell NT llama embryo (Treatment B).
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40 µm

Figure 4.6. A 2-cell llama NT embryo labeled with Hoechst-33342 to
visualize nuclei in blastomeres (40 X objective).
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initiation of superstimulation were effective in ensuring the start of a new cohort of follicles that
were in the growing phase at the time of ovariectomy. In addition, there have been few reports of
IVM of llama oocytes. Del Campo et al. (1994) have reported a 30.4% nuclear maturation which
was lower than the 52% achieved in the present study.
To our knowledge, this is the first report of somatic cell NT, in vitro culture and transfer
of NT embryos in the llama. Although llama oocytes appeared darker than goat oocytes, the
micromanipulation protocol previously used for the goat in our laboratory (Reggio et al., 2001)
was effective in the enucleation and reconstruction of llama oocytes. This study has shown that
serum-starved llama adult fibroblasts nuclei can be activated by ooplasmic factors and are
suitable donor karyoplasts for NT in the llama. Exposure of presumably quiescent nuclei to
ooplasmic factors for a 3-h period resulted in 32% and 40% of cleaved embryos from Treatments
A and B, respectively.
In the present study, activation of reconstructed couplets was accomplished using
ionomycin prior to inhibition with cycloheximide (CHX), a nonspecific inhibitor of protein
synthesis. Ionomycin increases free cytosolic calcium resulting in decreased maturation promoting factor (MPF) levels. However, no single activation agent available is known to induce
physiological calcium oscillations capable of supporting development. Therefore, compounds
such as CHX or dimethylaminopurine (DMAP) are used to prevent calcium levels from dropping
before MPF inactivation takes place. Studies completed in mice (Gordo et al., 2000), pigs (Knott
et al., 2002) and horses (Choi et al., 200a, 2002b) have suggested that certain species may heed
on the injection of sperm cytosolic factor to induce adequate calcium oscillations and trigger the
initiation of development of reconstructed NT embryos. It is possible that the microinjection of
sperm cytosolic factor might be beneficial in the llama.
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We have demonstrated that llama NT transfer embryos can be produced from traditional
NT protocols. These results have implications not only in the conservation of superior genetics in
the llama, but also in future applications of NT technology for the conservation of endangered
species. In the future, interspecies NT using llama oocytes and vicuña karyoplasts could apply to
the conservation of the vicuña. Further research should focus on developing protocols to improve
NT efficiency in the llama, as well as basic research on cell cycle characteristics of the llama and
the vicuña.

76

CHAPTER V
INTERSPECIES NUCLEAR TRANSFER IN THE HORSE AND THE
LLAMA USING BOVINE RECIPIENT CYTOPLASTS
Introduction
Even though numerous improvements made since the announcement of Dolly’s birth, the
efficiency of the nuclear transfer (NT) procedure remains low, and the percentage of live
offspring obtained after the transfer of embryos usually does not exceed 3% (Wilmut et al., 1997;
Cibelli et al., 1998; Wakayama et al., 1998; Campbell, 1999; Dominko et al., 1999b; Colman,
2000). In addition, the high embryonic loss and perinatal mortality observed with the NT
procedure requires that large number of oocytes must be available for the numerous attempts
needed to establish pregnancies and produce live offspring (Colman, 2000; Hill et al., 1999,
2000a, 2000b, 2001a, 2001b).
In several domestic and exotic species, the low numbers of animals available for oocyte
collection and embryo transfer, coupled with the low rates of oocyte recovery and maturation
preclude the use of traditional NT protocols. Several studies have demonstrated that the bovine
cytoplast is capable of reprogramming somatic cell nuclei from other species including the horse
(Hinrichs et al., 2000b; Reggio et al., 2000; Li et al., 2002), pig (Yoon et al., 2001), tiger (Hwang
et al., 2001), Korean cattle (Roh and Yoon, 2001), human (Cibelli et al., 2001), buffalo
(Kitiyanant et al., 2001; Saikhun et al., 2002), saola (Bui et al., 2002), bongo (Lee et al., 2002),
goat (Park et al., 2003), mouse (Koo et al., 2003), black bear (Ty et al., 2003) and eland
(Damiani et al., 2003). In one of the first studies exploring the potential of the bovine oocyte as a
universal recipient for NT, skin fibroblast cells from cows, sheep, pigs, monkeys and rats were
used as sources of nuclei while undergoing progression through the cell cycle to achieve various
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degrees of development (Dominko et al., 1999a). Although no pregnancies were established, this
study speculated that the mechanisms involved in regulating early embryonic development might
be conserved among mammalian species. Even though many studies have been conducted, only
2 live offspring have been reported to date in the scientific literature. A live birth was produced
using gaur (Bos gaurus) somatic cells nuclei transferred into readily available domestic cow
cytoplasts (Lanza et al., 2000). Also, a cloned endangered sheep was produced by injecting
mouflon (Ovis orientalis musimon) somatic cells obtained from a deceased animal into the
enucleated cytoplasts of domestic sheep (Loi et al., 2001).
Both the horse and the llama are species that could clearly benefit from the use of an
alternative source of cytoplast for NT procedures. The low number of oocytes available for
research (Cochran et al., 2000; Brogliatti et al., 2000; Brown, 2000; Hylan et al., 2002; Ratto et
al., 2002), the variable oocyte maturation rates reported by several laboratories (Choi et al.,
1993; Del Campo et al., 1994; Correa et al., 1997; Hinrichs and Schmidt, 2000a; Tremoleda et
al., 2001), the lack of understanding of the optimal in vitro conditions required for embryo
culture and blastocyst production (Dell'Aquila et al., 2003; Vanderwall, 1996) and the need to
perform cumbersome oviduct transfers to recipients to avoid prolonged periods in culture would
make interspecies NT a valuable tool in the study of the factors that affect the development of
cloned embryos in both species.
Therefore, the main objective of this study was to evaluate the ability of the bovine
cytoplast to reprogram nuclei from horse and llama donor cells. Additionally, an effort was made
to use the development of interspecies NT embryos to compare donor cells used as karyoplast
donors. The specific objectives of Experiment 5.1 were (a) to use the in vitro development of
horse interspecies NT embryos as a tool for screening cell line cloning efficiency and (b) to
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compare the early development of horse interspecies NT embryos produced with either
proliferating or serum-starved donor cells. In Experiment 5.2, the objective was to compare
female and male adult llama fibroblast cell lines by monitoring in vitro embryo development.

Materials and Methods
Experiments 5.1(a) and 5.1(b)
Preparation of Horse Donor Cells
Skin biopsies (6 mm2) were taken from two adult mares (Experiment 1a, Treatments A
and B) of similar age (14 to 16 years), body weight (500 to 600 kg) and body condition score (8
to 8.5, on scale 1 to 9) using a 6-mm diameter biopsy punch (Miltex Instrument Co, Bethphage,
NY). One adult female bovine cell line (Treatment C) was obtained from a 7-year old Angus
cow. All skin samples were obtained from the epidermal and dermal layer overlaying the
serratus cervicis muscle, and all samples were processed identically on the same day, using the
same medium, by the same technician. Briefly, the epidermal layer and fat were trimmed and
discarded. The remaining tissue was minced finely and washed three times, placed in 35-mm
tissue culture plates, covered with 1 mL of tissue culture media consisting of TCM-199, 10%
FCS (HyClone, Logan, UT) and 1% genatmicin, and incubated at 38.5ºC in humidified
atmosphere of 5% CO2.
After a fibroblast monolayer had formed around the tissue explants, cells were allowed to
reach 95% confluency at which time they were trypsinized and re-seeded into 25 cm2 flasks. All
cell lines used in the study were between the 3rd and 4th subpassage. Experimental designs for
Experiments 5.1(a) and 5.1(b) are shown in Tables 5.1 and 5.2, respectively. Treatment groups
for Experiment 5.1(a) consisted of enucleation and reconstruction with two adult female equine
fibroblast cell lines (Treatments A and B), one adult female bovine fibroblast cell line
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Table 5.1. Experimental design for Experiment 5.1(a): Equine cell line A vs. equine cell line B
Treatment group

Source of cells/gametes

Treatment A

Adult female equine fibroblasts (cell line A)a

Treatment B

Adult female equine fibroblasts (cell line B)b

Treatment C

Adult female bovine fibroblastsc

Treatment D

Enucleated / activated bovine oocytesd

Treatment E

Parthenogenically activated bovine oocytesd

a,b

Adult equine fibroblast cells derived from skin biopsies obtained from two cycling mares of similar age and body weight.
Adult bovine fibroblast cells derived from a skin biopsy obtained from an Angus cow.
d
Bovine oocytes were obtained from abattoir.
c
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Table 5.2. Experimental design for Experiment 5.1(b): Serum starved vs. proliferating equine
donor cells
Treatment group

Source of cells/gametes

Treatment A

Serum-starved adult female equine fibroblastsa

Treatment B

Proliferating female equine fibroblastsb

Treatment C

Enucleated / activated bovine oocytesc

Treatment D

Parthenogenically activated bovine oocytesc

a

Adult equine fibroblasts serum-starved (0.5% FBS) for 3 to 5 consecutive days prior NT.
Adult equine fibroblasts allowed to proliferate (10% FBS) in culture.
c
Bovine oocytes were obtained from abattoir.
b
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(Treatment C), an enucleation/activation bovine oocyte control group (Treatment D) and
parthenogenically activated bovine oocytes (Treatment E). Treatment groups for Experiment
5.1(b) consisted of enucleation and reconstruction with either proliferating or serum-starved
(serum concentration of the cell culture medium was reduced from 10% to 0.5% FBS 3 to 5 d
prior to the NT procedure to induce presumptive quiescence) equine fibroblast cells from a single
mare (Treatments A and B), an enucleation/activation bovine oocyte control group (Treatment
C) and parthenogenically activated bovine oocytes (Treatment D). To avoid bias, the cell line
identity was coded randomly blinded until the culmination of the experiment. Unless otherwise
stated, experimental procedures for Experiments 5.1(a), 5.1(b) and 5.2 were identical.
Nuclear Transfer
Abattoir-derived oocytes were obtained (Ovagenix, San Angelo, TX), matured overnight
and shipped by air courier. Cumulus-oocyte complexes (COC) were denuded after 18 to 22 h of
maturation by vortexing in 1.2 mg/mL of hyaluronidase (Sigma). Mature, metaphase-II oocytes
were selected under a dissecting scope based on the visualization of a first polar body, and
randomly assigned to treatment groups. Nuclear DNA was labeled with 3 µg/mL of Hoechst33342. Bovine oocytes were enucleated in an elongated 150-µL micromanipulation droplet
containing 6 µg/ml of cytochalasin D (Sigma) overlaid with embryo tested mineral oil (Sigma)
on the stage of an inverted microscope (Nikon Diaphot) equipped with Hoffman Modulation
Contrast objectives, Narishige micromanipulators, Uniblitz VMM-D1 shutter system (Vincent
Associates, Rochester, NY) and epifluorescent illumination. Enucleated bovine cytoplasts were
reconstructed by the injection of a single donor cell into the perivitelline space. To improve
membrane contact prior to electrofusion, a small amount of ooplasm was aspirated into the
injection pipette and expelled along with the donor cell.
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Fusion of the interspecies couplets was performed in a microslide fusion chamber with
stainless steel electrodes separated by a 1-mm gap. The fusion medium consisted of 0.3 M
mannitol, 0.1 mM MgSO4⋅7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4 mg/mL of BSA
(Fraction V, Sigma). The couplets were fused by two consecutive DC pulses (1.9 kV/cm for
25 µs) delivered by a BTX Electrocell Manipulator 200 (Genetronics, San Diego, CA). At this
time, the bovine oocytes allocated to the parthenogenic activation treatment group were placed in
the microslide fusion chamber and pulsed once (1.9 kV/cm for 25 µs) to initiate activation.
All treatment groups were chemically activated by a 4-min exposure to 5 µM of
ionomycin (Sigma) followed by 5 min in TL-HEPES with 30 mg/mL BSA (Fraction V, Sigma)
and 3-h incubation in 10 µg/mL of cycloheximide (Sigma) with 6 µg/mL of cytochalasin D
prepared in CR1aa medium (Rosenkrans et al., 1993) and cultured in 35-µl droplets of CR1aa
medium in a modular incubator chamber (Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5%
O2, 5%CO2 and 90% N2 in humidified atmosphere. Embryos were evaluated for cleavage after 2
d of in vitro culture and the medium was then replaced with CR1aa with 5% FBS and allowed to
proceed in culture for 5 more days.
Embryo Transfers - Experiment 5.1(a)
After 3 days of in vitro culture, quality grade-1 embryos were selected and transferred
surgically to the oviduct of synchronized recipient mares (n=2). Embryos (all quality grade-1)
were transferred (4 embryos per recipient mare) to the oviduct ipsilateral to the corpus luteum. A
plastic Embryon catheter (Rolon Medical, UK) was inserted through the ostium advancing the
catheter as far as possible into the infundibulum of the oviduct and interspecies equine NT embryos (4 embryos from Treatment A and 4 embryos from Treatment B) were gently expelled
along with 30 to 50 µL of transfer medium (TL-HEPES supplemented with 10% FBS and 1%
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gentamicin). All recipient mares were treated with oral altrenogest (Regumate® Hoechst Roussel
Vet., Warren, NJ; 0.444 mg altrenogest/kg body weight) daily, beginning on the day of embryo
transfer and continuing until pregnancy status was determined by rectal ultrasonography (Aloka
500, 5 MHz transducer, Aloka Co., Tokyo, Japan) on d 14 d post-transfer.

Experiment 5.2
Preparation of Llama Donor Cells and Nuclear Transfer
Skin biopsies were obtained from animals in a llama herd located in Bozeman, Montana
(Genesearch, Inc., Bozeman, MT). Two healthy adult llamas (one male and one female) were
sampled. Animals were led into a palpation chute and allowed to spontaneously adopt sternal
recumbency position. Fiber from the hip area was clipped and scrubbed with povidone, cleansed
with 70% ethanol and allowed to air-dry. A 6-mm biopsy of the epidermal and dermal layer
overlaying the gluteus superficialis muscle was taken using a biopsy punch tool (Miltex
Instrument Co, Bethphage, NY) and placed in TCM-199 supplemented with 1% v/v gentamicin.
Tissue samples were kept refrigerated (4˚C) until processed (within 24 h of collection). All skin
samples were processed on the same day using the same medium, by the same technician.
Primary cell cultures and establishment of cell lines were prepared as described in Experiment
5.1.
For NT procedures, both male and female cell cultures were between the 2nd and 3rd
subpassage and were serum-starved (0.5% FBS, 3 to 5 d prior to NT procedure). To avoid bias,
cell line identity was randomly coded until the culmination of the experiment. Treatment groups
for Experiment 5.2 consisted of enucleation and reconstruction with either male or female adult
llama fibroblasts, which had been serum-starved (0.5% FBS) for 3 to 5 d prior to NT (Treatments
A and B), one adult female bovine fibroblast cell line (Treatment C), an enucleation/activation

84

bovine oocyte control (Treatment D) and parthenogenically activated bovine oocytes (Treatment
E) (Table 5.3). Nuclear transfer procedure was conducted in a similar manner to that described in
Experiment 5.1.
Statistical Analysis
Mean cleavage rates on d 3 of in vitro culture were compared across treatment groups by
Chi-square analysis (SAS Institute, 1995). Different mean values between treatment groups were
considered statistically significant at the P<0.05 level.

Results
Experiment 5.1(a)
This experiment was conducted in replicates to evaluate the development of NT embryos
reconstructed with two equine cell lines. Four replicates consisted of interspecies nuclear transfer
using equine cell line A (Treatment A), 4 replicates consisted of interspecies nuclear transfer
using equine cell line B (Treatment B) and 4 replicates consisted of nuclear transfer using a
bovine cell line (Treatment C). In addition, bovine oocytes were enucleated and activated as a
control to ensure effective removal nuclear DNA from the oocyte (Treatment D) and
parthenogenic activation of bovine metaphase-II oocytes was included to control for activation
protocol and in vitro culture conditions (Treatment E). Replicates using equine cell lines A
(Treatment A), B (Treatment B), or bovine cell line (Treatment C) were performed in alternate
order, with both Treatments D and E included in each one of the treatment replicates.
The development of interspecies horse embryos in vitro is summarized in Table 5.4. Of a
total of 146 bovine cytoplasts reconstructed with equine cell line A (Treatment A), 54% were
fused following two electrical pulses. Of fused couplets, 70% of the embryos cleaved but none
reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell stage. Of a
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Table 5.3. Experimental design for Experiment 5.2: Female vs. male llama cell lines
Treatment group

Source of cells/gametes

Treatment A

Adult female llama fibroblastsa

Treatment B

Adult male llama fibroblastsb

Treatment C

Adult female bovine fibroblastsc

Treatment D

Enucleated/activated bovine oocytesd

Treatment E

Parthenogenically activated bovine oocytesd

a

Adult female llama fibroblast cells derived from a skin biopsy obtained from a female llama in Bozeman, MT.
Adult male llama fibroblast cells derived from a skin biopsy obtained from a male llama in Bozeman, MT.
c
Adult bovine fibroblast cells derived from a skin biopsy obtained from an Angus cow.
d
Bovine oocytes were obtained from abattoir.
b
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Table 5.4. Development of interspecies equine embryos reconstructed with adult equine female cell lines A and B
Treatment
group

Cell
donor

No. of M II1
oocytes

No. (%)
fused

No. (%)
cleaved

No. (%)
BLST

No.
transferred

No.
recipients

No.
pregnant

Treatment A

Equine

146

79 (54)

55 (70)a

0

4

1

0

Treatment B

Equine

134

80 (60)

40 (50)b

0

4

1

0

Treatment C

Bovine

138

70 (51)

36 (51)b

18 (26)

-

-

-

Treatment D

Enucleated/activated

154

154 (100)@

97 (63)b

0

-

-

-

Treatment E

Parthenogenic

136

136 (100)@

84 (62)b

40 (29)

-

-

-

ab

Values with different superscripts in the same column are significantly different (Chi square; P<0.05).
1
M II = metaphase-II spindle.
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation.
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total of 134 bovine cytoplasts reconstructed with equine cell line B (Treatment B), 60% were
fused following two electrical pulses. Of the fused couplets, 50% of the embryos cleaved but
none reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell stage.
Of a total of 138 bovine cytoplasts reconstructed with a bovine cell line (Treatment C),
51% were fused following two electrical pulses. Of fused couplets, 51% of the embryos cleaved
and 26% of the fused couplets reached the blastocyst stage after 168 h of in vitro culture. Of a
total of 154 enucleated and activated bovine cytoplasts (Treatment D), 63% of the embryos
cleaved but none reached the blastocyst stage, with all the embryos arresting between the 8- to
16-cell stages.
A total of 136 parthenogenically activated bovine oocytes (Treatment E), 62% cleaved
and 29% reached the blastocyst stage after 168 h of in vitro culture. There was no significant
difference in the number of fused couplets among treatment groups. However, the equine cell
line A used as karyoplast donor (Treatment A) had a significantly greater (P<0.05) cleavage rate
than the rest of the treatments. No pregnancies resulted from the 8 embryos transferred to two
synchronized recipient mares.

Experiment 5.1(b)
This experiment was conducted in replicates to compare the development of NT embryos
reconstructed with either proliferating or serum-starved equine donor cells. Four replicates
consisted of interspecies nuclear transfer using serum-starved adult equine fibroblasts (Treatment
A) and 4 replicates consisted of interspecies nuclear transfer using proliferating equine
fibroblasts (Treatment B). In addition, bovine oocytes were enucleated and activated as a control
to ensure effective removal of nuclear DNA from the oocyte (Treatment C) and parthenogenic
activation of bovine metaphase-II oocytes was included to control for activation protocol and in
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vitro culture conditions (Treatment D). The replicates using serum-starved (Treatment A) or
proliferating (Treatment B) equine donor cells were performed in alternate order, with both
Treatments C and D included in each of the replicates as in-house controls.
Development of interspecies horse embryos reconstructed with proliferating or serumstarved donor cells is summarized in Table 5.5. Of a total of 103 bovine cytoplasts reconstructed
with serum-starved horse fibroblasts (Treatment A), 79% were fused following two electrical
pulses. Of fused couplets, 80% of the embryos cleaved but none reached the blastocyst stage,
with all the embryos arresting at the 8- to 16-cell stage in vitro. Staining with Hoechst-33342 at
the end of in vitro culture revealed that 89% of the embryos had nuclei in all blastomeres (Figure
5.1). Of a total of 102 bovine cytoplasts reconstructed with proliferating horse fibroblasts
(Treatment B), 63% were fused after two electrical pulses. Of fused couplets, 66% of the
embryos cleaved but none reached the blastocyst stage, with all the embryos arresting between
the 8- to 16-cell stage. Of these embryos, 71% revealed nucleated blastomeres after Hoechst33342 staining.
Of a total of 105 enucleated and activated bovine cytoplasts (Treatment C), 74% of the
embryos cleaved but none reached the blastocyst stage. As expected, staining revealed that none
of these embryos had nuclei in any of the blastomeres. Of a total of 101 parthenogenically
activated bovine oocytes (Treatment D), 84% cleaved and 28% reached the blastocyst stage after
168 h of in vitro culture.
Embryos reconstructed with serum-starved (Treatment A) donor cells had a significantly
higher (P<0.05) fusion rate than those reconstructed with proliferating (Treatment B) donor cells.
The number of embryos from proliferating donor cells that cleaved after two days of culture was
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Table 5.5. Development of interspecies equine embryos reconstructed with serum-starved or proliferating adult equine fibroblasts
Cell
donor

No. of M II1
oocytes

No. (%)
fused

No. (%)
cleaved

No. (%)
BLST

No. (%)
nucleated blastomeres

Treatment A

Equine serum-starved

103

81 (79)a

65 (80)a

0

58 (89)a

Treatment B

Equine proliferating

102

64 (63)b

42 (66)b

0

30 (71)b

Treatment C

Enucleated/activated

105

105 (100)@

78 (74)a

0

0 (0)

Treatment D

Parthenogenic

101

101 (100)@

85 (84)a

28 (28)

85 (100)

Treatment
group

abc

Values with different superscripts in the same column are significantly different (Chi square; P<0.05).
M II = metaphase-II spindle.
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation.
1

90

a

b

40 µm

40 µm

Figure 5.1. Eight-cell interspecies horse NT embryos (a) With Hoechst-33342 staining. (b) Without Hoechst-33342 staining, 40 X
objective.
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significantly lower (P<0.05) than the number of cleaved embryos in the rest of the treatments.
Nuclei staining revealed a higher (P<0.05) number of embryos with non-nucleated blastomeres
in those reconstructed with proliferating donor cells than in those reconstructed with serumstarved cells.

Experiment 5.2
This experiment was conducted in replicates to evaluate the development of NT embryos
reconstructed with male and female llama cell lines. Three replicates consisted of interspecies
nuclear transfer using an adult female llama cell line A (Treatment A), 3 replicates consisted of
interspecies nuclear transfer using an adult male llama cell line B (Treatment B) and 3 replicates
consisted of nuclear transfer using a bovine cell line (Treatment C). In addition, bovine oocytes
were enucleated and activated as a control to ensure effective removal of the nuclear DNA of the
oocyte (Treatment D) and parthenogenic activation of bovine metaphase-II oocytes was included
to control for activation protocol and in vitro culture conditions (Treatment E). Replicates using
llama female (Treatment A), male (Treatment B), or bovine fibroblast cell lines (Treatment C)
were performed in alternate order, with both Treatment D and E included in each one of the
replicates. Cell line identity was randomly coded throughout the experiment to avoid bias.
Development of interspecies llama embryos is summarized in Table 5.6. Of a total of 164
bovine cytoplasts reconstructed with an adult female llama cell line (Treatment A), 63% were
fused following two electrical pulses. Of fused couplets, 53% of the embryos cleaved but none
reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell stage. Of a
total of 150 bovine cytoplasts reconstructed with an adult male llama cell line (Treatment B),
51% were fused following two electrical pulses. Of fused couplets, 51% of the embryos cleaved
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Table 5.6. Development of interspecies llama embryos reconstructed with either female or male llama donor cells
Cell
donor

No. of M II1
oocytes

No. (%)
fused

No. (%)
cleaved

No. (%)
BLST

Treatment A

Llama female

164

104 (63)

55 (53)

0

Treatment B

Llama male

150

76 (51)

39 (51)

0

Treatment C

Bovine

121

68 (56)

39 (57)

14 (20)

Treatment D

Enucleated/activated

124

124 (100)@

77 (62)

0

Treatment E

Parthenogenic

130

130 (100)b@

87 (67)

15 (11)

Treatment
group

1

M II = metaphase-II spindle.
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation.
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but none reached the blastocyst stage, with all the embryos arresting between the 8- to 16-cell
stage.
Of a total of 121 bovine cytoplasts reconstructed with a bovine cell line (Treatment C),
56% were fused following two electrical pulses. Of fused couplets, 57% of the embryos cleaved
and 20% of the fused couplets reached the blastocyst stage after 168 h of in vitro culture. Of a
total of 124 enucleated and activated bovine cytoplasts (Treatment D), 62% of the embryos
cleaved but none reached the blastocyst stage, with all the embryos arresting between the 8- to
16-cell stage. Of a total of 130 parthenogenically activated bovine oocytes (Treatment E), 67%
cleaved and 11% reached the blastocyst stage after 168 h of in vitro culture. No significant
differences were found in fusion and cleavage rates among treatment groups.

Discussion
The series of events that take place after the fusion of the recipient ooplasm and the donor
cell have been poorly described in the scientific literature. The nuclear remodeling and
reprogramming that enables a newly introduced genome to recall its embryonic characteristics
depends, among other factors, on the cell cycle stage of the recipient ooplasm and the donor cell.
The early stages of normal embryogenesis are regulated by maternally inherited gene
products stored in the oocyte cytoplasm. As development proceeds and maternally inherited
informational molecules decay, the process of early embryogenesis becomes dependent on the
expression of genetic information derived from the embryonic genome. There are speciesspecific differences in the developmental period at which the transition from control by maternally inherited molecules to that of embryonic genome-derived transcription products occurs.
The loss or decay of mRNA of maternal origin, the initiation of embryonic transcription, the
developmental arrest in presence of transcriptional inhibitor and the changes in protein synthesis
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pathways are the main characteristics of the events during embryo genome activation (Telford et
al., 1990).
The results of this study showed that the bovine recipient ooplasm is capable of
reprogramming somatic nuclei from other species. The fact that horse and llama interspecies NT
embryos progressed through a few mitotic divisions and nuclei were present in the blastomeres
indicates that the factors contained in the bovine ooplasm were capable of at least partially
reprogramming the foreign nucleus and driving cell division. In contrast, oocytes that were
enucleated and activated without the injection of a donor cell progressed only through one or two
mitotic divisions, showing high degrees of fragmentation and poor quality blastomeres.
In our study, however, neither of the horse nor llama interspecies NT embryos progressed
to the blastocyst stage and all embryos arrested consistently at the 8- to 16-cell stage in vitro. Although blastocyst stage interspecies sheep NT embryos have been reported in the past (Dominko
et al., 1999b), other groups have also reported a consistent in vitro developmental block in
interspecies horse, bear and goat NT embryos (Hamilton et al., 2003; Koo et al., 2003; Yoon et
al., 2001), which is supported by the findings in our present study.
In the cow, the timing of the switch from maternal to embryonic genome control appears
to occur at the 8- to 16-cell stage (Camous et al., 1984), although others have reported it to occur
as early as the 8-cell stage (Kopency et al., 1989a). When the qualitative patterns of protein
synthesis were examined at different stages of development, marked changes were detected in 8to 16-cell stage embryos (Frei et al., 1989). The quantitative and qualitative changes in protein
synthesis and the late onset of new RNA synthesis in bovine embryos is consistent with the
hypothesis that maternal messages are gradually degraded from fertilization through the 8-cell
stage, at which time control of transcription shifts from the maternal to the embryonic genome.
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As in mouse embryos, the shift from maternal stores to embryonic control of transcription in the
cow is associated with the in vitro developmental block observed in cultured embryos.
To date, the timing of genomic activation has not been described for the horse or the
llama. Recent evidence from equine NT experiments may indicate that the transition from maternal to genomic control occurs earlier in the horse that in the cow. Nuclear transfer experiments
conducted in the horse (using equine donor cells and recipient oocytes) have shown that high
proportions of reconstructed embryos arrested at the 2- to 4-cell stage (Choi et al., 2002a; Li et
al., 2002b; Choi et al., 2003; Li et al., 2003). Because maternally stored products in the bovine
cytoplast may last up to the 8- to 16-cell stage, it is possible that the arrest observed in our
interspecies study using horse and llama donor cells could be attributed to a lack of shift from the
maternal to embryonic control, thus resulting in the observed in vitro developmental block at the
time corresponding to the depletion of active maternal mRNA for the cow cytoplast.
The reasons for the lack of embryonic takeover in interspecies NT embryos still remain
unclear. Successful interspecies NT, either giving birth to live offspring or producing nearly
termed fetuses, has been achieved by several groups concerned with at the preservation of endangered species. When dermal fibroblasts of a gaur bull (Lanza et al., 2000), granulosa cells
from a deceased mouflon (Loi et al., 2001) and fetal fibroblasts of a water buffalo (Kitiyanant et
al., 2001) were introduced into enucleated oocytes from cow, sheep and cow, respectively, 12%,
30% and 33% of the reconstructed embryos developed to the blastocyst stage in vitro. One
cloned gaur was recovered after a late-term abortion and one mouflon was spontaneously delivered. The birth of live interspecies NT offspring suggests that the nuclear reprogramming
mechanisms among different species are conserved, in particular in closely related species. In
contrast, when nuclei from human somatic cells were transferred into enucleated bovine oocytes,
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only 6 of the 56 interspecies NT embryos produced developed to the 4- to 16- cell stage (Lanza
et al., 1999b). It is important to note that in all the live offspring produced to date by interspecies
NT all the recipient oocytes were recovered from a species closely related to the one providing
the donor somatic nuclei. It is possible that incompatibilities between nuclear and ooplasmic
components from more distant species are responsible for the limited success of other
interspecies NT experiments and also for the in vitro developmental block found in this
experiment.
Further research using serial nuclear transfer could be used in an attempt to overcome the
in vitro developmental block found in interspecies NT embryos. The technique of serial nuclear
transfer involves conducting a first NT procedure using somatic cells as nuclear donors and a
second NT procedure, this time using the blastomeres of the previously obtained NT embryos as
source of nuclei. This procedure has been reported to improve blastocyst rates in the rabbit
(Piotrowska et al., 2000), mice (Ono et al., 2001; Heindryckx et al., 2002), goats (Yong et al.,
1998) and this approach could be used in the interspecies model, in an attempt to overcome
nuclear-ooplasmic incompatibilities. A first interspecies NT procedure could be conducted using
a somatic donor cell and the bovine enucleated oocyte as Universal Recipient. The second NT
could be conducted using blastomeres from the interspecies NT embryos as nuclei donors.
The use of alternative NT techniques, such as interspecies NT, is an exciting possibility
for species with limited availability of oocytes and recipients. This study has demonstrated that
the interspecies model could be used to study events occurring during early embryonic
development. Although the bovine cytoplast seems capable of supporting a few mitotic divisions,
it is possible that heteroplasmy, mitochondrial incompatibilities or epigenetic effects may affect
nuclear-ooplasmic events occurring at the time of genomic activation.
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CHAPTER VI
BANTENG (Bos javanicus) EMBRYOS AND PREGNANCIES PRODUCED
BY INTERSPECIES NUCLEAR TRANSFER
Introduction
The banteng (Bos javanicus), a member of the bovidae family, was first characterized by
d’Alton in 1823 (Gotch, 1979). This unique bovid is mainly found in South-East Asia (below
2000 m), Java and Kalimantan. Today, the survival of the banteng is seriously threatened. The
species is extinct in India, Bangladesh and West Malaysia and the population is in decline on the
Asian mainland (IUCN/SCC, 1995). The number of banteng present in Thailand decreased by
approximately 80% during the past 25 years, and it is estimated that the total world population is
fewer than 10,000 animals (Srikosamatara and Suteethorn, 1995). The banteng is currently listed
as threatened by the IUCN Red List (2002), and a recent petition suggested it was included in
CITES list of endangered species (Duckworth and Hedges, 1998). Hunting, habitat degradation,
changes in the dynamics of the native species, hybridization and diseases from domestic
livestock have been the major reasons for the reduction in the wild banteng population
(IUCN/SCC, 1995).
Advanced reproductive technologies such as in vitro fertilization (IVF), artificial insemination (AI) and embryo transfer (ET) are becoming increasingly important tools in the
conservation and management of endangered species. Somatic cell nuclear transfer (NT) has
been successfully applied in Bos taurus and Bos indicus cattle using homologous oocytes,
resulting in the establishment of pregnancies and the production of live offspring. (Cibelli et al.,
1998; Galli et al., 1999; Shiga et al., 1999; Wells et al., 1999; Hill et al., 2000c; Kubota et al.,
2000). Also, the use of somatic cell NT has been suggested for the preservation of species
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threatened with extinction (Dominko et al., 1999a). The current low efficiencies of the NT
procedure, in addition to the high perinatal mortality, demand that numerous attempts are needed
to produce live offspring (Colman, 2000; Hill et al., 2000b, 2000c). In exotic or endangered
species, the lack of oocytes and recipients precludes the use of traditional somatic cell NT, and
an approach such as interspecies NT may be the only alternative to produce embryos and
offspring.
One of the first attempts of interspecies NT using the enucleated bovine oocyte as
recipient cytoplast was reported by (Dominko et al., 1999a). Monkey, sheep, pig and rat somatic
cells were used as donor karyoplasts, resulting in various degrees of early in vitro development,
however, no pregnancies were reported in this study. Further interspecies NT attempts using the
bovine cytoplast and the karyoplasts from other species include somatic cells from pigs (Yoon et
al., 2001), saolas (Bui et al., 2002), elands (Damiani et al., 2003), horses (Li et al., 2002a;
Sansinena et al., 2002), bears (Ty et al., 2003) and humans (Cibelli et al., 2001) .
Recently, a cloned gaur (Bos gaurus) was born after interspecies NT using bovine
oocytes but unfortunately died within the first 48 h (Lanza et al., 2000). In another study, two
pregnancies were established after interspecies NT using the domestic sheep (Ovis aries) as
recipient cytoplasts and an exotic argali (Ovis ammon) as donor karyoplasts. Both of these
pregnancies were then lost by 59 d of gestation (White et al., 1999). Also, domestic sheep (Ovis
aries) oocytes used as recipients for mouflon (Ovis orientalis musimon) cells resulted in one live
offspring (Loi et al., 2001) and enucleated oocytes of a mare used as recipients for somatic cells
of a mule have produced pregnancies (Woods et al., 2001) and two live offspring (Woods et al.,
2003) at the time of writing this literature review.
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Therefore, the objectives of this study were to evaluate the bovine oocyte as cytoplast
recipient of interspecies NT in the banteng. In addition, an effort was made to compare male and
female banteng cell lines by monitoring development of interspecies NT embryos.

Materials and Methods
Preparation of Banteng Donor Cells
Adult fibroblasts were isolated from 6-mm skin biopsies taken from one mature male
(726 kg) and one mature female (499 kg) adult bantengs (Peace River Refuge, Zolfo Springs,
FL). Primary cultures were obtained by mincing dermal tissue using sterile curved scissors in a
35 x 10-mm Falcon™ petri dish (Becton and Dickinson, Lincoln Park, NJ). The culture medium
consisting of TCM-199 (Gibco, Grand Island, NY) with 10% fetal bovine serum (FBS, HyClone,
Logan, UT) and 0.1% gentamicin (Gibco).
Tissue samples were washed by swirling the tissue suspension in a 15-mL centrifuge tube
and allowing the tissue to settle to the bottom. Supernatant was discarded and 3 mL of fresh
culture medium was added to the tube. This process was repeated three times, after which tissue
was transferred to a 35-mm petri dish. All but 500 to 700 µL of excess medium was aspirated to
allow oxygen tension over the tissue. All cultures were conducted at 38.5ºC and 5% CO2 in
humidified atmosphere.
Once a fibroblast cell layer was established (7 to 10 d), cells were grown in 25-cm2 tissue
culture flasks (Costar™, Cambridge, MA) until they reached 95% confluency. Cells were then
trypsinized (Sigma, St. Louis, MO), counted with a hemocytometer and re-seeded at a density of
100,000 cells in 25-cm2 tissue culture flasks. After two subpassages, cultured cells were exposed
to a cryoprotectant solution consisting of TCM-199, 20% calf serum, 5% dimethylsulfoxide
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(DMSO) and frozen in aliquots of 500,000 cells/mL of cryoprotectant in CryoTubes™ (Nunc,
Fisher Scientific, Pittsburgh, PA).
To prepare adult fibroblasts as donors for NT, the cells were thawed and cultured in
TCM-199 containing 10% FBS and 0.1% gentamicin in 25-cm2 tissue culture flasks.
Nuclear Transfer
Abattoir-derived oocytes were collected (Ovagenix, San Angelo, TX), matured overnight
and shipped by air courier. At 18 to 22 h of maturation, cumulus-oocyte complexes were
exposed to vortexing for 2 min in TCM containing 1.2 mg/mL of hyaluronidase (Sigma) to
remove cumulus investments. After removal of cumulus investments, all mature, metaphase-II
oocytes were selected, based on the visualization of a first polar body, and randomly assigned to
treatment groups. Treatment groups (Table 6.1) consisted of enucleation and reconstruction with
male adult banteng fibroblasts (Treatment A), female adult banteng fibroblasts (Treatment B)
and parthenogenically activated oocytes served as laboratory control (Treatment C).
Nuclear DNA was labeled with 3 µg/mL of Hoechst-33342 for 3 min. Oocytes were then
washed in modified TL-HEPES (mTLH; TL-HEPES supplemented with 10% FBS and 0.1%
gentamicin) and placed in groups of 25 oocytes in an elongated 150-µL micromanipulation
droplet containing 6 µg/mL of cytochalasin D (Sigma) overlaid with embryo tested mineral oil
(Sigma). All micromanipulations were conducted on the stage of an inverted microscope (Nikon
Diaphot) equipped with Hoffman Modulation Contrast objectives, Narishige micromanipulators,
Uniblitz VMM-D1 shutter system (Vincent Associates, Rochester, NY) and epifluorescent
illumination. A 120-µm diameter (o.d.) borosilicate pipette was used to hold the oocytes by
negative pressure. After a brief exposure (<5 s) to ultraviolet light to visualize nuclear DNA, the
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Table 6.1. Interspecies nuclear transfer (NT) in the banteng using male and female cell lines
Treatment group

Source of cells/gametes

Treatment A

Interspecies NT using male adult banteng fibroblastsa

Treatment B

Interspecies NT using female adult banteng fibroblastsb

Treatment C

Parthenogenically activated bovine oocytesc

a

Male adult banteng (Bos javanicus) fibroblast cells derived from a skin biopsy obtained from a male banteng in
Peace River Refuge, Zolfo Springs, FL.
b
Male female adult banteng (Bos javanicus) fibroblast cells derived from a skin biopsy obtained from a female
banteng in Peace River Refuge, Zolfo Springs, FL.
c
Bovine oocytes were obtained from an abattoir.
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polar body and metaphase spindle with a small amount of surrounding ooplasm were removed by
negative pressure applied to an enucleation pipette (20 µm o.d., 35º bevel, spiked).
Once enucleated, the cytoplasts were held in modified TCM (mTCM; TCM-199
supplemented with 10% FBS and 0.1% gentamicin) at 38.5ºC and 5% CO2 in humidified air.
Banteng adult fibroblasts were used as nuclear donors at the third subpassage of culture (Figure
6.1). Donor cells were serum starved (0.5% FBS) for 3 to 5 d to induce quiescence prior to NT
procedures. Reconstruction was performed in working groups of 25 cytoplasts in a 200-µL
elongated droplet of mTLH containing 6 µg/mL of cytochalasin D overlaid with mineral oil
(Sigma, embryo tested).
One single adult banteng fibroblast (15 to 20 µm in diameter) was inserted into the
perivitelline space of an enucleated oocyte. The fusion of karyoplast-cytoplast couplets was
performed in a microslide fusion chamber with stainless steel electrodes separated by a 1-mm
gap. The chamber was filled with fusion buffer (0.3 M mannitol, 0.1 mM MgSO4⋅7H2O, 0.05
mM CaCl2, 0.5 mM HEPES and 4 mg/mL of BSA (Fraction V, Sigma). The couplets were then
fused by two consecutive DC pulses (1.9 kV/cm for 25 µs) delivered by a BTX Electrocell
Manipulator 200 (Genetronics, San Diego, CA). The couplets were evaluated for fusion by
microscopic examination within a 1-h period. At this time, oocytes randomly allocated to the
parthenogenic activation treatment group were placed in the microslide fusion chamber and
pulsed once (1.9 kV/cm for 25 µs) to initiate activation.
Chemical activation of all treatment groups was performed by a 4-min exposure to 5 µM
of ionomycin (Sigma) followed by 5 min in TL-HEPES with 30 mg/mL BSA (Fraction V,
Sigma) and 2-h incubation in 10 µg/mL of cycloheximide (Sigma) with 6 µg/mL of cytochalasin
D prepared in CR1aa medium.
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a

b

Figure 6.1. Adult banteng fibroblasts. (a) Male banteng cell line, subpassage no. 2. (b) Female
banteng cell line, subpassage no. 2.
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The embryos produced were cultured in 35-µl droplets of CR1aa medium in a modular
incubator chamber (Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5% O2, 5% CO2 and
90% N2 humidified atmosphere. Embryos were checked for cleavage after 3 d of in vitro culture
and medium was then replaced with CR1aa with 5% FBS. Blastocysts were selected on 7 d of in
vitro culture (fusion = d 0) for nonsurgical transfer. Transfers were performed 7 d after naturally
occurring estrus (estrus = d 0) to mature, mixed breed, cycling beef cows (body condition score 6
to 8). Each recipient received two blastocysts of embryo quality grade-1 or -2 (in a range of 1 to
4, with grade-1 being the best quality and grade-4 being worst quality), transferred in CR1aa
with 5% FBS medium into the uterine horn ipsilateral to the corpus luteum. Pregnancy status was
assessed by rectal ultrasonography (Aloka 500, 5 MHz transducer, Aloka Co., Tokyo, Japan) at
30 and 60 d post-NT. Fetal viability was assessed by detection of fetal heartbeats.
Statistical Analysis
Mean cleavage rates on day 3 of in vitro culture and embryo development rate on day 7
were compared across treatment groups by Chi-square analysis (SAS Institute, 1995). In this
study, different mean values between treatment groups were considered statistically significant at
the P<0.05 level.

Results
This experiment was conducted in replicates to evaluate the development of NT embryos
reconstructed with male and female banteng fibroblasts. Four replicates consisted of interspecies
nuclear transfer using male adult banteng cell line (Treatment A) and 4 replicates consisted of
interspecies nuclear transfer using a female adult banteng cell line (Treatment B). In addition, a
parthenogenic control (Treatment C) was included in each of the replicates. Replicates using
male or female cell lines were performed in alternate order. All replicates of the experiment

105

yielded blastocysts following in vitro culture (Figure 6.2). Development of interspecies embryos
reconstructed with adult male and female banteng fibroblasts and parthenogenically activated
oocyte control is summarized in Table 6.2. Of a total of 143 enucleated cytoplasts in Treatment
A, 94% were successfully reconstructed with male banteng fibroblasts and 68% subsequently
fused following two electrical pulses. Of the fused couplets, 1% lysed post-fusion, 67% of the
embryos cleaved and 28% reached the blastocyst stage in 168 h of in vitro culture. Of a total of
205 enucleated cytoplasts in Treatment B, 90% were successfully reconstructed with female
banteng fibroblasts and 77% of these fused after two electrical pulses. Of the fused couplets,
12% lysed post-fusion, 51% of the embryos cleaved and 15% reached the blastocyst stage in 168
h. Of a total of 103 parthenogenically activated oocytes in Treatment C, 93% of the embryos
cleaved and 42% reached the blastocyst stage in 168 h.
There was no significant difference in the number of fused couplets among treatment
groups. However, there were significantly fewer (P<0.05) lysed couplets reconstructed with male
banteng cells (Treatment A) than in couplets reconstructed with female banteng cells (Treatment
B). No lysed oocytes were observed in the parthenogenic activation control (Treatment C).
Furthermore, the male adult banteng cell line used as a karyoplast donor (Treatment A) had a
significantly greater (P<0.05) cleavage rate and blastocyst production rate than the embryos
derived from the injection of the female adult banteng cells (Treatment B).
Embryo transfer and pregnancy data are summarized in Table 6.3. Of a total of 24
blastocysts transferred into 12 synchronized recipients (2 embryos per recipient) from the
embryos reconstructed with the male banteng cell line in Treatment A, two pregnancies (17%)
were established with normal appearing morphology and heartbeats detectable at 30 d of
gestation via rectal ultrasonography. The first singleton pregnancy was lost after d 40 d of
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a

b

100 µm

40 µm

c

d

40 µm

40 µm

Figure 6.2. Transferred interspecies NT banteng blastocysts. (a) Male cell line (Treatment A, 20
X objective. (b) Male cell line (Treatment A, 40 X objective). (c) Female cell line (Treatment B,
40 X objective). (d) Female cell line (Treatment B, 40 X objective).
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Table 6.2. Development of interspecies embryos reconstructed with male and female adult banteng fibroblasts
No. of M II1
oocytes

No. (%)
enucleated

No. (%)
reconstructed

No. (%)
fused

No. (%)
lysed2

No. (%)
cleaved

No. (%)
BLST

A (Male cell line)

143

143 (100)

134 (94)

91 (68)a

1 (1)a

60 (67)a

25 (28)a

B (Female cell line)

205

205 (100)

185 (90)

142 (77)a

17 (12)b

64 (51)b

19 (15)b

C (Parthenogenic)3

103

-

-

103 (100)@

0 (0)

96 (93)c

43 (42)c

Treatment
group

abc

Values with different superscripts in the same column are significantly different (Chi square; P<0.05).
M II = metaphase-II spindle.
2
Lysed post-activation.
3
Parthenogenic control consisted of chemically activated bovine oocytes.
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation.
1
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Table 6.3. Transfer of interspecies banteng NT embryos and pregnancy data
No. of
recipients1

No. of embryos
transferred

No. (%)
pregnant2,3

A (Male line)

12

24

2 (17)4

B (Female line)

7

14

0

C (Parthenogenic)

-

-

-

Treatment
group

1

Two embryos were nonsurgically transferred to the uterine horn ipsilateral to the ovary with a corpus luteum.
Pregnancy verified with heartbeats by rectal ultrasonography at 30 d of gestation.
3
Percentage based on the number of recipients.
4
One pregnancy was lost after 40 d of gestation and the second conceptus was lost after 65 d of gestation.
2
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gestation and the second pregnancy was lost after d 65 of gestation. No pregnancies resulted
from the transfer of 14 blastocysts transferred to 7 recipient females from the embryos
reconstructed with the female banteng cell line in Treatment B.

Discussion
The use of alternative NT techniques, such as interspecies NT, is an exciting possibility
for species with limited availability of oocytes and recipients. An in vitro developmental block
has been previously reported using this procedure (Yoon et al., 2001; Li et al., 2002a; Sansinena
et al., 2002, 2003a), particularly when the species of donor karyoplasts and recipient cytoplasts
are far apart in their taxonomic classification. An 8- to 16-cell stage in vitro developmental block
has previously been reported for the pig (Yoon et al., 2001), horse (Li et al., 2002a; Sansinena et
al., 2002) and llama (Sansinena et al., 2003a) when using bovine recipient cytoplasts. It has been
suggested that although the bovine cytoplast seems capable of supporting a few mitotic divisions,
heteroplasmy or mitochondrial incompatibilities may affect nuclear-ooplasmic events occurring
at the time of genomic activation (Sansinena et al., 2002).
Correspondingly, the interspecies NT research studies that have resulted in pregnancies,
namely the gaur (Lanza et al., 2000), the mouflon (Loi et al., 2001) and the banteng in the
present study have used animals of the same genus but different species both as source of
oocytes and surrogates for embryo transfers. Interspecies NT live offspring has previously been
reported in the gaur (Lanza et al., 2000) and the mouflon (Loi et al., 2001). In the study reported
by Lanza et al. (2000), domestic cattle (Bos taurus) oocytes were enucleated and gaur (Bos
gaurus) adult fibroblasts were used as donor cells, producing several pregnancies and one single
offspring that lived for a couple of days following birth. Cytogenetic analysis of cloned gaur
fetuses revealed a normal gaur karyotype of 58, and allele-specific PCR confirmed exclusively
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Bos taurus mtDNA in fetal tissues, indicating no detectable mitochondrial contribution from the
donor gaur cells. With a similar approach, Loi et al. (2001) used domestic sheep (Ovis aries)
oocytes as recipient cytoplast and mouflon (Ovis communis musimmon) donor granulosa cells as
donor karyoplasts. Two pregnancies were established, one resulting in a live birth and a viable
offspring.
In our study, no in vitro developmental block was detected using the banteng as donor
karyoplasts and the bovine cytoplast and embryos proceeded beyond the 8- to 16-cell stage to
achieve high blastocyst rates. Moreover, the two pregnancies established from the male cell line
overcame the reported stage of maternal recognition in the cow (Thatcher et al., 1995), indicating
these were actually viable embryos. Bantengs have 60 acrocentric chromosomes, similar to
domestic cattle, except for minor rearrangement seen on banding studies (Gallagher et al., 1999),
such as a metacentric Y-chromosome. The fact that both donor karyoplasts (banteng) and
recipient cytoplast (domestic cattle) species have a chromosome number of 60 may indicate that
chromosome number could be related to the in vitro developmental block found when
interspecies NT procedures were undertaken in species with dissimilar chromosome number.
Several studies have reported inheritance of mitochondria and mitochondrial DNA
(mtDNA) after NT procedures. Sheep (Evans et al., 1999) and calves (Takeda et al., 1999)
produced by somatic cell NT have been reported to inherit their mitochondria entirely from the
oocyte and not from the donor cell. However, other authors have indicated the presence of
heteroplasmy after NT and the potential for mitochondrial mismatch could possibly impair
embryo development (Nagao et al., 1998a). Steinborn et al. (2000) have reported presence of
mtDNA heteroplasmy in cloned cattle generated from fetal and adult donor cells. More recently,
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mtDNA was reported to be present in somatic cell NT-derived embryos by allele-specific PCR,
direct DNA sequencing and DNA chromatography of the D-loop region (Do et al., 2002).
In humans, ooplasm transfer from fertile donor oocytes into oocytes from infertile
patients has produced the birth of healthy babies (Cohen et al., 1997, 1998). Later, heteroplasmy
was identified in 2 of 15 ooplasm transfer children using direct polymerase chain reaction (PCR)
(Brenner et al., 2000; Barritt et al., 2001b). Correspondingly, Nagao et al (1998) reported
decreased physical performance in congenic mice with a mismatch between the nuclear and the
mitochondrial genome. Since foreign mitochondria are introduced when conducting interspecies
NT procedures, it is possible that mitochondrial heteroplasmy, as well as, chromosome number
per cell, may be key factors that affect embryonic development and in utero survivability of
interspecies NT embryos.
Although two singleton pregnancies with heartbeats were established in our study, one
was lost between 40 d of gestation and the second conceptus was lost after 65 d of gestation.
Interspecific transfer of gaur (Bos gaurus) embryos into domestic cattle (Bos taurus) has resulted
in pregnancies and live offspring (Stover et al., 1981; Hradecky et al., 1988; Pope et al., 1988).
However, Hammer et al. (2001) reported poor branching of the villi and inability to penetrate
maternal caruncular crypts sufficiently, suggesting feto-maternal incompatibility between gaur
embryos and the uterus of domestic cattle. In addition, first trimester losses of more than 50% are
common for NT pregnancies in cattle (Hill et al., 1999, 2000a, 2000c, 2001a, 2001b, 2002) and
placentation abnormalities have been extensively documented for NT pregnancies (Hill et al.,
2000b, 2000c, 2001a, 2001b). Hill et al. (2000a) reported that 82% of 30 days NT fetuses did not
survive to day 90 of gestation, with more than 80% of deaths occurring between days 30 and 60,
with half of these occurring between 30 and 40 days and half between day 40 and 60 of
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gestation. The reason for the loss of the two pregnancies established in the present study remains
unclear and further research is needed in this area.
In addition, our study also found significant differences between male and female
banteng cell lines, with significantly greater cleavage and blastocyst rates for those cytoplasts
reconstructed with male adult banteng fibroblasts compared with female adult banteng donor
cells. Early in the development of female eutherian mammals, one of the two X-chromosomes is
transcriptionally inactivated (Xi) to ensure compensation for the X-linked products (Lee and
Jaenisch, 1997). An untranslated RNA, encoded by the Xist (X-inactive specific transcript) gene
that is expressed only from Xi, is necessary and sufficient for the initiation of X inactivation (Lee
and Jaenisch, 1997). In somatic cell NT, the oocyte receives one Xi and one Xa. Aberrant
patterns of X-chromosome inactivation have been reported in bovine clones derived from female
cell lines (Wrenzycki et al., 2002). Although individual variations between cell lines cannot be
overruled, it is not known whether X-chromosome inactivation and/or other epigenetic effects
may be affected by the sex of the donor karyoplasts, and this area deserves further investigation.
To our knowledge, this is the first scientific report of banteng embryos and pregnancies
produced by interspecies NT. The present study demonstrates that the bovine cytoplast supports
mitotic cleavage of banteng karyoplasts, and is capable of reprogramming the nucleus to achieve
blastocyst stage embryos and pregnancies in exotic bovids.
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CHAPTER VII
OOPLASM TRANSFER AFTER INTRESPECIES NUCLEAR TRANSFER:
PRESENCE OF FOREIGN MITOCHONDRIA, PATTERN OF
MIGRATION AND EFFECT ON EMBRYO DEVELOPMENT
Introduction
The technique of somatic cell nuclear transfer involves the removal of the nuclear DNA
of a metaphase-II-stage oocyte (enucleation) followed by the insertion of a single cell into the
perivitelline space of an enucleated oocyte or cytoplast (reconstruction). This is followed by
electrofusion, chemical activation and in vitro culture of embryos. Somatic nuclear transfer (NT)
has been successfully applied in Bos taurus and Bos indicus cattle using homologous oocytes,
resulting in establishment of pregnancies and live offspring. (Cibelli et al., 1998; Shiga et al.,
1999; Wells et al., 1999; Hill et al., 2000b, 2000c). However, the current low efficiencies of the
NT procedure, in addition to the high gestational loss and perinatal mortality, require that
numerous attempts are needed to produce live offspring (Wells et al., 1999; Colman, 2000). In
exotic or endangered species, the limited availability of both oocytes and recipients precludes the
use of traditional somatic cell NT, and an approach such as interspecies NT may be the only
alternative to produce embryos and offspring.
One of the early attempts of interspecies NT using the enucleated bovine oocyte as
recipient cytoplast was reported by Dominko et al. (1999a). In their study, karyoplasts from
monkey, sheep, pig and rat somatic cells were injected into bovine cytoplasts, resulting in
various degrees of early in vitro development. Although no pregnancies were reported, this study
indicated that the bovine oocyte is capable of supporting mitotic divisions after the introduction
of a differentiated nucleus.
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Further interspecies NT attempts using the bovine cytoplast and karyoplasts from other
species include somatic cells from pigs (Yoon et al., 2001), saolas (Bui et al., 2002), elands
(Damiani et al., 2003), horses (Li et al., 2002a; Sansinena et al., 2002), bears (Ty et al., 2003)
and humans (Cibelli et al., 2001; Chang et al., 2003). The first interspecies NT offspring was
reported for the gaur by Lanza et al. (2000), but unfortunately died within the first 48 h after
birth. Using domestic sheep (Ovis aries) as recipient cytoplasts two pregnancies were established
after interspecies NT using an exotic argali (Ovis ammon) as donor karyoplasts, but both of these
pregnancies were lost by 59 d of gestation (White et al., 1999). Subsequentlt, domestic sheep
(Ovis aries) oocytes used as recipients for mouflon (Ovis orientalis musimon) cells resulted in
one live offspring (Loi et al., 2001).
An in vitro developmental block has been previously reported using the procedure of
interspecies NT when the species of donor karyoplasts and recipient cytoplasts are far apart in
their taxonomic classification (Loi et al., 2001; Bui et al., 2002; Li et al., 2002). An 8- to 16-cell
stage in vitro developmental block has been reported for the pig (Yoon et al., 2001), horse (Li et
al., 2002; Sansinena et al., 2002) and llama (Sansinena et al., 2003a) when using bovine recipient
cytoplasts. Progression through the early stages of embryogenesis is regulated by maternally
inherited gene products derived from the ooplasm. Development beyond the early stages
becomes dependent on embryonic gene activation at a species-specific developmental stage
(Telford et al., 1990). It has been suggested that although the bovine cytoplast seems capable of
supporting a few mitotic divisions, heteroplasmy or mitochondrial incompatibilities may affect
nuclear-ooplasmic events occurring at the time of genomic activation (Sansinena et al., 2002).
Ooplasm or cytoplasmic donation (OT) is a technique recently developed in the human
field (Cohen et al., 1997, 1998) in which a small volume of the ooplasm from the donor oocyte
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to be injected into a recipient oocyte prior to fertilization, using the intracytoplasmic sperm
injection technique. The mechanisms by which ooplasm transplantation can restore growth and
viability of developmentally compromised embryos still remain unclear. Cellular components
that might benefit development include the pool of stored mRNAs and proteins that might
regulate oocyte function and embryo development, as well as mitochondria and other organelles.
To this date, there have been no reports of ooplasmic transfer used in combination with
interspecies nuclear transfer in an attempt to overcome the previously observed in vitro block. To
our knowledge, no reports of heteroplasmy after ooplasmic transfer or patterns of migration of
foreign mitochondria are available in animal studies.
Therefore, the objectives of this study were to establish a repeatable procedure for
ooplasmic transfer in combination with nuclear transfer in the cow. In addition, the presence and
pattern of migration of foreign mitochondria after ooplasmic transfer procedure was investigated.
Finally, the effect of the transfer of caprine ooplasm into bovine oocytes used as recipients for
interspecies NT in the goat was examined.

Materials and Methods
Experiment 7.1
Preparation of Bovine and Caprine Donor Cells
Adult fibroblasts were isolated from 6-mm skin biopsies taken from one mature, cycling
mixed breed beef cow (body condition score 6, scale 1 to 9) and one mature, cycling Spanishtype crossbred doe (body condition score 5, scale 1 to 9). The primary cell cultures were
obtained as previously described (Reggio et al., 2001). Briefly, dermal tissue was minced using
sterile curved scissors in a 35 x 10-mm Falcon™ petri dish (Becton and Dickinson, Lincoln
Park, NJ). Culture medium consisting of TCM-199 (Gibco, Grand Island, NY) with 10% fetal
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bovine serum (FBS, HyClone, Logan, UT) and 0.1% gentamicin (Gibco) was added to the petri
dish. Tissue samples were washed by swirling the tissue suspension in a 15-mL centrifuge tube
and allowing the tissue to settle to the bottom. The supernatant was discarded and 3 mL of fresh
culture medium was added to the tube. This process was repeated three times, after which tissue
was transferred to a 35-mm petri dish. All but 500 to 700 µL of excess medium was aspirated.
Cell cultures were conducted at 38.5ºC and 5% CO2 in humidified atmosphere.
Once a fibroblast cell layer was established (~7 to 10 d), cells were grown in 25-cm2
tissue culture flasks (Costar™, Cambridge, MA) until they reached 95% confluency. Cells were
then treated with 0.25% trypsin-EDTA (Sigma, St. Louis, MO), counted with a hemocytometer
and re-seeded at a density of 100,000 cells in 25-cm2 tissue culture flasks. After two
subpassages, cultured cells were exposed to a cryoprotectant solution consisting of TCM-199,
20% calf serum, 5% dimethylsulfoxide (DMSO) and frozen in aliquots of 500,000 cells/mL of
cryoprotectant in 1.5 mL CryoTubes™ (Nunc, Fisher Scientific, Pittsburgh, PA). To prepare
adult fibroblasts as donors for NT, cells were thawed in the water bath at 37˚C for 1 min and
cultured in TCM-199 containing 10% FBS and 0.1% gentamicin in 25-cm2 tissue culture flasks.
Bovine Oocyte Preparation
Abattoir-derived bovine oocytes were collected (Ovagenix, San Angelo, TX), matured
overnight and shipped by air courier. After 18 to 22 h of maturation, cumulus-oocyte complexes
were exposed to vortexing for 2 min in TCM containing 1.2 mg/mL of hyaluronidase (Sigma) to
remove the cumulus investments. Mature, metaphase-II oocytes were selected based on the
visualization of a first polar body, and randomly assigned to treatment groups.
Treatment groups consisted of ooplasmic transfer followed by nuclear transfer in the cow
(OT-NT, Treatment A), nuclear transfer followed by ooplasmic transfer in the cow (NT-OT,
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Treatment B) and parthenogenically activated cow oocytes served as a laboratory control
(Treatment C) (Table 7.1).
Ooplasmic Transfer
Oocytes were manipulated in modified TL-HEPES (mTLH; TL-HEPES supplemented
with 10% FBS and 0.1% gentamicin) in two elongated, parallel 120-µL droplets overlaid with
mineral oil, one containing the oocytes to be used as ooplasmic donors and one containing the
oocytes to be used as ooplasmic recipients. Micromanipulations were conducted on the heated
stage (39°C) of an inverted microscope (Nikon Diaphot) equipped with Hoffman Modulation
Contrast objectives, Narishige micromanipulators and epifluorescent illumination. A 120-µm
diameter (o.d.) pipette was used to hold the oocytes by negative pressure.
Ooplasm from the donor oocyte was aspirated into a 7 µm (o.d.) glass pipette until the
oolema was ruptured. Ooplasm was taken from the pole opposite to the polar body to avoid the
metaphase spindle and it was aspirated until it filled about 200 µm of the micropipette (~ 5% of
the total volume of the oocyte). Aspirated ooplasm was then injected into the recipient oocyte.
The oolema of the recipient oocyte was also ruptured by partial aspiration into the micropipette,
and both donor and recipient ooplasm were deposited into the pole opposite to the metaphase
spindle (Figure 7.1).
Nuclear Transfer
Nuclear DNA was labeled with 3 µg/mL of Hoechst-33342 for 3 min. Oocytes were then
washed in mTL-HEPES and placed in working groups of 25 oocytes in an elongated 150-µL
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Table 7.1. Experimental design for Experiment 7.1: Nuclear transfer (NT) and ooplasm transfer
(OT) in the cow
Treatment group

Experimental procedure

Treatment A

Ooplasm Transfer (OT) followed by Nuclear Transfer (NT)

Treatment B

Nuclear Transfer (NT) followed by Ooplasm Transfer (OT)

Treatment C

Parthenogenically activated bovine oocytes
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1st
polar body

Aspirate ooplasm from donor oocyte

DONOR OOCYTE

1st
polar body

Inject ooplasm into recipient oocyte

RECIPIENT OOCYTE

Figure 7.1. Ooplasm transfer procedure for oocytes.
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micromanipulation droplet containing 6 µg/mL of cytochalasin D (Sigma) overlaid with embryo
tested mineral oil (Sigma). All micromanipulations were conducted on the stage of an inverted
microscope (Nikon Diaphot) equipped with Hoffman Modulation Contrast objectives, Narishige
micromanipulators, Uniblitz VMM-D1 shutter system (Vincent Associates, Rochester, NY) and
epifluorescent illumination. A 120-µm diameter (o.d.) pipette was used to hold the oocytes by
negative pressure. After a brief exposure (<5 s) to ultraviolet light to visualize nuclear DNA, the
metaphase spindle and polar body with a small amount of surrounding ooplasm were removed by
negative pressure applied to an enucleation pipette (20-µm o.d., 35º bevel, spiked). Once
enucleated, the cytoplasts were held in modified TCM (mTCM; TCM-199 supplemented with
10% FBS and 0.1% gentamicin) at 38.5ºC and 5% CO2 in humidified air.
Cow adult fibroblasts were used as nuclear donors at passage three of culture. Donor cells
were serum starved (0.5% FBS) for 3 to 5 d prior to the NT procedures. Reconstruction was
performed in working groups of 25 cytoplasts in a 200-µL elongated droplet of mTLH
containing 6 µg/mL of cytochalasin D overlaid with embryo tested mineral oil (Sigma). A single
adult cow fibroblast (15 to 20 µm in diameter) was inserted into the perivitelline space of an
enucleated oocyte. Fusion of karyoplast-cytoplast couplets was performed in a microslide fusion
chamber with stainless steel electrodes separated by a 1-mm gap and the chamber was filled with
fusion buffer (0.3 M mannitol, 0.1 mM MgSO4⋅7H2O, 0.05 mM CaCl2, 0.5 mM HEPES and 4
mg/mL of BSA (Fraction V, Sigma). The couplets were then fused by two consecutive DC
pulses (1.9 kV/cm for 25 µs) delivered by a BTX Electrocell Manipulator 200 (Gentronics, San
Diego, CA). Couplets were evaluated for fusion by microscopic examination within a 1-h period.
At this time, oocytes randomly allocated to parthenogenic activation treatment group (Treatment
C) were placed in the microslide fusion chamber and pulsed once (1.9 kV/cm for 25 µs) to
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initiate activation. Chemical activation of all treatment groups was performed by a 4-min
exposure to 5 µM of ionomycin (Sigma) followed by 5 min in TL-HEPES with 30 mg/mL of
BSA (Fraction V, Sigma) and 2-h incubation in 10 µg/mL of cycloheximide (Sigma) with 6
µg/mL of cytochalasin D prepared in CR1aa medium (Rosenkrans et al., 1993). Embryos were
cultured in 35-µl droplets of CR1aa medium in a modular incubator chamber (BillupsRothenberg, Del Mar, CA) at 38.5ºC and 5% O2, 5%CO2 and 90% N2 humidified atmosphere.
Embryos were checked for cleavage after 3 d of in vitro culture, the medium was then replaced
with CR1aa with 5% FBS and blastocyst production was checked at days 7 and 9 (fusion = d 0)
of in vitro culture.
Statistical Analysis
Mean cleavage rates and embryo development rates were compared across treatment
groups by Chi-square analysis (SAS Institute, 1985). In this study, different mean values
between treatment groups were considered statistically significant at the P<0.05 level.

Experiment 7.2
Mitochondrial Staining of Donor Ooplasm
Oocytes to be used as ooplasmic donors were stained with 200 nM of MitoTracker Green
FM (M-7514, Molecular Probes Inc., Eugene, OR) in mTCM (mTCM; TCM-199 with 10% fetal
bovine serum and 0.1% gentamicin) for 45 min. Stained oocytes were washed for 30 min in
mTCM and were then placed in micromanipulation droplets of mTLH for ooplasmic transfer.
Ooplasmic transfer and nuclear transfer procedures were conducted as described in Experiment
7.1. Couplets were cultured in 35-µL droplets of CR1aa medium in a modular incubator chamber
(Billups-Rothenberg, Del Mar, CA) at 38.5ºC and 5% O2, 5%CO2 and 90% N2 humidified
atmosphere and imaged for the presence and distribution of labeled mitochondria at 12 (pre-
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cleavage), 72 and 144 h post-fusion. Fluorescence was assessed using a Leica TCS SP2 laser
scanning confocal microscope using a 20X objective at excitation (ex) of 490 nm and emission
(em) of 516 nm (Figure 7.2).

Experiment 7.3
Surgical Goat Oocyte Retrieval
All does were maintained in accordance with the Institutional Animal Care and Use
Committee Guidelines at Louisiana State University. Does were implanted subcutaneously (d 1)
on the dorsal side of the ear with a 3-mg norgestomet implant (Synchro-Mate B, Rhone Merieux,
Athens, GA) and then subjected (d 6) to ovarian superstimulation (i.m.) by twice daily
administration of pFSH (Sioux Biochemical, Sioux Center, IA) in a decreasing total dose of 50
units/doe (10, 7.5, 5, 2.5). Implants were then removed and does were aspirated 24 h after the
final FSH injection. Cumulus-oocyte complexes (COC) were harvested as previously described
(Reggio et al., 2001) and placed in groups of 10 to 15 oocytes in 35-µL droplets of maturation
medium overlaid with mineral oil. Maturation medium consisted of TCM-199 supplemented
with 10% goat serum (Sigma), 10 µg/mL of LH, 5 µg/mL of FSH and 1 µg/mL of estradiol 17β
and COC were allowed to mature for 18 to 22 h.
Cumulus-oocyte complexes were vortexed for 1.5 min in TCM containing 0.6 mg/mL of
hyaluronidase (Sigma) to aid in the removal of cumulus investments, metaphase-II oocytes were
selected based on the visualization of a first polar body and maintained in mTCM at 38.5°C and
5% CO2 in humidified air until they were used as ooplasmic donors.
Bovine Oocyte Preparation
Abattoir-derived bovine oocytes were obtained and prepared as described in Experiment
7.1. Metaphase-II bovine oocytes were selected and randomly assigned to treatment groups.
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Somatic cell nuclear transfer

Ooplasm transfer
(donor oocytes stained with MitoTracker green)

Confocal assessment of reconstructed embryos
(12, 72 and 144 h post-fusion)

Figure 7.2. Flow chart of experimental procedures for Experiment 7.2.

124

Treatment groups for this experiment consisted of interspecies NT using enucleated bovine
oocytes and goat adult fibroblasts as karyoplast donors followed by the transfer of goat ooplasm
(Interspecies NT-OT, Treatment A), interspecies NT only (Treatment B) and parthenogenically
activated bovine (Treatment C) and caprine (Treatment D) oocytes served as a laboratory control
(Table 7.2).
The transfer of goat ooplasm into bovine oocytes (Figure 7.3) was conducted as described
in Experiment 7.1. Nuclear transfer procedure was performed as described in Experiment 7.1,
except goat adult fibroblasts were used as nuclear donors at the third subpassage of culture.
Chemical activation of all treatment groups was performed at approximately 24 to 26 h
post IVM by a 4-min exposure to 5 µM of ionomycin (Sigma) followed by 5 min in TL-HEPES
with 30 mg/mL of BSA (Fraction V, Sigma) and a 2-h incubation in 10 µg/mL of cycloheximide
(Sigma) with 6 µg/mL of cytochalasin D prepared in CR1aa medium (Rosenkrans et al., 1993).
In vitro culture of embryos was conducted as described in Experiment 7.1.

Results
Experiment 7.1
This experiment was conducted in replicates. In 2 replicates the sequence of events was
OT followed by NT (Treatment A) and in 2 replicates the sequence of events was NT followed
by OT (Treatment B). In addition, a parthenogenic control (Treatment C) was included in each of
the replicates. All the replicates of the experiment yielded blastocysts following 7 d of in vitro
culture. Development of embryos and parthenogenically activated oocyte control is summarized
in Table 7.3.
Of a total of 48 reconstructed couplets in Treatment A (OT – NT), 65% fused following
two electrical pulses. Of the fused couplets, 87% of the embryos cleaved, 48% reached the
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Table 7.2. Experimental design for Experiment 7.3: Interspecies nuclear transfer (NT) using
bovine oocytes and goat donor cells in combination with transfer of goat ooplasm (goat OT)
Treatment group

Experimental procedure

Treatment A

Interspecies NT – goat OT

Treatment B

Interspecies NT

Treatment C

Parthenogenically activated bovine oocytes

Treatment D

Parthenogenically activated caprine oocytes
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1) Interspecies NT
(cow - goat)

Goat somatic cell

Cow oocyte (recipient)

Inject goat ooplasm

2) Ooplasm
transfer
Interspecies NT
couplet

Goat oocyte

Figure 7.3. Experimental procedure of interspecies NT (cow oocyte-goat donor cell) in combination
with OT (goat ooplasm) for Experiment 7.3.
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Table 7.3. Development of embryos after nuclear transfer (NT) and ooplasm transfer (OT) in the cow
Treatment
group

No. of M II1
oocytes

No. (%)
fused

No. (%)
cleaved

No. (%)
BLST2 (d 7)

A (OT-NT)

48

31 (65)

27 (87)

15 (48)

10 (32)

15 (100)

B (NT-OT)

45

33 (73)

28 (85)

13 (39)

9 (27)

13 (100)

C (Parthenogenic)4

55

-

44 (80)@

20 (36)

14 (25)

20 (100)

1

M II = metaphase-II spindle.
BLST = blastocysts.
3
HBLST = hatched blastocysts.
4
Parthenogenic control consisted of chemically activated bovine oocytes.
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation.
2
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No. (%)
No. (%) nucleated
3
HBLST (d 9)
blastomeres

blastocyst stage in 168 h and 32% hatched after 216 h of in vitro culture. Of a total of 45
reconstructed couplets in Treatment B (NT – OT), 73% fused after two electrical pulses. Of the
fused couplets, 85% of the embryos cleaved, 39% reached blastocyst stage in 168 h and 27% of
the blastocysts hatched after 216 h of in vitro culture. Of a total of 55 parthenogenically activated
bovine oocytes in Treatment C, 80 % of the embryos cleaved, 36% reached the blastocyst stage
in 168 h and 25% hatched after 216 h of in vitro culture.
Presence of nuclei was confirmed in all blastocysts by Hoechts-33342 (Figure 7.4). There
were no significant differences in the number of fused couplets among treatment groups. Also,
no significant differences were found in embryo cleavage, blastocyst and hatching rates among
treatment groups.

Experiment 7.2
The findings from embryos imaged with confocal laser microscopy at 12, 72 and 144 h
are summarized in Table 7.4. Of reconstructed couplets that were imaged at 12 h post-activation
(pre-cleavage), 83% displayed a localized cluster pattern of foreign mitochondria (Figure 7.5)
and 17% did not produce a detectable signal. Of cleaved embryos that were imaged at 72 h postactivation, 75% displayed a cluster pattern of foreign mitochondria (Figure 7.6), 17% had a
dispersed pattern and 8% did not produce a detectable signal. Of cleaved embryos imaged at 144
h post-activation, 33.3% displayed a cluster pattern of foreign mitochondria, 33.33% displayed a
dispersed pattern and 33.3% had no detectable mitochondria. The localization of a typical
mitochondrial cluster is shown in Figure 7.7.
All the embryos imaged with confocal microscopy were quality-graded before they were
mounted onto microslides. The embryos were graded on a 1 to 4 scale, with quality grade-1
corresponding to excellent quality embryo with evenly-shaped blastomeres and no cytoplasmic
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a

b

100 µm

100 µm

Figure 7.4. Bovine NT-OT hatched blastocyst (Treatment B). (a) Without Hoechst-33342
staining (40 X objective). (b) With Hoechst-33342 staining (40X objective).
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Table 7.4. Laser confocal results of OT-derived mitochondria stained with MitoTracker® Green FM in embryos imaged
after 12, 72 or 144 h of in vitro culture
Time of confocal imaging
(h of IVM)
12

72

144

1

No. of
embryos
12

12

9

Mitochondria present
Y
N
10

2

11

1

6

3

Embryo quality grade not available (pre-cleavage confocal microscopy observation).
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Confocal results

Embryo quality
grade

10 localized in distinct cluster

N/A1

2 undetectable

N/A1

9 localized in a distinct cluster

1 and 2

2 spread throughout cytoplasm

3

1 undetectable

4

3 clustered in a few blastomeres

1 and 2

3 spread throughout cytoplasm

3

3 undetectable

4

a

b

40 µm

40 µm

c

40 µm

Figure 7.5. A bovine NT-OT embryo imaged after 12 h of in vitro culture. White arrows indicate
presence of the fluorochrome. (a) Fluorescence MitoTracker green emission. (b) Differential
interference contrast (DIC) image. (c) Overlay.
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40 µm

Figure 7.6. Bovine NT-OT embryo imaged after 72 h of in vitro culture. The white arrow
indicates presence of fluorochrome.
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Figure 7.7. Z-stack showing the localization of MitoTracker green emission from foreign
mitochondria introduced by OT (72 h of IVC). The thickness of each section is 2-3 µm.
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fragments and a quality grade-4 corresponding to a poor quality embryo with uneven
blastomeres and cytoplasmic fragments. Embryo quality grade was not available for confocal
observations at 12 h of IVC (pre-cleavage). Of the embryos imaged at 72 and 144 h of IVC,
grade-1 and -2 embryos displayed a cluster patter of mitochondria, whereas quality grade-3
embryos displayed a dispersed pattern of mitochondria and quality-4 embryos did not emit a
signal for mitochondria.

Experiment 7.3
This experiment was conducted in replicates. The development of embryos and
parthenogenically activated oocyte control is summarized in Table 7.5. Of a total of 60
reconstructed couplets in Treatment A (cow-goat NT followed by goat OT), 52% fused
following two electrical pulses.
Of the fused couplets, 55% cleaved and all embryos arrested at the 8- to 16-cell stage. Of
a total of 55 reconstructed couplets in Treatment B (cow-goat interspecies NT only), 82% fused
after two electrical pulses. Of fused couplets, 78% of the embryos cleaved but none of the
embryos progressed through the 8- to 16-cell stage. Of a total of 40 parthenogenically activated
bovine oocytes in Treatment C, 80 % of the embryos cleaved, 40% reached the blastocyst stage
in 168 h and 22% of the blastocysts hatched after 216 h of in vitro culture. Of a total of 25
parthenogenically activated goat oocytes in Treatment D, 88 % of the embryos cleaved, 32%
reached the blastocyst stage in 168 h and 12% hatched after 216 h of in vitro culture.
Couplets from interspecies NT followed by the transfer of goat ooplasmic transfer
(Treatment A) had a significantly lower fusion rate (P<0.05) than couplets from interspecies NT
alone (Treatment B). In addition, the numbers of cleaved embryos from interspecies NT
followed by goat ooplasmic transfer (Treatment A) was significantly lower (P<0.05) than the
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Table 7.5. Development of embryos from transfer of goat ooplasm into bovine recipient oocytes of goat interspecies NT
(Interspecies NT-OT) or interspecies NT only (Interspecies NT)
No. of M II1
oocytes

No. (%)
fused

No. (%)
cleaved

No. (%)
BLST2 (d 7)

No. (%)
HBLST3 (d 9)

No. (%) nucleated
blastomeres

A (Interspecies NT-OT)

60

31 (52)a

17 (55)a

0

0

17 (100)

B (Interspecies NT)

55

45 (82)b

35 (78)b

0

0

35 (100)

C (Parthenogenic cow)

40

-

34 (80)@

16 (40)

9 (22)

16 (100)

D (Parthenogenic goat)

25

-

22 (88)@

8 (32)

3 (12)

8 (100)

Treatment
group

ab

Mean values with different superscripts in the same column are significantly different (Chi square; P<0.05).
MII = metaphase II spindle.
2
BLST = blastocysts.
3
HBLST = hatched blastocysts.
@Also exposed to fusion buffer and electrical pulse (not fused) prior to chemical activation.
1
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number of embryos cleaving from interspecies NT alone (Treatment B). However, there was no
significant difference in the number of cleaved embryos between interspecies NT alone
(Treatment B), parthenogenically activated cow (Treatment C) and goat oocytes (Treatment D).

Discussion
Early studies in the animal field lead to the ultimate implementation of the OT technique
in humans. Levron et al. (1996) conducted studies in mice that provided the basis for the first
attempts of OT in humans. Since the birth of a child was announced after OT (Cohen et al.,
1997), the technique has become the subject of debate in the human field. Its application to
overcome fertilization failures in older women has become a matter of concern due to the
possibility of heteroplasmy of mitochondrial DNA.
Meirelles and Smith (1998) have produced heteroplasmic mice after transfer of cytoplasts
followed by electrofusion and demonstrated that mitochondrial genotypes in cytoplast- and
karyotyped-reconstructed embryos were segregated during the preimplantation period. Recently,
Barritt et al. (2001b) attempted to determine if active mitochondria were transferred from human
donor oocytes to recipient oocytes, and if these mitochondria persisted in preimplantation
embryos. Their observations after 48 h showed segregation of labeled mitochondria to some, but
not to all, blastomeres and demonstrated the recipient oocyte contained a heteroplasmic
population of mitochondria after ooplasm transfer. Heteroplasmy was identified in 2 of 15
ooplasm-transfer children using direct polymerase chain reaction (PCR) (Brenner et al., 2000).
To our knowledge, the present study is the first report of the ooplasmic transfer technique
used in combination with the nuclear transfer procedure. In the first experiment, it was
demonstrated that the two procedures can be successfully combined (within the same species)
without any further effect on in vitro embryo development. Furthermore, the sequence of events
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(OT followed by NT or vice versa) did not seem to affect subsequent cleavage, blastocyst or
hatching rates. Although the fact that none of these embryos were transferred to recipients
precludes any speculations about their viability, the presence of nuclei indicated the embryos
underwent apparently normal karyokinesis in conjunction with cytokinesis.
The second experiment of our study confirmed the hypothesis that foreign mitochondria
are incorporated at the time of OT. This is in agreement with other studies conducted by
Meirelles and Smith (1998) and Barritt et al. (2001a). Our study also indicated the majority of
the foreign mitochondria remain in a distinct cluster after 72 h of in vitro culture. However, the
pattern of distribution after genomic activation seems harder to predict. Although some embryos
still showed clustering of foreign mitochondria, only 33.3% exhibited a dispersed pattern
indicating foreign mitochondria could have been relocated to other blastomeres. Constant levels
of mtDNA have been detected in mice during development from mature oocytes to blastocyst
stage, leading to suggestions that mitochondria do not replicate their genomes during this early
period of development (Pikó and Taylor, 1987; Ebert et al., 1988).
In our study, the use of MitoTracker Green FM appeared to have no detrimental effect of
subsequent embryo development. Because this probe appears to preferentially accumulate in
mitochondria regardless of its membrane potential (Molecular Probes’ Product Information), it
was chosen as a tool to identify the presence of foreign mitochondria introduced by the OT
procedure, as well as, a means to track the redistribution of foreign mitochondria during in vitro
culture. The use of this probe, however, does not allow for speculation about the level of activity
of the organelles and further studies using MitoTracker Red, a probe that accumulates in the
mitochondria according to their membrane potential, would be useful to clarify this point.
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It is known that the movement and redistribution of mitochondria is an important part of
normal cell function. Subcellular organelle dynamics are strongly influenced by interactions with
cytoskeletal filaments and their associated motor proteins (Knowles et al., 2002). In our study,
the higher quality-grade embryos (embryo quality grades-1 and -2) displayed a pattern of
transferred mitochondria clustered in a small portion of the cytoplasm. However, since embryos
had to be mounted on a microslide and covered with a coverslip for confocal imaging, we cannot
speculate whether this mitochondrial cluster was isolated in one single blastomere. It is possible
that the redistribution of organelles within the cytoskeleton is not only a function of their
association with cytoskeletal components, but also of their level of activity, the nuclearmitochondrial interactions and membrane potential and further studies are needed in this area.
The use of alternative NT techniques, such as interspecies NT, is an exciting possibility
for species with limited availability of oocytes and recipients. However, an 8- to 16-cell in vitro
developmental block has been previously reported using this procedure (Yoon et al., 2001; Li et
al., 2002a; Sansinena et al., 2002, 2003a), particularly when the species of donor karyoplasts and
recipient cytoplasts are far apart in their taxonomic classification.
Results from our third experiment indicate that the transfer of ooplasm from the same
species as the donor karyoplast into the bovine oocytes used for interspecies NT had no effect in
overcoming the in vitro block. However, the increased levels of heteroplasmy introduced after
interspecies OT may explain the decreased cleavage rates observed. Previously, Nagao et al.,
(1998a) have reported decreased physical performance in congenic mice with a mismatch
between nuclear and mitochondrial genome. It is possible that although the bovine cytoplast
appears to be capable of supporting a few mitotic divisions after interspecies OT-NT,
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heteroplasmy or mitochondrial incompatibilities may affect nuclear-ooplasmic events occurring
at the time of genomic activation.
In conclusion, the present study demonstrates that foreign mitochondria are introduced at
the time of OT and that these mitochondria tend to remain as a distinct cluster without relocation
after a few mitotic divisions. To our knowledge, this is the first scientific report of OT used in
combination with interspecies NT in an attempt to overcome the in vitro developmental block.
Further research is needed to determine the characteristics of foreign mitochondrial dynamics as
well as the replication of foreign mitochondria introduced into NT embryos.
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CHAPTER VIII
SUMMARY AND CONCLUSIONS
Although the first successful report (Wilmut et al., 1997) of the production of a live
offspring from adult somatic cell nuclear transfer (NT) marked the advent of a renewed interest
in the area, no major improvements in the efficiency of the procedure have been reported since
then. The current efficiency of the NT procedure remains disappointingly low, with most of the
laboratories reporting 3 to 4% viable offspring based on the initial number of oocytes.
Inefficiencies associated with the NT procedure include donor cell-recipient oocyte
degree of cycle synchronization (Campbell et al., 1993, 1996a; Collas and Robl, 1991; Wells et
al., 2003) differences among cell lines (Kasinathan et al., 2001; Collas et al., 1992a, 1992b;
Miyoshi et al., 2003), epigenetic alterations (Reik et al., 2001; Niemann et al., 2002; Shi et al.,
2003), aberrant patterns of gene expression (Bourc'his et al., 2001; Niemann et al., 2002; Xue et
al., 2002), placentation abnormalities (Hill et al., 1999, 2000a, 2000b, 2000c, 2001a, 2001b,
2002) and the high perinatal morbidity/mortality (Brem and Kuhholzer, 2002b; Colman, 2000;
Heyman et al., 2002). Since these inefficiencies require that numerous attempts are needed to
produce live offspring, large numbers of oocytes are needed to undertake NT experiments. In
exotic or endangered species, the limited availability of both oocytes and recipients precludes the
use of traditional somatic cell NT, and an approach such as interspecies NT may be the only
alternative to produce embryos and offspring.
In the horse, one of the largest obstacles in establishing a repeatable protocol for NT has
been the inability to collect and mature large numbers of good quality oocytes from donor mares.
The low number of follicles per ovary (Del Campo et al., 1995; Hinrichs, 1991; Hinrichs et al.,
1993), the difficulty recovering oocytes from follicles (Hawley et al., 1995) and the limited
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information regarding the process of selection of oocytes for optimal meiotic and developmental
competence (Dell'Aquila et al., 2001) have been key factors contributing to the overall
inefficiency of the NT procedure in the equine species.
The low efficiency of the somatic cell NT procedure requires that large numbers of
meiotically competent equine oocytes must be available for maturation. In vitro maturation rates
of equine oocytes have been reported by several laboratories, and are generally lower and more
variable than those of other domestic species (Hinrichs et al., 1993; Del Campo et al., 1995; Alm
and Hinrichs, 1996; Squires, 1996; Choi et al., 2000a; Hinrichs and Schmidt, 2000a; Franz et al.,
2001; Hinrichs et al., 2002; Dell'Aquila et al., 2003; Marchal et al., 2003).
With the overall objective of increasing the number of mature, metaphase-II oocytes
available for NT, a first experiment was conducted to evaluate the nuclear status of equine
oocytes matured in vitro using a sequential maturation medium. A second study was conducted
to evaluate the effect of roscovitine prematuration in oocytes from small equine ovarian follicles
and to use these in vitro matured oocytes for equine NT procedures. Our results indicated that the
prematuration of oocytes pooled from all follicle sizes in roscovitine with follicular fluid did not
improve nuclear maturation rates obtained after permissive maturation. Our results also indicated
that the pretreatment of oocytes from small follicles in roscovitine did not have a significant
effect on the proportion of oocytes reaching the metaphase-II stage after maturation.
Our results are in agreement with previous studies that have shown that, although roscovitine was effective in maintaining the oocytes in meiotic arrest, the nuclear maturation rates
were not significantly affected by the preincubation treatment (Khatir et al., 1998; Mermillod et
al., 2000; Ponderato et al., 2001; Franz et al., 2002). In addition, when roscovitine pre-incubated
equine oocytes were used for NT in our study, no fusion of karyoplast and cytoplast was
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observed and no subsequent cleavage was attained. Because the roscovitine-treated oocytes
remained in culture for as long as 84 h, it is possible that membrane stability might have been
compromised. This would explain the lack of fusion in that treatment, and more research is
needed to clarify this point.
The llama, a member of the Camelidae family, has not been cloned to date. The
application of the NT technology to the llama industry could be helpful in the propagation of
genetically valuable animals. Also, future experiments in interspecies NT using llama oocytes as
hosts and vicuña donor cells could potentially aid in the conservation and propagation of
endangered species. A study was conducted with the objective to produce NT llama embryos and
to compare their development in two different in vitro culture conditions. This resulted in the
first scientific report of somatic cell NT, in vitro culture and transfer of NT embryos in the llama
(Sansinena et al., 2003b). Furthermore, our results showed that although llama oocytes appeared
darker than goat oocytes, the micromanipulation protocol previously used for the goat in our
laboratory (Reggio et al., 2001) was effective in the enucleation and reconstruction of llama
oocytes. It was demonstrated that llama NT transfer embryos can be produced from traditional
NT protocols and these results have implications not only in the conservation of superior
genetics in the llama, but also in future applications of NT technology for the conservation of
endangered species.
Because large numbers of oocytes from horse and llama oocytes are expensive and
difficult to obtain, a series of experiments was conducted to examine the aptitude of the cow
oocyte as a ‘Universal Recipient’ for NT as well as its capability to reprogram nuclei from
different species. At the time of the initiation of these experiments, only a few reports of
interspecies NT were available. In one of the first studies exploring the potential of the bovine
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oocyte as a universal recipient for NT, skin fibroblast cells from cows, sheep, pigs, monkeys and
rats were used as sources of nuclei; undergoing progression through the cell cycle to achieve
various degrees of development (Dominko et al., 1999a). However, this study failed to control
for parthenogenesis and efficiency of enucleation, which raised some questions about the validity
of their results.
The results of our interspecies studies showed that the bovine recipient ooplasm is
capable of reprogramming somatic nuclei from other species. The fact that horse and llama
interspecies embryos progressed through a few mitotic division indicated that the factors
contained in the bovine ooplasm were capable of reprogramming the foreign nucleus and driving
cell division. In addition, significant differences were found in the development of equine
interspecies NT embryos, suggesting the interspecies model could be used as a tool for cell line
cloning efficiency.
However, an important finding of our interspecies study was that neither horse nor llama
interspecies NT embryos progressed to the blastocyst stage, with all embryos arresting
consistently at the 8- to 16-cell stage in vitro. Interestingly, this stage corresponds to the timing
of maternal to embryonic genomic take-over of development reported for the cow (Telford et al.,
1990; Memili et al., 1998). These findings suggested that, although the bovine cytoplast seemed
capable of supporting a few mitotic divisions, heteroplasmy or mitochondrial incompatibilities
may affect nuclear-ooplasmic events occurring at the time of genomic activation.
Our next interspecies NT experiment aimed at the study of the previously observed in
vitro developmental block. It was hypothesized that nuclear-ooplasmic interactions could be
species-specific and therefore, if more closely related donor cell and recipient oocytes were used
(domestic cow and an endangered bovid, the banteng) the in vitro developmental block could be
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overcome. The results of our study showed that no in vitro developmental block was detected
using the banteng as donor karyoplasts and the bovine cytoplast and embryos proceeded beyond
the 8- to 16-cell stages to achieve high blastocyst rates. Moreover, two pregnancies with
heartbeats established from the male cell line indicated these were actually initially viable
embryos. Although the two pregnancies were subsequently lost after 40 and 65 days of gestation,
respectively, the study demonstrated that the bovine cytoplast supports mitotic cleavage of
banteng karyoplasts, and is capable of reprogramming the nucleus to achieve blastocyst stage
embryos and pregnancies in exotic bovids.
In addition, at the time of writing this dissertation, two cloned banteng births were
announced from interspecies NT by a joint effort between a private biotechnology company
(Advanced Cell Technology, Worcester, MA), Trans Ova (Sioux Center, IA) and the San Diego
Zoo (San Diego, CA). One was euthanized 2 days after birth due to respiratory failure and the
other remains alive at the San Diego Zoo. No scientific publication had been made available at
the time of writing this dissertation.
Finally, a series of experiments was conducted to investigate the effect of mixed
mitochondrial populations (heteroplasmy) on early embryonic development. Previous studies had
reported mtDNA heteroplasmy in cloned cattle generated from fetal and adult donor cells
(Steinborn et al., 2000). More recently, mtDNA was reported to be present in somatic cell NTderived embryos by allele-specific PCR, direct DNA sequencing and DNA chromatography of
the D-loop region (Do et al., 2002). Presence of heteroplasmy after NT and the potential for
mitochondrial a mismatch has been suggested to impair embryo development (Nagao et al.,
1998a) and decreased physical performance has been reported in congenic mice with mismatch
between nuclear and mitochondrial genomes. Since foreign mitochondria are introduced when
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conducting interspecies NT procedures, mitochondrial heteroplasmy as well as chromosome
number, may be key factors that affect embryonic development and in utero survivability of
interspecies NT embryos.
To evaluate the effect of combine both NT and OT procedures on in vitro embryonic
development, an experiment was conducted injecting donor bovine ooplasm (ooplasmic transfer,
CT) into bovine oocytes prior to being used for NT. Subsequent embryo development to the
blastocyst stage demonstrated that the procedures of OT and NT can be successfully combined
(within the same species) without any further effect on in vitro embryo development.
Furthermore, the sequence of events (OT followed by NT or vice versa) did not seem to affect
subsequent cleavage, blastocyst or hatching rate.
In addition, by staining the donor ooplasm prior to OT with MitoTracker, we have
confirmed the hypothesis that foreign mitochondria are incorporated at the time of OT. This is in
agreement with other studies (Meirelles and Smith, 1998; Barritt et al., 2001a; 2001b). Our study
also indicated the majority of the foreign mitochondria remain in a distinct cluster after 72 h of in
vitro culture.
Finally, our research has shown that the transfer of ooplasm from the same species as the
donor karyoplast into the bovine oocytes used for interspecies NT had no effect on overcoming
the in vitro block. Interestingly, lower cleavage rates were observed after OT and this could be
due to the increased levels of heteroplasmy introduced after interspecies OT. It is possible that
although the bovine cytoplast appears to be of supporting a few mitotic divisions after
interspecies OT-NT, heteroplasmy or mitochondrial incompatibilities may affect nuclearooplasmic events occurring at the time of embryonic genome activation.

146

In conclusion, it is possible to use the bovine ooplasm to reprogram the nucleus of other
species, however, a consistent in vitro developmental block is observed when the karyoplast and
ooplast are far apart in their taxonomic classification. Although many other factors could affect
the early events in interspecies NT embryos, the increased levels of heteroplasmy or incomplete
nuclear reprogramming could be a possible explanation for the impaired nuclear-ooplasmic
interactions. Further studies using serial NT could be explored in an attempt to overcome the in
vitro embryo developmental block and the nuclear-ooplasmic incompatibilities found in interspecies NT embryos.
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APPENDIX
LIST OF ABBREVIATIONS
CB .................................................................................................................. Cytochalasin B
CD .................................................................................................................. Cytochalasin D
CHX ................................................................................................................Cycloheximide
COC ...............................................................................................Cumulus-oocyte complex
CSF .............................................................................................................. Cytostatic factor
DMAP ............................................................................................... 6-dimethylaminopurine
EGF ..................................................................................................Epidermal growth factor
FBS .......................................................................................................... Fetal bovine serum
FSH ...........................................................................................Follicle stimulating hormone
GV................................................................................................................Germinal vesicle
GVBD ....................................................................................... Germinal vesicle breakdown
ICM .................................................................................................................Inner cell mass
IGF .................................................................................................Insulin-like growth factor
IVC.................................................................................................................. In vitro culture
IVF .......................................................................................................... In vitro fertilization
IVM...........................................................................................................In vitro maturation
LH ......................................................................................................... Luteinizing hormone
M I....................................................................................................................... Metaphase-I
M II ....................................................................................................................Metaphase-II
MAP................................................................................... Mitogen-activated protein kinase
MPF........................................................................................... Maturation promoting factor
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mtDNA................................................................................................... Mitochondrial DNA
NEBD....................................................................................... Nuclear envelope breakdown
NT ................................................................................................................. Nuclear transfer
OT ............................................................................................................... Ooplasm transfer
PCC ................................................................................. Premature chromatin condensation
TCM................................................................................................... Tissue culture medium
TUGA .................................................... Transvaginal Ultrasound-guided follicle aspiration
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